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Preface 
 In conducting this study on the Social Patterns and Pathways of HIV Care 
among HIV-Positive Transgender Women it was my ambition to shed light on a 
population of women who are often overlooked, ridiculed, and misunderstood. I 
made it my personal mission to give voice to these women who were essentially 
voiceless and hidden, and to educate my peers and colleagues about the need to 
include them in research, and to treat them as human beings. 
When I presented my idea for this study to the faculty in the T32 Health 
Behaviors Research Training Program in 2010 I was met with some resistance 
and encouraged to pursue a different topic. The concerns of the faculty were 
valid in that I could not answer the basic questions of, “How many people are 
transgender?” and “How many transgender people have HIV? All that I had to go 
on at the time were estimates from surveys that had been conducted in large 
metropolitan areas and a small, but slowly growing body of literature that 
suggested it was time to pay attention to the transgender population. 
Unfortunately it was not enough for me to say, “Well, we need to do this study 
because so little is known about this population.”  
Fortunately, as I was preparing my F31 application in the spring of 2011, 
the Institute of Medicine released its groundbreaking report: The Health of 
Lesbian, Gay, Bisexual, and Transgender People: Building a Foundation for 
Better Understanding. I vividly remember the day that this report was released 
because I received an email from Dr. Susan Rawl with a link to the IOM report 
that read, “What an awesome argument you are making for the need for this 
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important study. Congrats!” This was huge victory and game-changer for me in 
that it gave credence to my proposed dissertation topic and gave me the 
momentum to push forward. 
As I progressed through course work, attended various conferences, and 
talked to people in the community about my work I quickly learned that everyone 
was not an advocate for transgender health. I was often (and still am) asked 
questions like, “How can you work with those people?” To which I would politely 
respond, “Because they are people, and they matter.” We often talk about the 
stigma, discrimination and prejudices that people have towards gender and 
sexual minority populations. But we rarely talk about the stigma and 
discrimination towards researchers who are involved in HIV and LGBT research. 
This is something that I have personally experienced. Since pursuing the topic of 
HIV in transgender women, I have been asked (or it has been assumed) 
questions such as: “Are you a lesbian?” “Are you HIV-positive?” “Do you believe 
that being transgender is a sin?” Fortunately, I have tough skin-you have to in 
this line of work, so these questions did not emotionally distress me. But what 
these experiences have done is make me more empathetic and compassionate 
towards transgender people and other LGB people who live with this chronic 
stress and discrimination every day.  
I am often curious as to why people feel entitled to interrogate me or other 
researchers involved in similar work about our gender and sexuality; particularly 
when these questions are not asked of scientists who conduct research in other 
areas such as cancer, diabetes, asthma and so on. I think it speaks to the 
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pervasiveness of homophobia, heterosexism, and sexual prejudice in our society, 
and helps explain why transgender and other LGB health issues and concerns 
were ignored for so long. This phenomenon that is still very perplexing to me and 
perhaps is something that I will explore more formally later on in my research 
career.   
In the four years since the preliminary work for this dissertation study 
began, transgender health issues have become a top research priority and the 
NIH and other national agencies have earmarked more funds towards research 
in this area. Also in the last four years we have witnessed an uprising within the 
transgender population. Now, more than ever we see transgender people being 
celebrated in pop culture, being cast in television series, signing major book 
deals and modeling contracts, and more than anything, demanding equal rights. 
While progress is being made, we must be mindful that the transgender 
population is not a monolithic group and that the transgender men and women 
that mainstream society encounters via social media and pop culture enjoy a 
certain amount of social and class privilege that is not awarded to the average 
transgender person in this country. Therefore we must continue to advocate for 
equality and acceptance for the transgender men and women who exist outside 
the realm of stardom. Still, this remains a very exciting time for transgender 
people and transgender allies in this country, and I am very excited to be part of 
this movement and to be a pioneer for nursing-led transgender health research.  
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Dana D. Hines 
SOCIAL PATTERNS AND PATHWAYS OF HIV CARE AMONG HIV-POSITIVE 
TRANSGENDER WOMEN 
Transgender women have the highest HIV prevalence rates of all gender 
and sexual minorities, yet are less likely to enter and be retained in HIV care. As 
a result, they are at high risk for HIV-related morbidity and mortality. This study 
aimed to describe the illness career of transgender women living with HIV and to 
describe how interactions with health care providers and important others 
influenced their illness trajectory. The findings are a theoretical model that 
includes four stages: Having the world come crashing down, shutting out the 
world, living in a dark world, and reconstructing the world. Relationships within 
the social network (family, friends, and romantic partners) and the network of 
health care providers provided the context of the women’s illness careers. Pivotal 
moments marked movement from one phase to the next. Having the World 
Crashing Down was the first stage that occurred when the participants were 
diagnosed with HIV. They felt that their lives as they knew them had been 
destroyed. They indicated that the “whole world just shattered” the moment they 
found out they had HIV. Shutting Out the World occurred next. During this stage, 
many participants experienced withdrawal, denial, social isolation and loneliness. 
As they struggled with their diagnosis, they often avoided HIV care and avoided 
contact with important others. During the third stage, Living in a Dark World, 
participants descended into a dark phase of self-destructive life and health-
threatening behaviors following their diagnosis. During the fourth stage, 
 
 
xiii 
Reconstructing the World, participants began to reestablish themselves in the 
world and found new ways to reengage with important others and resume 
meaningful life activities. Findings confirm that the illness careers of HIV-positive 
transgender women are influenced by the social context of the health care setting 
and interactions with health care providers and important others. 
Claire Burke Draucker, PhD, RN, FAAN, Co-Chair 
Barbara Habermann, PhD, RN, FAAN, Co-Chair  
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Chapter I: Introduction 
Significance of the Problem 
 
Human Immunodeficiency Virus (HIV) continues to be one of the most 
significant and preventable diseases threatening public health in the world. In the 
US alone there are more than one million people currently living with HIV.1 
Despite public health interventions such as condom use and needle exchange 
programs aimed at reducing behavioral risks and new prevention strategies such 
as pre-exposure prophylaxis (use of antiretroviral treatment2 in uninfected, high-
risk populations), there are approximately 56,300 newly reported cases of HIV 
each year.1,3,4 Of the one million people livings with HIV/ Acquired 
Immunodeficiency Syndrome (AIDS), 42-59% of do not receive HIV care, and 
nearly one third fail to make their initial medical visit to establish care.5-12   
Timely access to HIV care and treatment following an initial HIV diagnosis 
and retention in care throughout the course of illness plays a vital role in reducing 
HIV transmission and decreasing HIV-related morbidity and mortality. 5-7,10-16 
However, more than one-third of all new HIV cases are diagnosed late, meaning 
that AIDS progression occurs within one year or at the same time of the initial 
HIV diagnosis.1,17 Advanced disease progression at initial diagnosis suggests 
missed opportunities for HIV testing, delays access to recommended anti-
retroviral therapies, which can reduce HIV transmission rates,1,17 and contributes 
to the more than 18,000 AIDS related deaths that occur annually in the US.18 
Lack of routine HIV testing also contributes to poorer health outcomes, 
particularly among high-risk populations such as African Americans, intravenous 
 
 
2 
drug users, men who have sex with men (MSM), African American transgender 
women, and Hispanic/Latinos,19-21 and higher medical expenditures.1,17   
Human Immunodeficiency Virus among Lesbians, Gay, Bisexual and 
Transgender Populations 
 
Data on HIV transmission among women who have sex with women, or 
lesbians, is scarce. Though female-to-female transmission is plausible, there 
have been no confirmed cases of female-to-female transmission in the US.22,23 
Similar to the transgender population, the lack of data on HIV transmission 
among lesbians has resulted in this population being ignored within the broader 
spectrum of HIV research.23-25 By comparison, gay and bisexual men (men who 
have sex with men or MSM) are most severely impacted by HIV and accounted 
for more than half of all newly diagnosed cases of HIV in the US from 2008-
2010.3 Within this subpopulation of MSM, Black MSM aged 18-25 have the 
highest rates of new infection.3 26   
Male to female (MTF) transgender women are biological men who identify 
and live their lives as women. Transgender women are often classified within the 
population of MSM, yet have unique social and behavioral characteristics that 
has led to them being one of the sub-populations most severely impacted by 
HIV.21,27  
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Transgender Population 
 The transgender population makes up an estimated 0.5 to 1 percent 
(about 700,000) of the US population.28,29 Estimates vary in part because 
transgender persons often identify themselves as their psychological, rather than 
natal, gender and because the varying definitions of transgender are difficult to 
standardize for population-based surveys.28,30 Lack of conceptual clarity 
regarding transgenderism, the absence of direct survey questions about 
biological sex at birth and preferred gender identity, and fear of discrimination 
associated with claiming a transgender identity are among the other major 
factors contributing to these poor estimates.28,31,32 
 In its broadest sense, the term transgender is used to characterize people 
whose gender identity, expression or behavior, does not conform to the norms 
and expectations traditionally associated with their biological sex assigned at 
birth.30,31,33-38 Within the transgender spectrum are gender subgroups which 
include cross-dressers (transvestites), transsexuals, gender-queer, male-to-
female, and drag queens/kings.32,36,39 Collectively this group may also be 
referred to as gender variant or gender-nonconforming people.40,41 These 
classifications are not static, have diverse meanings and interpretations,25,37 vary 
widely among racial and ethnic groups, cultures,42 and among transgender 
people themselves. In addition, all people in the transgender community do not 
readily accept these classifications.32,39 Because this study focuses on 
transgender women, it is essential to clarify, to the extent possible, the variations 
and areas of overlap within the broad category of transgender. The term 
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“transgender” will be used to describe the participants in this study because it is 
considered broad enough to encompass the wide range of gender variant people 
or subgroups that fall within the larger classification of transgender.40,43 A brief 
description of each subgroup follows. 
  Cross-dressers, also known as transvestites41 are biological men, usually 
heterosexual,37,39,40,44 who dress in women’s clothing, shoes, make-up, and wigs 
for sexual release and pleasure on a part-time basis.37,45,46 Cross-dressers often 
conceal their practice of wearing women’s clothing and once they have used the 
garments to complete their sexual acts, discard of the clothing.37,46 Within the 
gamut of cross-dressers or transvestites, and across the lifespan, gender 
expressions and identities vary. For instance, cross-dressing before the age of 
10 is thought to be more predictive of transsexualism, which is characterized by a 
desire to change one’s biological sex, and not sexual gratification.40,45  
“Committed cross-dressers”, are men who regularly dress in women’s clothing as 
part of their dual gender identity and in order to, express their feminine identity 
and play a feminine role.37        
 Transsexuals (TS) are biological men who cross dress as a means for 
expressing their psychological female gender identity, not to experience eroticism 
or sexual pleasure, and who desire sexual reassignment surgery and other 
physical transitions.37,39,41,45 Transsexuals often feel strongly that they were born 
into the wrong body and, as a result, experience a great amount of psychological 
and emotional distress. This distress is often categorized as Gender Dysphoria 
(GD). GD, previously known as Gender Identity Disorder and Gender 
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Incongruence in the DSM-V,37 and as pathological mental disorder among other 
helping and psychiatric professions.39,41 A more detailed discussion of GD is 
presented in the Illness Career section.   
 Gender-queer refers to the deliberate mixing and matching of gender roles 
and gender-assumed clothing, in order to defy societal assumptions about 
gender.37 Gender-queer people may or may not refer to themselves as 
transgender or may consider themselves to be androgynous,37 but usually have 
no desire to undergo sex reassignment.40 
 Male-to-female, or transwoman, refers to a biological male who has 
undergone sexual reassignment surgery, or, who identifies as a woman, but has 
not been sexually reassigned.41 Other variations of male-to-female include 
woman, transgender woman, and transsexual woman.37  
 Drag queens are usually, but not always, gay men,44 “perform” drag or 
dress as caricatures of women.37,38 Drag queens typically do not desire to have a 
woman’s body, however, some do undergo breast augmentation or acquire 
breasts through hormone therapy.44 
 Walker and Avant state that conceptual clarity on a phenomenon of 
interest allows researchers to “get inside” a concept and see how it works.47 
Further, having a clearly defined concept ensures that anyone who sees the 
concept and its definition can understand exactly what is being discussed, 
described, explained or predicted.47 As a concept “transgender” reflects the 
ambiguity that calls for a concept analysis, yet because it encompasses such an 
array of variations may defy conceptual clarity. In addition because gender and 
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sexuality, both defining characteristics of transgenderism, are fluid48 in nature 
and thought to exist along a continuum, the definition of transgender may always 
be tentative.   
Heightened Health and Human Immunodeficiency Virus Risk in 
Transgender Women 
 
 Transgender identity, sex work, drug abuse, unmonitored use of 
hormones, social norms regarding gender and sexuality, and transgender 
discrimination and stigma contribute to the heightened health and HIV risks 
among transgender women. A discussion of each factor and how it contributes to 
illness and HIV risks follows.   
Transgender Identity 
Two major factors that set transgender women apart from MSM in the HIV 
epidemic and underscore the need to treat them as a separate population is their 
need to resolve their sexual identity and gender identity confusion and their 
desires to achieve a feminine appearance and state of mind.42,49 This resolution 
often manifests itself through high-risk sex acts, such as unprotected receptive 
anal intercourse, which validates and reinforces their feminine identity.42,50-52 
Engaging in unprotected receptive anal intercourse significantly increases HIV 
risk for both MSM and transgender women. Transgender women, however, use 
this act as a means to establish social acceptance as a woman, gain emotional 
support and love from their male romantic partners, and to attain financial 
support.51,52 In addition, because transgender women often engage in 
commercial sex with heterosexual men, 53 they function as a bridge to infection to 
heterosexual women and are a key risk group for HIV transmission.54,55 
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Sex Work 
 Transgender female sex workers constitute another subset of transgender 
women who are at risk for HIV and poor health outcomes. Not having insurance 
and a regular source of medical care adds to their poor health trajectory.56   
 Sex work has been regarded as a rites of passage for transgender 
women, especially those who are younger in age and who are African American, 
and those beginning their gender transformation.57 Even young (those under 30 
years of age)56 transgender women and those who have never engaged in 
commercial sex work, embark on this path as a means of establishing ties with 
other transgender women in the community and gaining social support.57 While 
reports vary on consistency of condom use in this population, it has been 
reported that efficacy to negotiate condom use decreases during times of 
financial hardship and when transgender women can earn more money for 
performing sex acts without protection.51,56,57  
 Structural barriers such as lack of job training, educational training, and 
non-inclusive work environments potentiate their grave economic situation, 
further increases their dependency on sex work for survival, and magnifies their 
vulnerability to violence and abuse.57 Prior history of incarceration, unstable 
housing, and minimal monthly income are other structural factors that reinforce 
their economic need to remain engaged in commercial sex work and other illegal 
activities.19,30,33,55,58 Taken together, these factors potentiate the greater 
likelihood for female transgender sex workers to be victimized, physically 
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assaulted, and raped when compared to their non-transgender sex worker 
counterparts.59  
Substance Abuse 
 
 Substance abuse tends to cluster within social networks and often 
overlaps with other high risk behaviors such unregulated hormone use and 
multiple sexual partners.60 Transgender women often use drugs as a means of 
coping with the stigma and discrimination associated with their gender status and 
those involved in sex work, as a means of emotionally escaping during sex acts 
with their clients.56,57 Drug use further diminishes their ability to negotiate condom 
use during sex acts and thereby increases their risk for HIV and other sexually 
transmitted diseases.57 HIV sero-positive rates among transgender women 
engaged in commercial sex work surpass the rates of those who do not 
exchange sex for survival needs.56 In addition, they tend to have more casual sex 
partners and to engage in sex while high on drugs.56 
Hormone Use 
 Because of transgender women’s desire to achieve congruency between 
their psychological gender and physical appearance, access to hormones takes 
priority over other health concerns. Hormones are often accessed without a 
prescription, may include needle sharing,51,60-65 and may be associated with other 
behavioral risks that overlap with drug use. Unmonitored use of female 
hormones, such as estrogen, pose additional health risks for transgender women 
such as hypercoagulability, thromboembolism, mood swings, depression, insulin 
resistance, and abnormal liver enzymes.63,66,67 Long-term complications such as 
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scarring, deformity, and infections have also been reported following injection of 
large quantities of viscous fluids such as silicone and mineral oil into the face, 
buttocks, hips, thighs, calves, and breasts by unqualified persons.68,69 Life-
threatening complications such as migration of mineral and silicone oil outside of 
the original injection site to vital organs and other areas of the body, acute 
pulmonary edema, and chronic inflammation of collagen and connective tissues 
have been reported.68-70 Other adverse side effects include breast granulomata, 
chronic cellulitis, and disfigurement resulting from radical excision of scar 
tissue.68-70 Even with the potential for serious complications following illicit 
hormone injections, the desire to attain rapid feminization takes precedence.68 
Cases of breast and prostate cancers have also been reported among 
transsexual women taking therapy and risks for acquiring these hormone related 
malignancies are likely to increase with age.67,71 
 In spite of these harmful health effects, transgender women often use high 
dose combinations of hormones to accelerate feminization and may not readily 
accept HIV therapies that interfere with hormone therapy or estrogen 
levels.63,64,72 Although this study focuses on transgender women who are HIV-
positive, it is important to highlight other potential health consequences 
associated with hormone therapy as these complications, rather than HIV, may 
prompt them to seek care within the formal treatment system. 
Social Construction of Gender and Sexuality  
 In Western cultures, the lay public associates transgenderism with 
homosexuality and social deviance. 35,37,73,74 This is due, in part, to the socially 
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constructed gender binary categories of male and female (also referred to a 
biological sex), the conflation of gender with sexuality, and the dichotomous 
social expectations regarding gender roles.27,38,40,73 The social construction of 
sexuality refers to how the society in which we live and culture of which we are a 
part, shape our emotions, desires, sexual relationships, and sexual identities.75  
 Interpersonal relationships and social interactions within our social 
networks play an integral role in how we define our sexuality, express our sexual 
behaviors, and dictate with whom and how we engage in sexual encounters.75,76 
In addition, social norms, power relations, and geographical location of one’s 
social network determine how we define and normalize sexual meanings.77 It is 
through the social network that an individual learns the social and sexual 
expectations of their ascribed gender role78 and comes to accept (often without 
interrogation) the definitions of normal sexual behaviors and expressions 
established by social institutions of power such as religion, medicine, and the 
state.75-77,79   
 The term transgender is used to describe one’s gender identity and is not 
reflective of sexual or romantic practices or preferences. Therefore, it should not 
be confused with sexuality or romantic attraction.19,31-33,80 Despite their assigned 
male sex at birth and their psychological female gender, sexual orientation 
among transgender women varies. Some may identify as lesbian, others as 
bisexual, heterosexual, simply “sexual” or in other diverse ways.31,46,53 Making 
clear distinctions between gender, gender identity, sex, and sexual orientation is 
critical to comprehending the disconnect between the internal identity and 
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physical body experienced by transgender people and the societal confusion that 
often arises in regards to their gender identity and sexual orientation.30,81 Gender 
and sexual identity labels are used to form collective identities82 which are 
instrumental in organizing social networks and forming social network ties83. 
Unfortunately they are also used to pathologize and marginalize vulnerable 
groups such as transgender women. 
Transgender Stigma and Discrimination 
  In general, people living with HIV often conceal their diagnosis due to fear 
of abandonment from friends, family and HIV related stigma.84 For multiple 
marginalized communities such as transgender women, the effects of stigma are 
more physically and emotionally debilitating. The stress associated with being a 
sexual minority increases the psychological need for gender affirmation, often 
resolved through high risk sexual behaviors, drug use, and risky body 
modifications,42 and is associated with delayed HIV testing and late stage 
diagnosis.2,84 This chronic, psychological stress and anxiety also lead to negative 
health consequences such as low self-esteem, depression and suicidal 
ideation.30,74,85-88 Rates of depression are high among transgender women, and 
because of their gender identities, they, are often victims of violence and 
harassment, and often receive inadequate care for their health care needs.30,50     
  The effects of stigma and discrimination on transgender women’s health 
extend well beyond those related to their HIV status. In an effort to avoid 
discrimination, transgender women are likely to conceal pertinent health 
information from health care and social service providers and to avoid situations 
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and environments where they are not accepted.89-92 This lack of disclosure limits 
their access to appropriate health screenings for conditions such as breast and 
prostate cancers and increases their likelihood for other adverse health events.87 
Fear of harassment and discrimination also force transgender women to use 
emergency rooms for their urgent and primary health care needs, thereby 
increasing their risk for living with untreated or undertreated chronic health 
conditions such as hypertension, diabetes, and HIV. 30,87  
Human Immunodeficiency Virus/Acquired Immunodeficiency Virus 
 Although national HIV data specific to the transgender population is 
lacking, studies conducted in major metropolitan cites indicate that transgender 
women are often unaware of their HIV status due to low rates of HIV testing. 
When they are diagnosed with HIV, these women have low rates of initial and/or 
follow-up medical appointments.9,13,33,50,88,93-97 As a result, they are more likely to 
infect others and experience HIV-related complications and death. 
19,33,50,61,93,96,98-100   
A recent CDC report estimated that 27% of transgender women are HIV-
positive.101 Several other prevalence studies have reported HIV infection rates 
that range from 11-78% among transgender women; these rates are staggering 
and exceed those of all gender and sexual minorities.19,33,61,98,99 Among high risk 
groups, such as African American transgender women and transgender women 
who engage in commercial sex work, the HIV disparities widen.33,34,42,50,55,61,88,102 
Worldwide the burden of HIV in transgender women escalates to an astonishing 
rate, with recent reports showing that transgender women are 49 times more 
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likely than non-transgender persons to be HIV infected.103 These rates 
underscore the urgent need for HIV prevention, treatment, and care that focuses 
specifically on this population.   
Transgender Health Research 
HIV has long been thought of as a sexually transmitted disease that is 
acquired by socially and sexually irresponsible people. While it is true that HIV is 
transmitted sexually, it is also a complex phenomenon that results, in part, from 
individual behaviors and decision-making, that is influenced by factors in an 
individual’s social, economic and geographical environment. HIV is also a 
disease of poverty, low educational and socioeconomic attainment, and 
disempowerment, that disproportionately impacts vulnerable and minority 
populations. Risky sexual behaviors such as unprotected sexual intercourse, 
receptive anal intercourse, and multiple sexual partners, have long since been 
the primary focus of HIV public health research. The emphasis on these factors 
has obscured the influence of the social network in the epidemic and has 
resulted in the pathologization of certain races, sexual acts, gender identities, 
and sexual orientation.25,104-108    
 Public health research involving the transgender population has been 
minimal and focused primarily on sexual deviance, homosexuality, mental 
disorders, and behavioral risk factors involving sex and drug use.30-32,58,109 The 
few studies that have examined the unique health needs of the transgender 
population have done so within the collective group of other sexual 
minorities.96,110,111 Although the acronym LGBT is frequently used as an umbrella 
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term to describe lesbian, gay, bisexual and transgender persons, these 
populations are very diverse. Therefore, research findings from one group cannot 
be generalized to others, and combining groups masks differences that exist 
between them.110 In the context of HIV/AIDS research, most studies have 
focused on gay men and lesbians and with health research in general,111,112 few 
studies have focused solely on the social processes and factors that influence 
transgender women’s health care utilization.19,32,50,93,95,100,113,114 This 
epidemiological and biomedical approach to research has obscured the health 
and service utilization needs specific to the transgender population.  
 One such example is the Centers for Disease Control (CDC) and 
Prevention’s HIV/AIDS surveillance system, a national data management system 
that is used to track the HIV epidemic. Data obtained through this surveillance 
system is used to identify high risk populations, influence intervention strategies, 
and to establish priorities for HIV prevention funding.4 The CDC began 
conducting population-based AIDS surveillance in 1981; and in 1985 their 
surveillance efforts were expanded to include HIV.115 Cases of HIV/AIDS are 
reported by mode of transmission, race, ethnicity, gender as in male or female, 
but not transgender. Currently many federal, state, and local agencies do not 
collect data about individuals’ sexual orientation or gender identity, therefore data 
on individuals who fall outside of the dichotomous margins of male or female, 
and heterosexual are often not captured.88,94,109,110,116 For example, public health 
HIV surveillance categorizes transgender women as men who have sex with 
men19,109,110 even though these women do not self-identify as men. This 
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emphasis on sexual orientation (e.g. being gay or bisexual), rather than sexual 
behaviors (e.g. receptive anal intercourse regardless of sexual orientation) 
presents unique challenges for public health workers and medical providers who 
usually rely on self-report of sexual orientation to screen for HIV risk 
behaviors.53,117   
    Data obtained from leading health agencies and policy makers are used to 
establish health priorities, to monitor trends in illness and disability, and to track 
progress toward achieving national health objectives. These data are essential 
for the dissemination of reliable and public health information and critical for the 
development of meaningful prevention programs and care 
services.88,94,110,113,116,118,119 Historically, efforts to collect meaningful data on the 
transgender population have been poorly coordinated.30,110,113 This lack of 
meaningful data has contributed to significant and persistent health disparities in 
the transgender population.30,74,89-91,97,116,120-123   
Need for the Study 
In their 2011 report, The Health of Lesbian, Gay, Bisexual, and 
Transgender People: Building a Foundation for Better Understanding, the 
Institute of Medicine (IOM) advised that in order to build a solid foundation of 
evidence in transgender health research that the role of social influences and 
structures on transgender health must be examined. The role of the social 
network in the HIV epidemic has significant implications for HIV prevention and 
treatment, yet have been overshadowed by the focus on biomedical 
determinants.25 Examination of individual health utilization behaviors without 
reference to the social network in which they are embedded provides only partial 
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insight into the complex nature of their sexual practices, health behaviors, and 
patterns of health care utilization.124 This is because the interaction that occurs 
within an individual’s social network influences health behaviors and health 
outcomes.124 The IOM also recommended that inequities in accessing health 
care and transgender-specific health needs be examined.110  
Finally, the IOM suggested that the National Institutes of Health implement 
a transgender-specific research agenda designed to support research that will 
advance knowledge and understanding of transgender health and encourage 
grant applications from investigators who focus on gender minorities as their 
primary research population.110 Similarly, the National AIDS Strategy calls for 
tailored strategies to reduce the rates of new infections among sexual and 
gender minorities and facilitate their entry into and retention in care.96 Lastly, the 
IOM recommends that trans-health research be guided by a social ecological 
perspective that allows for examination of health issues in various contexts, such 
as social network ties, social demographics, and environmental factors that affect 
physical and mental health.110   
Since the release of this report, funding for transgender health research 
has flourished and transgender health has become a leading health 
priority.101,125-128 Major cities and the District of Columbia have responded by 
modifying health surveys to include questions that will capture transgender 
identity data.129,130 Additionally, national agencies such as the CDC have 
intensified their efforts to improve the quality of HIV data collected on 
transgender communities.101 Department of health officials across various states 
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have also used the IOM report to guide policy changes and to inform health 
advocacy initiatives that target the transgender communities. Finally, the number 
of global transgender and intersex activists groups have also grown significantly 
since 2011.131  
Conceptual Framework and Study Aims 
 The Network Episode Model (NEM) is a sociological, health utilization 
model that was developed in response to the need to enhance our view of how 
contexts and social network structures influence health and illness.52,132 The 
NEM is based on the premise that the social support system is the primary 
influence on individual health care utilization and proposes a concept called the 
illness career, 133-138 which refers to the dynamic social processes that undergird 
the use of health care services during illness. An illness career starts with an 
event that triggers a sequence of actions and decisions that are used to cope 
with a physical or emotional illness. Understanding transgender women’s 
experiences of how they seek, enter, and engage in HIV care is a necessary first 
step before effective behavioral and public health HIV prevention and care 
interventions can be developed to facilitate health care utilization for these 
women. 
 Using the NEM, this study explored the illness careers of HIV-positive 
transgender women and the influences of important social relationships in their 
social support system on the illness career. In addition, this study described the 
influence of health care encounters within treatment systems on the patterns and 
pathways through which transgender women are linked to HIV care, and 
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described how these processes influenced their entry and retention in HIV 
care.29,58,88,96,110,111   
 Given our limited knowledge of transgender women’s experiences with 
health care utilization and their illness career, it was critical to maintain a 
discovery-oriented approach of exploratory methods that documented 
experiences from the perspectives of these women themselves.139 Therefore, a 
grounded theory approach was used because it allowed the basic social 
structural processes and meaning of the phenomenon of interest to emerge 
naturally.139,140   
The primary aim of this study was to describe the illness careers of HIV-
positive transgender women. The illness career is characterized by all the 
attempts that an individual uses to cope with an illness episode and maps out the 
steps (timing, sequencing, and actions) they use throughout the process.136 
Throughout the illness career, an individual makes decisions about whether or 
not to seek treatment and if so, when, where and how. These decisions are 
informed by various factors including the cost and benefit of treatment, formal 
and informal health advisors in their social network, and attitudes that people 
within their social network have towards healthcare utilization.136  
The first sub-aim of this study was to describe the influence of important 
social relationships in the social support system on illness careers. Social 
support systems, social networks and communities are important for studying 
health and illness; and provide valuable sources of information about health 
resources and health promotion efforts.25 Social networks can also be used to 
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mobilize interventions141 and promote health behaviors change such as 
accessing HIV care.   
The second sub-aim of this study was to describe the influence of health 
care encounters within treatment systems on the illness careers. Healthcare 
encounters and relationships within treatment systems shape and mold the 
pathways through which an individual seeks care. These encounters and 
relationships also affect the level of satisfaction with the care experience, 
influence acceptance and adherence to treatment, willingness to trust and 
disclose pertinent health information to the members of the care team, and the 
decision to remain engaged in care.31,133,138,142 
The final analytic product of this study is a theoretical, stage model that 
addresses each of the research aims, describes how transgender women 
experience the HIV illness career, and that describes how social relationships 
and health care encounters influences movement throughout each stage. This 
model is presented is chapter four.   
Contribution to the State of Science in Transgender Health 
 This study is consistent with the national health recommendations outlined 
by several major policy makers because it focused exclusively on  HIV in 
transgender women.  88,110,112,116,118,143 In addition, it focused on identifying 
barriers and facilitators to accessing HIV care and provided insight into strategies 
that can be used to reduce disparities in health care utilization this population. 
Finally, because this study focused solely on transgender women, it 
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acknowledges their human right to be recognized as an independent 
constituency group and as actors in the national HIV epidemic.   
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Organization of the Dissertation 
 Chapter II includes a discussion of the Network Episode Model (NEM), 
which was used to guide the review of literature and to inform interview guide 
questions (See Appendix G). This will include a comprehensive review of 
literature pertaining to the social context of transgender women, the illness 
career and related concepts, and a discussion of what is known about the 
influence of social relationships and health care encounters on the illness career. 
 Chapter III describes the grounded theory methodology that was used to 
guide this study and also includes a description of the data collection, study 
procedures, and data analyses used in this study. 
 Chapter IV will include a description of the sample, the results; and will 
include a detailed description of the theory Having the World Change, a four-
stage model that describes the illness careers of HIV-positive transgender 
women. The stages include: world come crashing down, shutting out the world, 
living in a dark world, and reconstructing the world. 
 Chapter V entails a summary of the complete study, a discussion of the 
importance of the study, its contribution to the state of the science, and a 
discussion of how Having the World Change can be used to inform strategies for 
increasing HIV health utilization, reducing delays in care and improving retention; 
and for improving our understanding of how social networks and health care 
interactions influence the illness career of HIV-positive transgender women.  
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Chapter II: Review of Literature 
Network Episode Model 
 The Network Episode Model (NEM) starts with the basic premise that 
illnesses or health problems are social processes that are managed through 
social networks. It is within the social content of the individual and through their 
social ties that individuals learn about, begin to understand, and develop 
strategies to handle life’s difficulties.132,136 Social networks consists of an 
individual, who is shaped and molded through his/her interactions with others in 
their network, people or nodes,  and network ties links (connections between 
individuals).132 The network serves as a framework for describing the relationship 
structures within a particular population and for describing how behavioral norms, 
values, and attitudes determine health behaviors and disease risks.52 144   
 The NEM proposes three important concepts that have been shown to 
influence health status, health behaviors and care utilization: the illness career, 
the social support system, and the treatment system (See Appendix A).133-
135,137,138 The NEM has been used to examine lay decision-making for medical 
care, explore social processes (patterns and pathways) through which individuals 
access care for medical problems, and as a model for organizing and guiding 
studies on social epidemiology.135,137  
 This model was selected to guide this study because it provides a useful 
foundation for examining how social demographics, social networks, and social 
interactions of HIV-positive transgender women influence their illness careers. 
These three concepts informed the review of literature, which includes a 
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definition of the major concepts and a discussion of literature related to 
transgender identity, HIV as an illness, and HIV care utilization. The review will 
start with an overview of the social content or episode base for the individual, as 
it lays the foundation for understanding the social context of the transgender 
population. A discussion of the three major concepts of the NEM, the illness 
career, social support system, treatment system, and related literature will follow.      
Social Content or Episode Base 
 
 Within the social content or episode base of the NEM are specific 
variables such as gender, age, education, work and marital status, income and 
occupation that form the basis of one’s social network, social status, and social 
support system. Individually these social factors define the social group structure, 
determine the type social interactions in which an individual engages, and 
determines the geographical position of their social network members.145 Prior 
history of illness, coping style, and access to medical insurance are influenced by 
the social demographics discussed above and by social network ties. These 
factors alone (and collectively) influence the nature and quality of an illness. 
More specifically, they determine the severity, visibility, duration and type (acute 
or chronic) of illness that one endures. Together, the factors within the social 
content or episode base of the NEM function as determinants of individual and 
social network health, health behaviors and access to care.  Access to care, the 
organization of care, and the financing of care are all part of larger organizational 
constraints, which plays a significant role in how, when, or if an individual 
accesses the treatment system, and how their illness careers unfold.   
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Social Content for Transgender Women & HIV 
Social and geographical location. For transgender women, gender 
identity functions as a deterrent to medical care and a barrier to effective 
discussions regarding sexual orientation and health behaviors that is critical to 
making informed health and treatment decisions.64,88,93,95,112,146 Research studies 
on health care access among transgender women also report that they are at risk 
for not accessing or delaying health care in part due to competing financial 
priorities, low educational attainment and unemployment.147 Compared to the 
general population, transgender people are four times more likely to live in 
extreme poverty (<$10,000/year) and because of their gender status, are limited 
in their income earning capacity, and career advancement.148,149 Subsequently, 
they are less likely to occupy formal, paid labor positions that would facilitate 
access to essential social services such as health insurance, stable housing, and 
transportation.150  
  In contrast to transgender men (female-to-male), transgender women are 
more socioeconomically disadvantaged, earn one-third less income, and are 
subjected to job harassment, termination, and loss of authority.33,151 As a result of 
non-accommodating, heterosexist work environments and discrimination,  
transgender women are often forced into survival sex work, face greater risk for 
physical exploitation, violence and incarceration, and suffer from adverse health 
outcomes such as illness, disability and death.19,33,34,150,152,153     
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Personal health background. Within social networks people and health 
are inter-connected. As a result, whatever is “seated” within a network becomes 
magnified and anything that is placed within a network will spread.154 HIV, 
sexually transmitted infections (STI), health behaviors, health practices, sexual 
partners, and the like are examples of phenomena that spread throughout 
networks. In fact, studies have reported that the risk for HIV transmission 
increases within social networks that have high rates of untreated HIV and other 
sexually transmitted infections such as genital herpes and syphilis.49  
 Social networks alone do not give rise to phenomenon,154 however 
behaviors within the network can spread and sustain disease once it is initiated. 
To illustrate this point, studies conducted on populations of MSM have shown 
that co-infection with STIs such as syphilis, gonorrhea, and chlamydia are 
common among men already known to be infected with HIV.155  This is indicative 
of continued engagement in high-risk sexual behaviors following an HIV 
diagnosis. Concomitant STI present additional health threats, such as re-infection 
and super-infection to people living with HIV and increases the likelihood of 
spreading the virus through oral and rectal mucosal shedding.155 Further, studies 
on spatial clustering of HIV have shown large clusters of HIV are often situated in 
geographical areas that are largely impoverished and have large populations of 
MSM and intravenous drug users.156,157   
 Transgender women are more likely to experience chronic psychological 
and emotional stress because of their gender status or sexual orientation. The 
minority stress model is helpful in understanding how stigma and discrimination 
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create negative health consequences such as low self-esteem, depression and 
suicidal ideation.89,90 Transgender stigma and discrimination produces chronic 
psychological stress and anxiety. As a result, transgender women are prone to 
avoidant coping, which forces them to conceal their transgender bodies and 
avoid situations and environments not accepting of their gender identities.89-91  
 Avoidance coping is common among socioeconomically disadvantaged 
minorities, drug users, and women and is correlated with higher levels of 
depressive symptoms or psychological distress.30,158-160 While stigma and 
discrimination are not new actors in the HIV epidemic, when partnered with a 
transgender identity, their interaction can be devastating, resulting in avoidance 
of medically necessary care, suboptimal adherence to HIV medication, and 
poorer health outcomes.30,61,161-163  
 Compared to the general population transgender women are less likely to 
have medical insurance and those who do are more likely to have public33 or 
state insurances such as Medicaid and Medicare.158 Among racial and ethnic 
groups, Black transgender persons have the lowest rates of insurance coverage 
of all.158 Lack of medical insurance directly restricts access to medically 
necessary and preventive medical care and worsens long-term health 
outcomes.164  
 Nature of the event and illness characteristics. Service utilization rates 
tend to be higher among individuals with a diagnosis of AIDS than among those 
diagnosed with HIV only. When controlling for race and gender, Blacks report 
more frequent hospital admissions and longer lengths of stays. Illness severity 
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and functional limitations due to illness and pain often motivate individuals to 
seek care.165 
 Engagement in HIV care is often described as a spectrum that ranges 
from not being aware of one’s HIV infection with high HIV viral loads to being fully 
engaged in care with optimal viral load suppression, defined as less than 200 
copies of HIV virus per milliliter of blood.166 Despite the benefits of early 
treatment and engagement in care, nearly half of the individuals who are HIV-
positive delay care for up to one year or more and enter care with advanced 
disease progression or AIDS.10,16,167-171 Blacks and black MSM, for example, are 
more likely to be diagnosed with AIDS at first diagnosis when compared to other 
racial and ethnic groups and are less likely to have virologic suppression within 
one year of starting antiretroviral therapy (ARV).166,171 ARV therapy plays a 
critical role in HIV viral load suppression, improving health outcomes, and 
minimizing the spread of HIV infection,72,171 yet transgender women are less 
likely to adhere to prescribed antiretroviral therapies (ART).72 This suggests that 
something other than access to recommended therapies is constraining their 
utilization of health services.   
Organizational constraints. The pathways through which an individual 
must travel to enter HIV care are complex and can discourage care 
utilization.167,168,172 For example, following an initial diagnosis of HIV, an 
individual is referred to an HIV care coordinator and HIV medical specialist for a 
psychosocial needs assessment, medical exam, and if needed, initiation of HIV 
medication therapy.167,173 Once in care, continued engagement (adherence) in 
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care is necessary to achieve and sustain optimal health outcomes, yet many 
people with HIV drop out of care. Comorbidities, competing financial priorities, 
lack of transportation, substance abuse, ability to cope with an HIV diagnosis, 
presence of symptoms, and quality of relationships with health care providers are 
factors that have been shown to influence an individual’s decision to remain in 
HIV care.170,172,174,175   
 For transgender people accessing the treatment system is 
problematic.92,123 That is because erasure, or exclusion from the institutional 
world, of the transgender population within the treatment system is inherent and 
social and institutional stigma towards the transgender population has created a 
systemic avoidance,123 or erasure of trans-health and social issues.92,123 One 
such example is the exclusion of transgender health care content from medical 
and nursing school curricula.92,123,176,177 Because transgender health care is not 
part of standard medical or nursing school education, physicians and nurses are, 
by default, not prepared to provide competent care to transgender patients.92,178 
This lack of preparation threatens the quality of patient-provider communication 
and reinforces a treatment system that is intrinsically designed to be 
unresponsive to the health needs of the transgender population.92,179 
 With such oversight at the institutional level, transgender women 
encounter a number of barriers to care,9,180 have many unmet needs,66 and 
report having fewer positive encounters with their health care providers.31,42,72 
The organization and accessibility of care for transgender women may look very 
different from that of their non-transgender counterparts. Specifically, because of 
 
 
29 
their gender status, transgender women may have two to three different health 
care providers--one to manage their hormones for gender transition, another to 
manage their general health care issues, and in the case of HIV-positive 
transgender women, a third to manage their HIV disease.30 Adding to the 
organizational constraints and complexities of care utilization is a general lack of 
knowledge among physicians, nurses, and other health care providers about how 
to manage the complex health needs of transgender women.63,66,72,88,112,114,123,181 
Insensitive and insulting comments and lack of trans-friendly health care 
environments123 further inhibit their access to healthcare.31,72,92  
 The variables which form the social content or episode base for the 
individual give rise to the type and quality of one’s social support system, act as 
antecedents or predisposing factors to illness, and can determine the level and 
types of care to which one has access within the treatment system.  
The Illness Career 
 The illness career refers to the dynamic social processes that undergird 
the use of health care services during illness. An illness career starts with an 
event that triggers a sequence of actions and decisions that are used to cope 
with a physical or emotional illness.132 Throughout the illness career, an 
individual is faced with having to make decisions about whether or not to seek 
treatment and if so, when, where and how. These decisions are informed by 
various factors including the cost and benefit of treatment, the combination of 
formal and informal health advisors in their social network, and the attitudes that 
people within their social network have towards healthcare utilization.132,136  
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The illness career is composed of pathways (key entrances and exits) through 
which an individual enters and exits healthcare, as well as patterns (timing and 
sequencing) of treatment events that an individual uses to cope with an illness 
episode.133,135-138 See Appendix A, Network Episode Model (NEM).   
 The illness career of HIV-positive transgender women has not been 
thoroughly described; therefore, much of what is known about healthcare 
utilization throughout an illness episode has been derived from studies on non-
transgender persons who do not have the added stressors associated with being 
a gender minority. Since it is not uncommon for individuals to have multiple 
illnesses at once and because one illness episode can trigger the onset of a new 
illness or worsen an existing one, the illness career within the NEM is ideal for 
studying individuals who have concurrent illness episodes. More specifically, it is 
ideal for describing the illness careers of HIV-positive transgender women who, 
in essence, have two overarching illness careers: Gender dysphoria and HIV. I 
surmise that while the illness careers of being transgender and HIV positive may 
start at different time points in a woman’s life, there are likely times when the two 
illness careers intersect thereby altering their illness perceptions, health 
utilization patterns, and nature of their healthcare encounters.   
 In the next section, gender dysphoria will be discussed within the concept 
of illness. Recognizing illness, asking for guidance and referrals, and a 
description of key concepts in the illness career and related literature will follow. 
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Gender Dysphoria 
 
 The belief that transgenderism is an illness is pervasive in general society 
and among institutions such as medicine and other regulatory bodies that define 
social norms and determine insurance eligibility for, and access to, healthcare 
services.40 Yet being transgender in and of itself does not constitute illness. 
Rather it is the emotional and psychological discomfort, or gender dysphoria 
(GD) that ensues as a result of the conflict between the biological sex and the 
psychological gender that qualifies it as a psychiatric illness treatable through 
psychotherapy and medication.35,40,41,80   
 Since GD is not experienced by all transgender people it could be argued 
that not all experience illness because of their transgender identity.41 At the same 
time, transgender people who desire hormone therapy and other surgeries such 
as chest reconstruction or breast augmentation to achieve secondary female sex 
characteristics, must assume the patient role and subscribe to the illness label in 
order to access the necessary medical care and treatment.41,60 Along with 
accepting the illness label, there are other pre-requisites to accessing these 
services through the treatment system. For example, in order to access 
hormones, one must have real life experience in their preferred gender role, 
exhibit progress towards resolving other life problems that contributed to their 
mental duress and demonstrate their ability to adhere to hormonal therapy as 
prescribed.46 Individuals desiring sex reassignment surgery must live in their 
preferred gender role, under supervision of a medical professional, for a 
minimum of 12 months.46,48 These “requirements” function as organizational 
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constraints for some transgender women who, due to accessibility and 
affordability of care and other organizational policies, resort to obtaining 
unmonitored hormones and obtaining surgical enhancements underground or 
outside of the formal treatment system.42,92 
 The distinguishing characteristic of GD is discomfort or distress that 
prompts a transgender person to seek treatment from medical professionals in 
hopes of alleviating this distress and finding comfort with their preferred gender 
role and expression.41,80,182 Treatment for GD varies from person to person and 
may include feminization or masculinization through hormones and/or sexual 
reassignment surgeries, psychotherapy, voice and communication therapy, and 
name and gender change on legal documents.36,41 Interventions such as these 
are medically and psychosocially necessary to alleviate the discomfort 
associated with GD and are critically important to helping transgender people 
achieve comfort with their self and identity.41   
Recognizing illness 
 The illness career begins with the onset of an illness or related symptoms 
and with an acknowledgement by an individual that they are ill.183 
Acknowledgement of illness alone is not enough to prompt health care seeking. 
In order for this to happen, an individual must think that the problem is serious 
enough to seek professional care, accept or admit that they are ill, and trust the 
health care provider enough to consult with them for treatment.183   
 The definition (meaning) of illness and the ability to recognize, 
acknowledge, and to know when to seek care varies according to race and 
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ethnicity, culture, gender, social class, and educational level.183 As a result, 
health status, quality and timing of onset for treatment, and health outcomes may 
also vary by these same variables. The social meaning ascribed to an illness 
also influences one’s decision to enter care. For instance, illnesses that are 
deemed serious may illicit a societal reaction that prompts an individual to seek 
professional medical care.183 On the contrary, highly stigmatized diseases such 
as HIV may be concealed and care seeking delayed until the manifestation of 
symptoms, which typically occurs in the later stages of disease.123,184 
Asking for Guidance and Referrals  
 Once an illness is acknowledged on a personal level, an individual will 
typically seek guidance and referrals, but not formally. In most instances, this 
process of seeking guidance starts within the individual’s social network. In his 
study on the lay construction of illness, Freidson discusses how the process of 
asking friends for help, guidance or referrals distinguishes friends from others (or 
non-friends).183 He further describes how the process of asking for help, 
particularly for stigmatizing illnesses such as psychiatric disorders, is not easy.  
The same then is true for stigmatizing illnesses such as HIV. Friedson holds that 
when an individual suffers from common illnesses such as a cold, the process of 
asking for help, even from a stranger, occurs without hesitation.   
 The process of asking for help and the characteristics of the helper are 
important in studying health and illness. This is because an individual is more 
likely to have the courage to share with a friend that they are ill, and admit that 
they need help, but is not likely to disclose to others (non-friends) such 
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information.183 Disclosure of one’s HIV or transgender status may result in a 
variety of responses that range from support and acceptance to physical abuse, 
discrimination, and abandonment.185 Fear and anticipation of how friends and 
non-friends may respond to disclosure of an HIV-positive status,184,185 or 
transgender identity, may discourage any level of disclosure and therefore limit 
access to potentially helpful guidance or treatment. 
 This underscores the importance of friends within social networks in not 
only helping guide an individual into care, but also keeping them in care, and 
perhaps determining when care is sought. This further emphasizes how the 
social support system, more specifically; the community network functions 
influence the illness trajectory. 
 Key entrances. Key entrances in the illness career are preceded by 
events that trigger an individual to seek care.138 These events or cues prompt an 
individual to take action and vary according to the severity of illness, signs and 
symptoms of disease, visibility of illness, and duration of signs and symptoms. A 
significant number of individuals who test HIV-positive wait longer than one year 
to enter medical treatment.186,187 Because of this, a substantial number of people 
have advanced HIV disease once they enter care they often begin their illness 
careers when they are dying.186.184   
 In a study to examine acceptance of HIV testing among women, the 
presence of illness symptoms or the illness of a family member or partner, were 
reported as cues for seeking HIV testing or treatment.185 By comparison, the 
absence of symptoms are known to reinforce denial about illness and delay entry 
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into care.186 In a study to examine health-related beliefs and decisions about 
accessing HIV medical care, participants indicated that not having symptoms of 
HIV meant that it was not necessary to seek care.188 Presence of symptoms in 
someone who is HIV infected is a late indicator of illness and is associated with 
poorer health outcomes.186,189        
 Mistrust of medical providers, fear of discrimination in health care settings, 
shock of receiving an initial HIV diagnosis, and poor social support have also 
been cited as reasons for avoidance or delay of entry into care.6,15,16,164,170,190 
Despite the nature of their illness, individuals, who lack trust in medical providers 
delay or avoid care until their illness symptoms worsen. Conversely, a person 
who trusts medical providers may enter their illness career at an earlier stage in 
illness and have greater options for treatment. Similarly, an individual who 
believes in the efficacy or benefit of a specified treatment may be more inclined 
to seek care sooner and more frequently.191 This illustrates how health care 
encounters, trusting relationships with medical providers, and welcoming 
environments of care can affect the pathways through which people enter care 
and alter the trajectory of the illness career. 
   Key exits. Key exits refer to events that result in discharge of an individual 
from the illness career. It refers to the period of time when care ends (termination 
of care) or when illness ends (recovery from illness or death). According to the 
NEM individuals exit care when they are no longer sick, meaning that the disease 
has been cured or they have started to feel better, when care has been 
terminated, when they have recovered from an illness, or once they have died.138  
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 Avoidance and disbelief of HIV status are two major reasons why people 
delay or drop out of care.188,192 Attending medical appointments, adhering to 
complex medication regimens, and discussing their disease with medical 
providers are constant reminders that one has HIV.188 In addition, receiving 
routine HIV lab tests, such as CD4 counts and HIV viral loads, become constant 
sources of anxiety as they are indicators of disease progression and yet another 
reminder of poor health.188 In this respect, exiting care is used as a means of 
coping (through avoidance) with a disease that is mentally and emotionally 
difficult for many people living with HIV to accept.188    
 Previous studies on drop-out rates show that factors such as being tended 
to by more than one practitioner, being male, younger, living alone, having limited 
knowledge of one’s illness, and having a history of psychiatric disorder are 
associated with higher risk of discontinuing care.193,194 Other factors contributing 
to breaks or termination of care includes lack of therapeutic alliance between the 
individual and health care provider,188 lack of helpfulness within the health care 
facility, and long delays between initial appointment and referrals to specialist.194 
These factors will be discussed in greater detail under the treatment system.  
 Key timing/sequencing. Key timing/sequencing refers to events that 
affect the timing and sequencing of entry and navigation through care. These 
include factors such as having multiple health care providers, the medical team 
composition, ordering of consultations, delay and spacing of consultations, and 
the degree and length of compliance.132   
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 Delay or failure to initiate ARV, lack of consistency (stopping and starting) 
with therapy, poor adherence and viral resistance are four main barriers to 
successful and timely treatment with ARV.195 Early HIV detection and treatment 
improves prognosis, but is challenging because acute HIV infection resembles 
common viral infections and may be dismissed as such. Of all new HIV cases, 
30-40% of all cases are diagnosed late, meaning that the person has AIDS at 
initial diagnosis. Therefore, the timing and sequencing of events within the illness 
career and the stage of illness once a person enters care will be affected. Lack of 
illness symptoms or clinical indicators may result in missed illness cues and 
therefore result in entrance into care at more advanced stage and a prolonged or 
impossible recovery altogether.196 Similarly, some people may present with 
symptoms such as weight loss, thrush and pneumonia that are indicative of 
AIDS, but are misinterpreted as complications of diabetes.197 Men, blacks and 
Hispanics, people 25 years and older, individuals who earn less than $10,000 per 
year, and those on state-based insurance programs such as Medicaid and 
Medicare are more likely to delay, or not access, HIV care.197,198 
 In a study of delayed entry into health care for women with HIV disease, 
Ickovics and colleagues found that women who knew their HIV status prior to 
becoming pregnant were four times more likely to delay entry into care.199 In 
addition, once the women presented for care, more than 64% were symptomatic. 
Similar findings were reported by Samet, et al. who concluded that, on average, 
most individuals who are aware of their risk for HIV delay recommended HIV 
testing for up to 2.5 years.187 
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 These findings suggest that a diagnosis of HIV alone or the awareness of 
one’s risk for HIV, are enough to prompt the search for adequate and timely care. 
On the other hand, it appears that the onset of symptoms may trigger healthcare 
seeking. Albeit, the diagnosis itself and the time that it takes for an individual to 
develop symptoms may alter the key timing and sequence of activities that occur 
within the illness career and limit treatment options. 
 Difficulty recognizing illness, acknowledging the existence of illness and 
following medical advice also influence the key timing and sequencing within the 
illnesses career. Mitchell & Selmes offer a framework for helping us understand 
the various reasons that care may be interrupted, delayed or avoided altogether. 
These reasons are both biomedical and health-care system related in nature and 
include factors such as being asymptomatic and therefore not being screened for 
illness or disease and denial, type of illness, and reluctance to accept diagnosis 
once informed of disease.194 The denial or reluctance to accept a diagnosis then 
triggers a series of other events that change the course of the illness career such 
as hesitance to start treatment if offered and lack of adherence and follow-up to 
medical appointments and prescribed treatment.194 These studies illustrate the 
complexity of factors that determine the course of the illness career.   
 So what does this mean for the illness career? For starters it means that in 
comparison to individuals with higher educational attainment and from higher 
socioeconomic levels, people from lower socio-economic classes are less likely 
to use traditional medical care and more likely to seek lay care and rely on home 
remedies.183 Next it may also mean individuals with less social, economic and 
 
 
39 
financial means may enter the illness career at a later stage, for example when 
they are terminally ill or dying, as opposed to at an earlier stage of illness when 
they are acutely or chronically ill. Third it suggests that the illness career is 
shorter lived for poorer persons and therefore, their options for treatment fewer 
and that individuals who are socially isolated, or who do not have friends with 
whom they can share information about their health, may endure worse health 
outcomes. Taken together, this means that in order to understand the factors that 
propel an individual into treatment, the meaning of illness and the methods used 
to gauge the severity of symptoms must be defined from the perspective of the 
social network of which the individual. Describing the illness careers of HIV-
positive transgender women will yield insight into what may prompt or cue 
transgender women to utilization health care and how their transgender status 
influences the illness career and impacts their ability to navigate the treatment 
system.  
Social Support System 
 Sociodemographic, behavioral, intrapersonal, and structural 
characteristics form the basis of membership in certain groups and people with 
similar characteristics tend to connect and interact with those whom they share 
the most similarities.200 Sexual minorities, who tend to construct their social 
networks around their sexual identities, practices, and values, are one good 
example.83 This principle, known as homophily structures network ties within 
marriages, friendships, work place relationships; and influences the type of 
information that is transferred and exchanged within the network. Homophily in 
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race and ethnicity form the deepest divides within social networks, with age, 
religion, education, occupation and gender following, respectively.200 Homophily 
has implications for the type of information that is received, attitudes and beliefs 
that are formed, and the type of interactions that are experienced.200 Social 
networks function as sources of social support, can impact health outcomes for 
populations and groups, and can be a springboard for social capital and political 
action.82,83     
 Social support may play a particularly important role in the lives of HIV 
positive transgender women who are coping with an HIV diagnosis and may 
assist them in managing the challenges associated with the illness.201 As such, it 
is essential to understand the role that a transgender woman’s social support 
system plays in her decision making, rationale for utilizing care, the means by 
which they access care, and the mechanisms that they use to cope with illness.83     
 Social networks vary in terms of the types and levels of social support 
provided, and have been shown to influence psychological health, physical well-
being, coping response to stress, access to health information, and receipt of 
health care.135,141,202,203 Likewise, beliefs and attitudes derived from the social 
network influence attitudes toward health and professional medical care,138 
impact the relationship between the patient and provider, shape the medical 
encounter, and impact health care utilization.138,191   
 Prior research on social support systems has emphasized the 
relationships among social support, quality of life and well-being for those living 
with HIV/AIDS and other chronic illnesses.63,142,173,204,205 Within the social support 
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system, family members, friends, and religious organizations serve as sources of 
informal and formal social support. Social networks can influence health norms 
and behaviors and can be used to mobilize interventions141 and promote 
healthier behaviors such as HIV care utilization. Contrastingly, HIV-related 
stigma and discrimination within the social support system, social isolation, and 
poor social relationships have been linked to lower rates of medication 
adherence206 and can prevent utilization of healthcare altogether.142 This is 
especially true of transgender women who may forego healthcare in order to 
avoid transgender stigma and discrimination during a healthcare encounter.   
  Since transgender women are at greater risk for social isolation, their 
social support systems may vary greatly from the general population and from 
other sexual minorities. As a result, they may be more likely to seek and receive 
social support from transgender friends, trans-friendly people,83 and through non-
traditional venues such as the ballroom community.66,207,208 Ballroom 
communities are social networks that are composed of homes that are led by 
“house” mothers and fathers.207,208 These homes provide a family-like structure 
for marginalized members of the LBGT community, particularly transgender 
women from racial minority groups, and may be instrumental in facilitating their 
healthcare utilization.207,208   
 Support offered throughout the course of the HIV illness career can 
influence how efficaciously one manages the HIV disease, adheres to medical 
treatment, perceives illness, and copes with illness.63,142,173,204,205 For instance, 
studies on HIV-positive transgender women have shown that social support 
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systems are helpful in managing complex social issues, such as violence and 
drug use; obtaining access to highly coveted medical goods such as hormones 
and silicone, and feeling more in control of their lives and capable of managing 
their illness.83 Moreover, social support systems provide protection from social 
isolation and a safe place for sharing survival strategies such as obtaining cash, 
accessing social services, and maintaining a feminine appearance.32,64,83,201,204  
On the contrary, people who do not perceive any social support and who fear 
that they will be abandoned and stigmatized by their friends and family, often 
conceal their HIV diagnosis to avoid being abandoned.204 Likewise, lack of social 
support is more debilitating for multiply marginalized communities such as 
transgender women and minority racial groups, and often results in delayed HIV 
testing, late stage diagnosis, and underutilization of care.204   
 These examples underscore the wealth of resources offered through the 
social support system and demonstrate how the network structure and function 
interact with cultural factors, to influence the illness career, health care decision 
making, basic survival, access to relevant health information, and health 
outcomes.52,209 These studies further accentuate the importance of engaging the 
social network of transgender women in the development of methods to increase 
their healthcare utilization and the need to design interventions in such a way 
that can be owned and implemented by the social network itself.     
Treatment system. Prior to entering the treatment system, an individual 
must manage organizational constraints such as accessibility and affordability of 
care.191 Their ability to do so greatly depends on their social resources such as 
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education, work status, income, occupation, and access to medical insurance. 
These constraints can delay or prevent health care utilization and can directly 
influence illness severity and health outcomes. 
Within the treatment system, variables such as the provider-patient 
relationship, organizational culture and climate, financing options or affordability 
of care, and coordination of care within and across the system influence the 
illness trajectory. Social networks within treatment systems determine the culture 
of care within an organization (e.g. attitudes towards gender minorities and 
involvement of family members and same sex partners in care), determine a 
health care provider’s scope of practice, influence the quality of care available 
within the system, and determine an individual’s level and type of access to 
care.133,138,170,210 138   
  In particular, healthcare encounters and relationships within treatment 
systems influence satisfaction with the care experience, acceptance and 
adherence to treatment, willingness to trust and disclose pertinent health 
information, and the decision to remain engaged in care.31,133,138,142  
Stigmatization of homosexuality and transgenderism are examples of social 
responses within treatment systems that cause gender and sexual minorities to 
delay HIV testing and screening for other sexually transmitted infections and 
delay of initiation of antiretroviral therapy.2   
 Organizational culture, organizational climate, service integration, and 
coordination also affect how health care providers respond to patients and impact 
an individual’s ability to navigate through the treatment system.133,138,164 The 
 
 
44 
effects of such have been reported on marginalized populations such as 
socioeconomically disadvantaged people of color who are less likely to access 
primary medical care and more likely to use emergency room departments for 
their primary care providers.142 And again in studies on referrals, specifically 
those that have reported a relationship between difficulties in accessing and 
navigating the HIV health care when HIV specialists, case managers, and social 
workers are geographically located in separate facilities.6,164,170,173,211,212    
 The effect of the treatment system on health utilization and health 
outcomes were reported in a national U.S. survey of over 7,000 transgender 
persons. In this survey respondents reported that they postponed medically 
necessary care and experienced significant barriers to accessing health care 
because of stigma and discrimination, inability to afford care, refusal of care due 
to their gender status, harassment and violence in the medical setting, and lack 
of provider knowledge about TG care. 30,33,50,88,91,113,132,213 Collectively, these 
factors cause transgender women to withhold pertinent information regarding 
their sexual orientation, illness, and health behaviors from their medical 
provider.64,88,95,112,132,146 Non-disclosure hinders effective treatment and care 
discussions, as well as informed decision-making, results in poorer health 
outcomes and alters the timing and sequencing of events within the illness 
career.64,88,95,112,132,146   
 By comparison, treatment systems that are trans-friendly or welcoming are 
more likely to engage transgender women in care. In a study to examine HIV 
prevention and primary care for transgender women in a community-based clinic, 
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participants indicated that clinics that did not identify itself as “gay or 
transgender-friendly” eliminated the need for the women to identify as “trans” and 
instead gave them the flexibility to identify themselves simply as women.214 
Transgender women’s need to identify as “women” cannot be understated, as it 
is this distinction that affirms their psychological gender identity and affirms their 
femininity. It is for this same reason that hormone therapy is so critically 
important to transgender women and why it often takes priority over HIV 
medication and related care because it represents the first step in solidifying their 
gender identities.83 
 In sum, the literature suggests several gaps in knowledge. The first is how 
the intersection of a transgender identity combined with a diagnosis of HIV 
shapes the illness career. The second and third are how important social 
relationships in the social networks and healthcare encounter within the 
treatment system influence the illness trajectory of HIV-positive transgender 
women.    
  Because social networks play an integral role in dissemination health 
information and influencing behavior change, it is imperative to identify how 
important social relationships and health encounters influence illness trajectories 
and care utilization among transgender women. In doing so, researchers are 
more likely to be successful in designing interventions that will be owned by and 
sustained through their social support systems.215  
 
 
 
 
46 
Chapter III: Methods 
 This chapter provides a description of the grounded theory methodology, 
recruitment strategies, data collection, and data analysis procedures that were 
used to guide this study.  
Research Design 
 Effective strategies for HIV prevention and treatment require 
understanding the experiences of what it is like to be a transgender woman living 
with HIV and trying to navigate the complex systems of care. This perspective 
can only be obtained by eliciting stories from the women themselves and is best 
achieved through qualitative research methods.51 Grounded theory methods 
were selected because this approach allows for exploration of shared social 
processes, experiences, and symbolic interactions.139,140   
Background and Philosophy of Grounded Theory 
 Grounded theory (GT) methods are best described as a “systematic, yet 
flexible guidelines for collecting and analyzing qualitative data to construct 
theories “grounded” in the data themselves” (Charmaz, p. 2).139 This 
methodological approach is based on the assertion that people who share 
common circumstances, have similar life experiences and maintain common 
beliefs and behaviors.139 GT methods emerged from the collaborative work of 
sociologists Barney G. Glaser and Anselm L. Strauss139 and originates from 
symbolic interactionism. Symbolic interactionism is a sociological, theoretical 
perspective that is based on the assumption people construct themselves, 
society and reality through social interaction.139 There are three core premises of 
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symbolic interaction. The first is that people act towards other objects and people 
in their social environment according to the meanings that they have for those 
objects and people.216 The second is that “meanings” arise from social 
interactions among individuals.216 The third is that meanings are established and 
modified through an interpretive process undertaken by individuals.216  
 Distinguishing characteristics. The hallmark features of GT include 
simultaneous data collection and analysis, theoretical sampling, constant 
comparison, coding and memo-writing, and theory, usually mid-range, 
development.139,217 GT focuses on process and trajectory, uses gerunds to 
indicate action and change, detect processes, and stick to the data, and has a 
core category or variable that ties stages and phases of the emerging theory 
together.139 
Justification for grounded theory methods 
 GT uses an inductive, discovery-oriented approach to guide development 
of substantive theories which can be used to describe the complexities of people 
undergoing change, explain the influence of social interactions on outcomes, and 
describe the ways in which the social environment influences their human 
experience.139,218  Since little is known about how the social network and social 
processes influence HIV-positive transgender women’s decisions to seek, enter, 
and be retained in care and how these factors affect their illness experiences, GT 
was felt to be the ideal method for this study.139,140,219 Basic assumptions of GT is 
that individual behavior, experiences, and the meanings ascribed to them by the 
individual are best understood from their perspective and most influenced by 
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their sociocultural environment.139,140,218 Therefore obtaining understanding of the 
phenomenon under study requires face-to-face interaction during which 
participants are given the opportunity to describe their experiences in their own 
words.220-223   
Research Team and Reflexivity 
 The PI conducted all 18 interviews as part of her doctoral dissertation. She 
is an African-American, non-transgender woman and transgender ally. For 
several years prior to, and during the course of this study, she served as the 
quality improvement nurse for a Ryan White HIV/AIDS services program at the 
county health department and attended the Ryan White Consumer Planning 
Council meetings, which were regularly attended by members of the LGBT 
community. This investigator has an interest in health equity and equitable 
access to care for gender and sexual minorities. She had a collegial relationship 
with one of the community advisory board members, a transgender woman, who 
also served as one of the study’s participants. As part of her role as a quality 
improvement nurse, the PI participated in cultural events such as the annual 
AIDS walk, Indy Gay Pride, and attended a House Ball, which consists of various 
forms of artistic performance (e.g. drag, dance, vogueing, and runway walks) by 
members from the LGBT community. 
Sampling and Recruitment Strategies 
 Multiple recruitment tools and sampling strategies were used to recruit a 
sample of transgender women with diverse health care experiences and illness 
careers. These strategies included use of a Community Advisory Board (CAB), 
direct phone calls from collaborating agencies, and informational meetings with 
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collaborating agencies. Recruitment flyers, introductory study letters, and 
recruitment palm cards were used to advertise the study. See Appendix J. 
Recruitment and Sampling Strategies 
 Snowball, convenience sampling, and venue-based sampling were used 
throughout the study. Recruitment for the study occurred in two stages. During 
Stage 1 and the first phase of data collection, introductory letters and study flyers 
were mailed to HIV-positive transgender women by the Indiana State Department 
of Health’s HIV/AIDS services program and the Marion County Public Health 
Department’s HIV/AIDS services program. Recruitment materials were mailed 
only to those transgender women who had given consent to receive HIV-related 
mail and who had accessed HIV-related care in the previous 12 months. The 
letters emphasized the voluntary nature of the study and the PI’s contact 
information; see Appendix D. The study flyer included a picture of the PI, the PI’s 
contact information, estimated length of the interview, inclusion criteria. See 
Appendix J. The flyer indicated that a gift card would be provided as a “thank 
you” for the participants’ time and information, but the amount of the incentive 
was not included on the recruitment flyers during this stage.  
In addition to mailing introductory letters and flyers to eligible participants, 
one collaborating HIV clinic opted to contact eligible transgender women by 
making direct phone calls to inform them about the study. During these calls, 
care providers introduced the study to the women and asked if they were 
interested in participating. Participants who were interested in participating in the 
study were given the option to contact the PI directly to schedule the interview or 
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to give permission for the PI to contact them and schedule the interview. The PI 
screened participants over the phone and scheduled a time to conduct the 
interview. Direct phone calls continued throughout the duration of study 
recruitment. See Procedure for Direct Call from Health Care Provider to 
Prospective Participants in Appendix C.  
During Stage 2 and the second round of data collection, the PI 
implemented use of a Community Advisory Board (CAB) that consisted of five 
members and held informational meetings with collaborating agencies. 
The CAB was used to ground the study in the needs of the community, to 
further establish trustworthiness of the PI, and to enhance recruitment efforts. 
The first CAB member was a transgender woman that the investigator met 
through her associations with the local health department. The PI met with this 
community member, provided her an overview of the study, and invited her to 
serve as a CAB member. This community member agreed to join the CAB and to 
assist the PI in recruiting other key people for the CAB. 
 CAB members were recruited from community-based organizations that 
were known to provide care to transgender women and from other venues 
identified by the first community member. There were a total of five CAB 
members: two African American transgender women, one black Hispanic 
transgender woman, one African American community-based street outreach 
worker, and one African American gay male who worked closely with the 
transgender community. All CAB members verbally agreed to assist with 
recruitment. The PI met with the full CAB once before starting the second round 
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of data collection and continued to meet with select members periodically 
throughout data collection. CAB members provided substantial input into the 
design of recruitment materials and selection of recruitment venues. Each CAB 
member was given a $50 gift card for each meeting they attended as a thank you 
for their time and contributions to the study.  
The CAB assisted in the design of two separate recruitment flyers; see 
Appendix J. Both flyers contained a picture of the investigator, a brief description 
of the study, a description of the social benefits of participation, a description of 
the potential personal benefit to the participants, and the incentive amount. One 
flyer was general and contained no language specific to HIV. CAB members felt 
that prospective participants would be reluctant to remove a pull-tab from a 
recruitment flyer that made references to HIV, especially if these flyers were in 
general social venues. The second flyer contained language specific to HIV. CAB 
members felt that potentially eligible participants would not hesitate to stop and 
read or remove a pull-tab from these flyers as long as they were in places known 
to provide HIV care such as HIV clinics, AIDS Service Organizations, and 
Community-Based Organizations. 
CAB members also suggested use of business card sized palm cards that 
they would use to directly approach eligible participants, see Appendix J. At the 
suggestion of the CAB, the term “HIV” was not used on the palm cards. CAB 
members advised that this would allow participants to place the cards in their 
pockets or purses without having to worry if someone found the card and thus 
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found out the participants’ HIV status. CAB members distributed these cards only 
to transgender women they knew to be HIV-positive.     
 To further enhance recruitment efforts, the PI held informational meetings 
with staff at collaborating agencies within the treatment system and at community 
venues identified by the CAB. During these meetings the aims and expected 
benefits of the study were described, and staff, community members were 
encouraged to share information about the study with their transgender female 
clients or friends and were given study fliers to distribute throughout their agency 
or community venues. Table 1 shows the total number of participants recruited 
by strategy. 
Table 1 Participants by Recruitment Method 
Recruitment strategy Number of participants 
Recruitment flyers N=4 
Referred by recruitment/collaborating 
agency 
N=7 
Community advisory board member N=7 
Total number of participants enrolled N= 18 
Institutional Review Board  
 The Institutional Review Board (IRB) at Indiana University Purdue 
University Indianapolis provided ethical approval for this study. To maximize 
confidentiality of participants, a waiver of written informed consent was obtained 
from the IRB. Prior to enrollment, all participants were asked to read a written 
information sheet and encouraged to ask questions before providing verbal 
consent for participation. 
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Inclusion Criteria and Data Collection 
 Inclusion criteria for study participants included being 18 years of age or 
older, identifying as a transgender woman, self-identifying as HIV-positive, and 
being able to participate in an interview in English. Each prospective participant 
was screened over the telephone; three were screened face-to-face. Participants 
meeting the inclusion criteria were scheduled for an interview at a site and time 
that was mutually agreeable to the participant and PI.  
 The PI conducted individual, semi-structured interviews with 18 HIV-
positive transgender women. Interviews were digitally recorded and transcribed 
verbatim by a professional transcriptionist. As social network map (See Appendix 
H) was also used to elicit the names of the important people in the participant’s 
social network and to generate a discussion of how each individual supported the 
participants and influenced their health care utilization following their initial HIV 
diagnosis. This methodological approach has been used in mental health studies 
to design social network interventions to facilitate mental health treatment.224 
 Prior to the start of each interview participants were asked to complete a 
demographic data collection sheet (See Appendix F). The demographic data 
collection sheet contained19 questions, 10 fill in the blank and nine multiple 
choice and included questions about age, race/ethnicity, current gender and 
gender at birth, sexual orientation, relationship status, employment status, 
educational attainment, insurance status, and health history. The verbal interview 
began immediately after participants completed the demographic data collection 
sheet. Interviews lasted between 60 minutes and three hours, with average of 
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two 90 minutes, and were conducted in quiet, private settings, such as the 
participants’ homes, study rooms in public libraries, and counseling rooms at 
participating sites. The interviews elicited detailed narratives about the women’s 
experiences with testing HIV-positive and accessing health care (See Interview 
Guide, Appendix G). Specifically, participants were asked about the role of 
important relationships in their social network and the role of their health care 
encounters on their utilization of HIV care. Participants were also asked 
questions about their gender identity, their experiences of coming out as 
transgender, and their experiences as a transgender woman. Participants were 
given a $50 gift card in appreciation for their time at completion of their interview.    
Sample Size Justification 
  In grounded theory, an exact determination of sample size cannot be 
established a priori. Initially a sample size of 20-25 HIV-positive transgender 
women was anticipated. This number was selected because qualitative research 
studies typically rely on 20-25 participants to achieve informational redundancy. 
The final sample size for this study was 18, as it was at this point that data 
obtained from interviews began to replicate.    
Data Analysis  
 The illness career refers to the dynamic social processes that undergird 
the use of health care services during illness. It starts with an event that triggers 
a sequence of actions and decisions that are used to cope with a physical or 
emotional illness. Throughout the illness career, an individual is faced with 
having to make decisions about treatment-whether or not to seek it and, if so, 
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when, where and how. These decisions are informed by many factors- the cost 
and benefit of treatment, health advisors in their social network, and their social 
network’s attitudes towards healthcare utilization. The primary aim of this study 
was to describe the illness careers of HIV-positive transgender women. The sub-
aims of this study were to describe how important social relationships, health 
care encounters, and social support influence the illness career. 
 Data were analyzed with procedures outlined by Charmaz.139 According to 
Charmaz, grounded theory coding forms the framework of the analysis. Coding is 
the link between data collection and the emerging theory. Coding allows the 
researcher to describe what is happening in the data and is used to generate 
initial thoughts about its meaning.  
Initial coding is first used to separate data into categories and to identify 
processes. During initial coding the researcher reads the data closely and begins 
to code each line. Initial codes are provisional and may be reworded to improve 
the degree to which they capture what is taking place in the data. Line-by-line 
codes are then used to identify analytic ideas to pursue in subsequent data 
collection and analysis.139,225  
In this study initial coding began after the first three interviews. The 
investigator read each transcript multiple times in their entirety, highlighted 
passages that reflected salient ideas and themes, and wrote line-by-line codes in 
the margins. As data collection and analysis progressed, questions in 
subsequent interviews were modified for in order to explore important areas that 
emerged during the first three interviews in more depth and to verify findings and 
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relationships that emerged between the concepts. This process was repeated for 
the 15 subsequent interviews. After completing initial coding of the transcripts, 
line-by-line codes were compared for similarities and differences and for 
commonalities and exceptions, and organized the codes into five broad 
categories. Throughout this process the investigator consulted with select 
members of my committee for validation of the initial codes and categories.   
According to Charmaz, axial coding is used to sort, synthesize, and 
organize large amounts of data and reconstruct them in new ways. During this 
process, the broad categories are broken down into subcategories and the 
concepts linking the categories together are described through memo writing. 
Memos are used to capture the researcher’s thoughts, comparisons and 
connections made between the data, to illustrate how they have made sense of 
the data, and to inform subsequent analysis.139  
For this study, axial coding was used to organize data into various tables. 
The investigator started with five tables, one for each broad category, and 
inserted the corresponding line-by-line codes within each the table. For example, 
the first column included the participant number, the second column included the 
line numbers for the corresponding code, and the third column included the 
codes, which were written as actions. Within each broad category subcategories 
were developed. For instance, the category of Testing Positive for HIV, was 
divided into subcategories of: Getting the Results, Feeling Scared and Anxious, 
Getting Caught Up in Thoughts and Feelings, Thinking I Would Die, Shutting 
Down and Shutting Others Out, and so on. After development of the 
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subcategories, the focus shifted to creating linkages between the data. The 
investigator used memos to document her thoughts on how the codes fit 
together, to round out the categories, and to document the analytic process. 
Finally, the investigator discussed the emerging ideas with select committee 
members. This phase of data analysis continued until all emerging categories 
and subcategories were placed into a theoretical framework that described the 
connections between the categories.   
According to Charmaz’s criteria, selective or theoretical coding is used 
towards the end of the study. These codes specify possible relationships 
between categories and help the researcher tell a coherent analytic story.139,225  
In this study, selective coding was used to identify the core categories in 
the model. The investigator constantly compared, revised, and expanded 
categories until theoretical “saturation,” the point when gathering new data did 
not spawn new theoretical insights or reveal any new properties of the core 
theoretical categories,139 was achieved. The theoretical relationships among the 
categories formed the basis of the theoretical framework, and were determined 
by iterative movement between the evolving theoretical framework and the data, 
theoretical sampling (obtaining additional data through modifications in the 
interview questions as data collection progressed and analytic memo writing).   
 The core theoretical constructs formed the basis of the theoretical 
narrative that is presented in the discussion. The final analytic product of this 
study, a theoretical model that contains narrative summaries that addresses the 
research aims and provided in-depth descriptions of important aspects of the 
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framework, is presented is chapter four. The model was the result of an iterative 
process of rereading the transcripts (data) several times, to review the line-by-
line codes and categories to confirm or modify the emerging stages in the model. 
The framework is presented in a schematic drawing and depicts the psychosocial 
stages through which the participants experienced the illness career following 
their diagnosis of HIV. Factors that enabled movement one from one phase to 
the next are depicted in a table format.  
Descriptive Validity/Qualitative Rigor  
 Charmaz’s criteria of credibility, originality, resonance, and usefulness was 
used to maintain validity and rigor.139 A discussion of Charmaz’s criteria and a 
description of how each was addressed in this study are presented in the 
following section.  
 Credibility. According to Charmaz, credibility in GT research is 
demonstrated through several criteria. First, the researcher has exhibited an 
intimate knowledge, or familiarity, of the research topic and setting. Second, 
there is evidence that systematic comparisons between observations and 
categories, which cover a wide range of empirical observations, were conducted. 
Third strong logical links between data, the argument being presented and 
analysis is evident. The last criteria that Charmaz suggests must be met to 
establish credibility is that the researcher provide enough evidence to support 
their claims and that be able to withstand an independent assessment of those 
claims.139    
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 In this study, the researcher used several measures to clarify her stance in 
relation to the participants and subject matter. First, interviews were audio-
recorded and transcribed to ensure that the participants’ experiences and 
perspectives were accurately recorded and quotations will be used to truthfully 
convey their lived experiences.226 Second, the researcher used open-ended 
questions to allow participants to speak in their own voice about their 
experiences. Third, the researcher reviewed all transcripts against interview 
recordings to enhance accuracy. 
 Originality. According to Charmaz, originality is demonstrated through 
new insights brought forth by the researcher. Studies that produce new concepts, 
challenge, expand, or clarify current ideas, concepts and practices are said to 
exhibit originality.139  
 This study is original because it focused on a concept of which little is 
known and generated new knowledge.139 In particular this study presented a four 
stage theoretical model that described the illness careers of HIV-positive 
transgender women and offered new insights into how these women manage 
their HIV over time. In addition, it provided insight into how relationships with their 
social network and network of health care providers formed the context of the 
participant’s illness careers. Finally, this study identified pivotal moments that 
marked movement from one phase of the process to the next.  
  Resonance. According to the criteria outlined by Charmaz, resonance is 
demonstrated in GT studies through several qualities. First, through categories 
that depict the richness of studied experience.139 Second, when categories reveal 
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both luminal (ambiguous) and taken-for granted meanings.139 Third, when the 
researcher uses data to make connections between larger collectivities or 
institutions and individual lives. Last, when the final theoretical product makes 
sense to the study participants and offers substantive insight about the 
participant’s lives and their world.139 
To ensure resonance of the final theoretical model in this study, the 
investigator, used line-by-line coding to ensure that the initial analyses 
accurately uncovered what participants said and ensured that important 
nuances and salient ideas in the data were not overlooked.139 Self-reflexivity 
was used to clarify and reflect on the investigator’s personal biases throughout 
the duration of the study139,227,228 and analytic memos were kept as an audit trail.  
The investigator also held bi-weekly meetings with the qualitative methods 
advisor and dissertation chair to discuss the interviews, analyses, 
interpretations, and conclusions.229 These steps ensured that the research 
process was clearly documented and the methods of data collection and 
analyses were clearly detailed.229  
 Usefulness. Charmaz states that usefulness in GT research means that 
the analysis offers interpretations that are useful to people in their daily lives. GT 
studies are said to be useful when they inspire further research in other robust 
areas.139 Implications for future research are discussed in chapter 5. 
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Chapter IV Results 
The purpose of this study was to describe the illness careers of HIV-
positive transgender women. The illness career includes all the attempts that an 
individual uses to cope with an illness episode and the steps (timing, sequencing, 
and actions) they use throughout the process.136 Throughout the illness career, 
an individual makes decisions about whether or not to seek treatment and if so, 
when, where and how to do so. These decisions are informed by various factors 
including the cost and benefit of treatment, formal and informal health advisors in 
individuals’ social network, and attitudes that people within their social network 
have towards healthcare utilization.136 
A sub-aim of this study was to describe the influence of important social 
relationships on illness careers of HIV transgender women. Social relationships 
can influence health beliefs and behaviors, and have either a harmful or 
beneficial effect on one’s health outcomes. It is through important social 
relationships that individuals learn about, begin to understand, and develop 
strategies to handle life’s difficulties.132,136,144 
A second sub-aim of this study was to describe the influence of health 
care encounters on the illness careers on HIV transgender women. Healthcare 
encounters influence how individuals seek care and experience their healthcare. 
The quality of health care encounters influences individuals’ acceptance and 
adherence to treatment, willingness to trust and disclose pertinent health 
information to the members of the care team, and decide to remain engaged in 
care.31,133,138,142 
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Description of Sample 
 The sample consisted of 18 urban-dwelling, transgender women. As 
shown in Table 2, the racial/ethnic makeup of the sample was as follows: 10 
African Americans (55% of sample), four Whites (22%), one Hispanic-Black 
(6%), one Native American Pacific Islander (6%), and two multi-racial (11%).  
At the time of the interview, 12 participants (66%) had been living with HIV 
between 1-5 years; three (16%) between 21-25 years; one (6%) between 6-10 
years, one (6%) between 11-15 years; and one (6%) for more than 25 years. 
Eight participants (45% of the sample) were diagnosed with HIV between the 
ages of 20-29, five (28%) were diagnosed between the ages of 18-19, four (22%) 
were diagnosed between the ages of 30-39, and one (5%) was diagnosed 
between the ages of 40-49. Participants received their initial HIV-positive test 
results in a variety of settings: Hospital (n=4, 22%), HIV counseling, testing, and 
referral (CTR) center (n=4, 22%), in a prison/jail (n=4, 22%), in a physician’s 
office (n=4, 22%), and at a commercial plasma center (n=2, 11%). This 
information was not collected on the demographic data collection sheet, but was 
provided during the interview.  
Ten (56%) reported their sexual orientation as heterosexual, three (17%) 
as gay, two (10%) as bisexual, one (6%) as “sexual,” one (6%) as “asexual,” and 
one (6%) as “transgender.” Asexual and transgender were not listed as options 
on the demographic data collection sheet, but were hand written on the form by 
the participants themselves. Asexuality is defined as the lack of interest in or 
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desire for sex. Sixteen (89%) participants reported their relationship status single 
and two participants (11%) reported being in a relationship.  
Eight participants (44%) reported the 12th grade as their highest level of 
education completed. Five (28%) reported having some college education, two 
(11%) reporting having completed college, two (11%) reported never completing 
high school, and one (6%) reported having a GED. 
Most participants in this study (n=10, 56%) were unemployed. The 
remaining participants (n=8, 44%) were employed in various settings such as the 
entertainment industry, retail, health care, and warehousing. 
 The majority of the participants (n=17, 94%) were insured. The most 
common type of insurance reported was Medicaid, followed by state-funded 
insurance programs such as Healthy Indiana Plan, MD Wise, and federal 
programs such as Ryan White Parts A and C, and private insurance.  
 The data collection sheet (Appendix G) did not contain questions about 
adverse life events. During the verbal interview, however, participants reported 
experiences such as substance abuse (n=11, 61%), sex work (n=9, 50%), forms 
of violence such as physical assault and harassment, rape, and intimate partner 
violence (n=7, 39%), incarceration (n=7, 39%), and childhood sexual assault 
(n=3, 17%).  
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Table 2 Participant Demographics 
Race/Ethnicity Number of participants 
African American 10 (55%) 
White 4 (22%) 
Hispanic/Latino 1 (6%) 
Native American/Pacific Islander 1 (6%) 
Multi-racial 2 (11%) 
Number of years living with HIV 
at the time of interview 
Number of participants 
1-5 years 12 (66%) 
6-10  years 1 (6%) 
11-15 years  1 (6%) 
21-25 years 3 (16%) 
>25 years 1 (6%) 
HIV counseling and testing 
center  
HIV counseling and testing 
center  
18-19 years 5 (28%) 
20-29 years 8 (45%) 
30-39 years 4 (22%) 
40-49 years 1 (5%) 
Sexual orientation Number of participants 
Heterosexual 10 (56%) 
Gay 3 (17%) 
Bisexual 2 (10%) 
Sexual 1 (6%) 
“Transgender” Age at time of HIV diagnosis 
“Asexual” 18-19 years 
Relationship status Number of participants 
Single 16 (89%) 
In a relationship 2 (11%) 
Highest completed level of 
education 
Number of participants 
High school 9 (50%) 
Some college 5 (28%) 
College graduate 2 (11%) 
Never completed high school 2 (11%) 
Employment status Number of participants 
Unemployed 10 (56%) 
Employed 8 (44%) 
Insurance status Number of participants 
Insured 17 (94%) 
Uninsured  1 (6%) 
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Description of Interviews 
 
 The interviews lasted between one to three hours with the average 
interview lasting 1.5 hours. Interviews were conducted in quiet, private settings, 
such as the participants’ homes, private study rooms in public libraries, and 
private offices at care coordination (recruitment) sites.  
 Some women were slightly apprehensive about the interview at first. One 
woman scheduled an interview then cancelled it because she felt nervous about 
telling her story. After talking it over with her friends, she called back and 
rescheduled her interview. Another woman said, “I wasn’t open at first…[but] it’s 
getting easier to be more open to talk about it.” 
 The women showed a range of emotions throughout the interviews. Many 
became tearful when they talked about their gender identity confusion as children 
and when they discussed coming out to their families for the first time as 
transgender. Several were also tearful when they discussed their experiences of 
testing HIV-positive and telling their families about HIV for the first time. Although 
the interviews focused on experiences as transgender women and HIV (Refer to 
Interview Guide, Appendix F), the women commonly described other adverse life 
events such as childhood sexual abuse. Yet while much of the interviews 
focused on hardship, the women also shared positive aspects of their lives. For 
example, a few laughed and smiled when discussing the first time they dressed 
up as girls and wore make-up. 
 The women were eager to share their stories and indicated that they felt 
good about participating in the interview. Some stated the interview “was a relief” 
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and that it allowed them to “get a lot of stuff of their chest.” Other women were 
happy to see that someone was genuinely interested in their experiences as 
transgender women and their experiences with health care. One participant said, 
“You could be doing your doctorate work on anything in the whole world, but you 
have chosen to do your doctorate study on transgender issues, and that means a 
great deal to me. So thank you.” Another participant said, “It feels good to do 
something like this. It should be done more often, on a regular basis, because I 
think a lot of us would have a lot to talk about, and a lot of us have a lot [that we 
need] to get out and deal with…”  
 Throughout each stage of the model, supporting quotes are provided as 
evidence to support the claims in the study. The participants’ demographics and 
pseudonyms are included in Table 3 Participant Pseudonyms and 
Demographics. 
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Table 3 Participant Pseudonyms and Demographics 
Participant Age Race Pseudonym Testing Site 
1 31 Black Elise Doctor’s office 
2 49 White Gretchen  HIV counseling 
& testing site 
3 36 Black Stephanie  Hospital 
4 30 Hispanic-
Black 
‘Drea  HIV counseling 
& testing site 
5 43 Black Maxine  Jail/prison 
6 60 White Jessica  Doctor’s office 
7 58 White  Brenda HIV counseling 
& testing site 
8 22 Black Cheron Commercial 
plasma center 
9 21 Asian/Pacific 
Islander 
Monique Jail/prison 
10 29 Black Erin  Commercial 
plasma center 
11 32 White Rachel Doctor’s office 
12 31 Black Denise Doctor’s office 
13 49 Black Chantel Jail/prison 
14 21 Black Tiffany Hospital 
15 51 Black Crystal Hospital 
16 26 Black Porsha Hospital 
17 35 Black Kim Jail/prison 
18 34 Black Star HIV counseling 
& testing site 
 
 
  
 
 
68 
Conceptual Model/Framework 
 
Results indicated that the participants found their illness careers to be 
complex and full of emotional “ups and downs.” They described frequent health 
care appointments for HIV and, for some, appointments and treatment for 
substance abuse and mental health problems. Many indicated that other life 
adversities such poverty and homelessness and conflicting family dynamics 
surrounding their transgender and HIV-positive status complicated their 
healthcare. Many began their illness careers with feelings of fear and anger, as 
well as denial, but over time they gained a sense of acceptance, resilience, and 
renewal. Interactions with family, friends, and romantic partners as well as a 
variety of health care providers influenced the participants’ illness trajectories.  
Data analysis revealed that the illness trajectory for transgender women is 
best described by a core process we have labeled Having the World Change. 
The analysis yielded four stages that constitute this process: having the world 
come crashing down, shutting out the world, living in a dark world, and 
reconstructing the world. I will first present the core process and then describe 
each of the four stages. For each stage, I will also discuss how the women’s 
healthcare encounters and interactions with important others influenced that 
stage.  
While the findings are presented as a model of a common process with 
four stages, the model is best understood as a conceptual rendering of the 
common ways in which transgender women experience the HIV illness career. 
The stages were actually fluid and iterative; not all of the participants moved 
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through all of the stages in the same order, some experienced the stages 
simultaneously, some lingered in one stage longer than others, and some 
reverted to earlier stages when they encountered new challenges.   The model is 
presented in Figure 1. 
 
Figure 1. Having the world change model. This figure illustrates the four 
psychosocial stages in the illness career of HIV-positive transgender women. 
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Having the World Change 
The participants claimed that being diagnosed with HIV altered their entire 
life and fundamental changed their perceptions of themselves. The metaphor 
“Having the World Change” is used to describe how having HIV was not just 
having a chronic disease for the participants, but rather a life experience that 
disrupted their sense of self, their connection to others, and most aspects of their 
daily lives  In her book, Trauma and Recovery, Herman (1997) writes that 
traumatic events “breach the attachments of family, friendship, love, and 
community” and “shatter the construction of the self that is formed and sustained 
in relation to others” (p. 51). Many parallels exist between Herman’s descriptions 
of life after trauma and the participants’ description of how their lives changed 
after HIV. The participants described HIV as a traumatic event that abruptly 
altered their lives and caused much chaos and confusion. Before their diagnosis, 
the participants identified as women or transgender women, but after they 
thought of themselves as “HIV-positive” first and women or transgender women 
second. Relationships with important others such as family, friends, and romantic 
partners changed in essential ways after participants were diagnosed with HIV. 
Herman writes that, in coming to terms with a traumatic event, the survivor must 
mourn the loss of their “old self that the trauma destroyed” and “develop a new 
self.” (p. 196). The metaphor of “Having the World Change” therefore captures 
the pervasiveness of the changes faced by the participants and the degree of 
transformation that they experienced as they managed the illness in the context 
of their identity as transgender women.  
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Having the World Come Crashing Down 
The first stage of Having the World Change occurred when participants 
were initially diagnosed with HIV. We labeled this first stage, Having the world 
come crashing down. This phrase is commonly used to denote an unpleasant or 
traumatic life event that occurs and suddenly leaves one feeling confused or 
upset.230 The term “crashing down” refers to the structural collapse of something 
and thus resonates with the women’s sense that their lives as they knew them 
had been destroyed.230 One woman, for example, claimed that her “whole world 
just shattered” when she found out she had HIV. Though a few women believed 
that acquiring HIV was an inevitable outcome of being transgender and were not 
surprised by their diagnosis, most were shocked to learn their HIV status. Upon 
learning the diagnosis, they experienced disbelief, fear, confusion, anxiety, 
devastation, rage, and doom. Women described the moments when hearing the 
news that they were HIV-positive as “crushing” and “devastating.” The way in 
which their worlds came crashing down was influenced by nature of the health 
care setting in which they were informed of their diagnosis and the dynamics of 
their encounters with health care providers.   
Health Care Encounters 
All the women were tested for HIV and received their results within the 
context of a healthcare setting. The healthcare settings included jails or prisons, 
hospitals, HIV counseling and testing sites, healthcare providers offices, and 
commercial plasma centers. The setting had a significant impact on how the 
women experienced the world come crashing down, as the type of support 
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received in the immediate moments following the diagnosis varied considerable 
according to setting.  
In jail or prison. Several women were tested for HIV as part of a jail or 
prison intake health-screening exam or as part of a plea agreement for criminal 
charges. During intake, jail and prison staff advised the women that they would 
be “called back” to the medical office by a member of the health care staff if their 
HIV test results were positive. Because several women were jailed on charges of 
prostitution and drug use, they were “shocked” but not “surprised” about their 
diagnosis. Monique said, “I felt shocked, but it wasn’t [shocking] because of the 
actions [that I was taking]. I knew that I was putting my life at risk and my health 
at risk for doing what I was doing. The money was not good for it, but it was good 
at that time.” Chantel described similar feelings of being surprised, but not 
shocked to learn that her test results were HIV-positive. She said,  
I had been [testing] regularly since like 1989 when my best friend 
died of AIDS. I had been doing it regularly because I was kind of 
scared…It was due to my own mistake because I took the condom 
off while I was having sex, but had been STD free for all that time, 
[from] 1989 to ’92. [Still when I tested HIV-positive] it just kind of 
threw me off, so I stayed in denial a long time.  
 
Kim also felt surprised with her diagnosis, even though she expressed 
feeling that she would eventually test HIV-positive one day. She said,  
I was [lost] for words. But in the same breath, I knew somewhere in the 
back of my mind [that] it was [only] a matter of time before I actually got it [HIV]. 
But how was I going to deal with it? I was in denial because you don’t really want 
to say to yourself “You’ve got HIV”. You know what I’m saying? Society has 
already scorned it as the killer gay disease. So you’re thinking, “Damn”. [I] knew 
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the lifestyle [that I] was leading, the unprotected sex [that I] was having, [that] it 
was just going to be a matter of time before it crept up through [my] blood 
stream. [I] just didn’t know when. For at least one participant, being diagnosed 
with HIV was completely shocking. For Maxine, who was diagnosed in the pre-
Highly Active Antiretroviral Therapy (HAART) era, the time period from 1981-
1996 when there were no effective treatments for HIV, and when she 19 years 
old, the news was completely shocking. Prior to testing positive, she had “never 
heard about HIV.” She explained,  
I had caught a charge for prostitution. One of the things that was 
part of the condition of the plea agreement…was that I had an HIV 
test going into the diagnostic center…I went to the center and they 
drew blood. I don’t even remember, prior to that, hearing anything 
about HIV really. I didn’t think it was ever a conversation about HIV 
that I ever remember having [when I was] younger, or prior to 
testing positive…My first introduction to HIV was when I tested 
positive, and I still didn’t really understand it.  
 
Kim shared a similar story. She said, 
 
I was called down after I did all of my little initial…blood work and 
counseling, and all of that. I didn’t know I was HIV-positive. I didn’t 
know that. They called me down to the doctor’s office, and the 
doctor told me, “Did you know you were HIV-positive?” And it 
seemed like my whole world just shattered. I was lost for words.  
 
In addition to the emotional stress of receiving an HIV diagnosis and other 
fears associated with being incarcerated, most women worried about issues 
specific to being HIV-positive while incarcerated. The fears included being 
“labeled in DOC [Department of Corrections] as getting meds,” being thought of 
as a bad person, and being shunned by other inmates. Lack of privacy was also 
a major concern. Chantel described the difficulties of keeping her HIV diagnosis 
a secret in prison. She said,  
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They called us down, and if it comes back positive, they come back 
and come get us and take us down, and tell us. But it’s kind of like 
putting your business out there too because most people know that 
once you done went through the orientation part, and if they call 
you back down there like that after the doctor did, you know, the 
blood work, then something’s not right. So it kind of puts a label on 
you, like oh you must be positive because it seem like the people in 
there look for that call back. You know oh, is this gay person going 
to get called back? And then when you get called back down there, 
it’s embarrassing and you come back and you’re trying to deny it, 
and you don’t want it to be true and you don’t want the people to 
start spreading rumors and gossip. 
 
Maxine described similar difficulties with maintaining her privacy in prison. She 
said, 
It was a horrible experience because the particular facility that I was 
in put these Plexiglas, sheets of Plexiglas up against our cells that 
had holes in it, moved our roommates out, we couldn’t eat in the 
chow hall, we couldn’t go to rec unless we went with each other. 
And this security panel where they open up all the bars, they had 
these huge, red things that said medical deadlock on them and 
everybody knew that [we were] HIV positive. 
 
The type of support the women received in prison or jail after receiving the 
diagnosis varied considerably. Maxine, for example, was given educational 
pamphlets to read about HIV transmission, Chantel was offered post-test 
counseling but refused because she was “too angry to talk to anyone” and was in 
“denial”, and Kim was offered, but declined post-test counseling because she 
was also in “denial.”  
In a hospital. Several women learned of their HIV status while 
hospitalized for treatment of other health conditions such as pneumonia, 
seizures, and infections. These women therefore had to manage the stress 
associated with those ailments along with the mental and emotional stress of 
being newly diagnosed with HIV. A couple of the women felt shocked, confused, 
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and distressed by news of their diagnosis. When Porsha learned that she was 
HIV-positive she was shocked. She said, “My heart was breaking because I know 
how careful I am with my sex life. I use a condom with doing everything. So it 
was like a real shocker. Like how did I get it? I had to really sit back and think.” 
By comparison, a couple of the women had suspected they were HIV-positive. 
Crystal, who was diagnosed when she was 47-years-old shared, “I think I had 
HIV for a long time and didn’t feel that I needed to get checked, and so that’s 
how I got to the point I was at with the pneumonia and stuff.” Similarly, Tiffany, 
who was 18 years old when she was diagnosed, expressed, “I was kind of in 
shock, but I was kind of relieved because I kind of knew.” 
The women who were diagnosed in the hospital had unique challenges 
that were not shared by women who tested positive in other settings. Most were 
given their test results right away and immediately experienced the world come 
crashing down. A couple of the women were intubated and unconscious when 
they first tested positive for HIV, and having the world come crashing down was 
delayed for them until they regained consciousness. Women who were critically 
ill sometimes learned of their diagnosis after a family member had already been 
informed. Crystal described how once she arose from her coma that her mother 
already knew about her HIV. She said, “My mother and my brother were there 
[and] when I woke up they already knew.” Most women learned of their HIV 
status from their health care provider, but one woman learned from her mother, 
that she was HIV-positive. When she admitted to the hospital after having a 
seizure, Porsha’s mother asked the doctor to “run all of the tests” to determine 
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why Porsha was having seizures. The doctor told the Porsha’s mother that the 
HIV test results were positive. When Porsha awoke from her coma her mother 
told her that she was HIV-positive. She said, 
My mom told me that I had HIV. [When] I woke up she made sure I 
was okay and everything. My brothers were there and then she was 
like, “Do you want them to know or do you want them to step out?” 
And I’m like know what? Because I’m lost, I just woke up out of a 
coma so I was like it don’t matter because they’re my brothers. So 
she told me, “Well I had some tests ran on you and we found out 
that you have HIV.”  
 
Unlike the health care providers who informed the women’s family about 
the women’s HIV-positive status first, Stephanie’s doctor asked her family to 
leave the room so that he could deliver the test results. She said, “They [the 
doctor] told everybody to leave the room, but I told him that my mom could stay.”   
Of all the women who tested HIV-positive in the hospital, Tiffany was the 
only one who received post-diagnosis counseling. She shared what happened in 
the moments after learning that her screening test came back reactive. A couple 
of women had little follow-up. Porsha, for example, said that the doctors talked to 
her about her high blood pressure and diabetes, but not her newly diagnosed 
HIV. Similarly, Crystal said, “Actually nobody said anything [about her 
diagnosis].” By comparison, Stephanie received only a referral upon discharge. 
She said, “I got discharged from the hospital and what they did was refer me to a 
primary care doctor and [then] he referred me to one of his colleagues in the 
building who was an infectious disease doctor.”   
In a HIV counseling and testing site. Several women learned of their 
HIV status at HIV counseling and testing site. This experience differed from 
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learning the diagnosis in prison or other settings because these women came to 
site specifically to find out if they were HIV-positive. Though most sought testing 
on their own, some were advised to seek testing. For these women the world 
come crashing down occurred the moment they were advised to seek testing and 
then again after learning their results. Star described how her “heart dropped” 
and she had “an out of body experience” when the health department contacted 
her to come in for testing. She stated, “A cold went over me and my heart was 
beating fast.” When a former romantic partner of Gretchen suggested that she 
get tested, she felt devastated. She stated, “In my heart I knew something’s 
going on. I think I knew I had it [HIV] before I even got it [the results].” Having the 
world come crashing down occurred multiple times over a several weeks for 
Gretchen: when it was first suggested that she get tested, when the rapid salivary 
test results were positive, when she received an inconclusive confirmatory blood 
test result, and when she was finally confirmed positive. She shared,  
I was kind of leery cause they did a swab thing and I thought no. 
The first one was reactive. She took a second one and sent it out to 
get a confirmatory result and it came back inconclusive. They 
wanted me to come back the following week to do a blood test. I 
had to wait three weeks just to get the results back on the second 
one and I’m dying over here to know. I wanted to know what was 
going on. 
 
Unlike most of the participants who learned their diagnosis in prison or jail 
or in the hospital, those who were tested at HIV counseling and testing center 
often felt supported by the staff after learning their HIV status. Brenda was 
diagnosed in 1990 (pre-HAART era) described her testing experience. She said, 
“It was very crushing, because I had a lot of friends that had passed away early 
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on. So when I found out it just devastated me…But the staff handled me with kid 
gloves, I couldn’t ask for better.” Star also felt supported by the HIV counseling 
and testing center staff. She said, “[They were] “real nice and sweet to me.” 
Despite her multiple experiences with repeat testing and inconsistent test results, 
Gretchen also indicated that the counseling and testing staff was supportive and 
helped her get the care she needed. ‘Drea, on the other hand, declined an offer 
for support because she was so angry about her diagnosis. She said, “They told 
me about counseling and things that I could get to help me cope with it [HIV], but 
I didn’t want to hear that. I was in so much rage. I was just in rage.”  
In a health care provider’s office. Other women learned of their HIV 
status in the office of a primary health care provider. The responses of the 
healthcare providers varied considerably and influenced how these women 
experienced their world crashing down. Elise felt supported by her doctor in the 
moments that followed her testing HIV-positive. She said,  
When I first found out about me having HIV I was on the verge of 
getting ready to give up. The doctor called me in and he got to 
talking to me and he was just telling me that just because I have 
HIV don’t mean that I’m going to die this soon.  
 
A couple of women, however, were not well supported by their health care 
providers. For example, Rachel’s doctor just gave her the news that she was 
positive. Unlike Elise, Rachel’s doctor did not provide additional verbal support. 
Rachel said, “She [the doctor] just told me, ‘You’re positive.’ Then [she] gave me 
a list of papers, numbers to call. I didn’t call for a long time. I just ran from it…you 
know.” Though these women were usually given test results face-to-face in the 
health care provider’s office, one woman received her test results from the doctor 
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over the phone and thus, received very little emotional or informational support. 
Denise described how she learned that she was HIV-positive. She said, “She [the 
doctor] called me. She called my home and told me, and I was ready to go then. I 
almost ended it all then.”   
Again women who tested HIV-positive in the pre-HAART era had 
especially difficult experiences throughout. Jessica, who was diagnosed in the 
late 80’s and was living as a gay man at the time, shared that she did not feel 
supported by her health care provider. She recalled: 
He talked me into getting tested and I was taken aback. I was afraid 
to get tested. I didn’t have any symptoms and this was 1987. I got 
tested and when I came back he gave me the news that I was HIV-
positive. I was hysterical. The only thing I remember him telling me 
is, “Well you probably don’t want to live to be old, do you?” I 
thought here is a gay man in his 60s telling me that I don’t want to 
live to be old. That was such a different time then too. There was 
only AZT.  
 
In a commercial plasma center. A couple of women were told of their 
HIV status while donating plasma to earn cash. Because commercial plasma 
centers did not have health care as their primary mission, the response of the 
staff to these women’s diagnosis of HIV could be matter-of-fact. Erica recalled 
the day that she learned that she was HIV-positive. She said, “I came in one day 
and was about to donate and they told me that I had become positive for HIV. So 
I went to an HIV clinic and I had them test me [again] and I came back positive.” 
Yet because staff in some centers knew the women, they could be quite 
supportive when the women learned of their HIV. For example, Cheron felt 
greatly supported by the plasma center staff in the immediate moments following 
her diagnosis. She said, “The people gathered around me, talked to me, and 
 
 
80 
things like that. I knew I could never go back there, but before I left [the plasma 
center] that day, I had a lot of support. I really did.”  
Interactions with Important Others 
Most participants interacted with important other people in their lives 
immediately following receiving a diagnosis of HIV. The responses of the others 
strongly influenced the participants’ experiences of the world come crashing 
down. These important others typically included family, friends, and romantic 
partners.  
Family members. Telling family members was difficult for some of the 
women because it required them to be vulnerable, trusting, and courageous 
during a time of emotional uncertainty. Some women found telling to be freeing 
because they were no longer burdened with keeping HIV a secret from their 
families, whereas others found it to be frightening because they realized it could 
lead to rejection and disgrace.  
Many women delayed telling their families about HIV, but some shared the 
news of their HIV status with their families without hesitation. These women felt 
safe immediately sharing the news with their loved ones because they were 
close to their family members and never worried that their families would reject 
them. Families of these women supported them through affirming messages and 
assurances. Tiffany, who was living as a gay male at the time she was 
diagnosed, and who tested positive while being treated in the emergency room 
for a tooth abscess, asked her physician to inform her mother of the diagnosis.  
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She said,  
The doctor told her, ‘I’m sorry, [but] your son did come back 
reactive for the HIV test. We would like to start him on meds and 
I’m going to link him up to a care coordinator.’ From there it went 
on. And my mother was like, ‘It’s going to be okay and from [then] 
on my mother [has been] very supportive. She was calm. I mean 
she cried…but other than that [was supportive.]   
 
Some families supported the women by listening, empathizing, and 
providing physical comfort. Rachel tested HIV-positive when she was 19-years-
old. She described how her family supported her in the immediate moments that 
followed her diagnosis: 
I [went] back [to the doctor’s office] and they told me I had it [HIV] 
and then I went to my grandpa’s house and laid in his lap and cried, 
[then] seen my uncle and cried. I was just a kid. I didn’t have 
[anybody]. My mom was a drug addict.  
 
For other women, not knowing how their families would respond made 
them apprehensive about telling about their HIV diagnosis. Women who had 
strained relationships with their families were especially unsure about sharing 
their news, and some avoided discussing their HIV status with family members 
from the onset. For some women, this apprehension was tied to their family’s 
previous reactions to news of their transgender identities. As a result, these 
women delayed telling their families about their HIV-positive status for many 
years. Drea’, for example, grew up in a very religious family and hid her 
transgender identity from her mom for many years said, “I kept it a secret for 
years that I was positive to friends and family. I didn’t want nobody to know.” Kim, 
who was rejected after coming out to her family as transgender when she was 
just 15, also feared how her family would respond to the news. She said, “If I 
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went to my family [about being HIV-positive], it probably would have been some 
negativity here and there, and it might have pulled me back to a place in my life 
that I didn’t want to go. So that’s why I haven’t told them yet.” Chantel, who kept 
her transgender identity from her family for years, also delayed telling her family 
about her HIV. She said, “It took me 17 years to tell my family because my family 
had just found out that I was transgender…And I didn’t think that my mother’s 
understanding would allow me to still be around my family.” 
Women who were hospitalized and critically ill when they were diagnosed 
and thought that they were going to die were forced to engage in the discussion 
about their HIV with their families. These interactions usually occurred before the 
women could process the news of their own diagnosis and even when they knew 
that their families would not be supportive. Crystal shared how unsettling it was 
to talk about HIV with her mom before she was ready. She said, “When I woke 
up they [mother and brother] already knew [that I was HIV-positive]. My mother 
was the type there was never any communication or discussion behind things…I 
didn’t like everybody knowing [about HIV] before I could really grasp what was 
going on.”     
Some families reacted to the news of the women testing positive for HIV 
with blaming responses. These family members were devastated by the news of 
the participants’ HIV, were angry with the participants for contracting it, and shut 
the participants out of the family members’ lives. The relationship between these 
women and their family members changed permanently and the quality of the 
relationship “went downhill” afterward the disclosure. Erin’s whose mom passed 
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away when Erin was just 14 and who was raised by her older sister, described 
how her sister reacted to her news that she was HIV-positive. She said, 
I told my sister [first] and she was devastated. I didn’t want to hide it from 
them [my family]. …When I told [her] she [said], “Okay, leave me alone 
right now. I have to be alone.” To be honest, [my] relationship [with my] 
sister went downhill [afterwards]. I’m pretty sure she was mad at me for 
contracting it [HIV]. She even told me that. She [said], “You should have 
known better!” She said, “I’m mad at you. I still love you, but I’m mad at 
you because momma raised us better than that. 
 
Rejection by family members added to the emotional trauma that 
participants experienced during this stage.  
Friends. A few participants initially kept their HIV status a secret from their 
families but shared the news with friends. The participants found that telling 
friends was often less challenging than tell family members, especially when the 
participants confided in a friend who was also HIV-positive. These friends were 
able to be empathic and responded to the participants’ news with compassion. 
Star described how her friend helped her through this stage. She said, “I told him 
[my friend] and he just talked to me. He [said], “Girl, I’ve been living with it [HIV] 
for this long and you see how I live? You see that I’m fine. You see that, you 
know?” And I was like, “You’re right. You are fine.” 
Because the fear of dying was heightened for women at this stage, their 
friends shared their own stories of living with HIV as a testimony of their survival 
to encourage and assure the women that “everything would be okay.” These 
women generally felt comforted by such survival stories and encouraged that 
they could successfully manage living with HIV as well.   
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Many of the women relied on their HIV-positive friends for help in getting 
connected to HIV care. Brenda, who worked as an entertainer, turned to a friend 
for help after her diagnosis. She said, “I went to work [that day], and I talked with 
another girl (transgender) that worked there in show. I told her and she guided 
me along because she was HIV-positive as well.” Similarly, Drea’ also turned to 
another transgender woman, who was also HIV-positive, for help.  These friends 
“guided” these women to services providing care coordination where they 
learned the “ins and outs” of getting a “good doctor” and staying healthy. 
Receiving assistance from friends with navigating HIV care minimized the angst 
that women felt during this stage.  
Romantic partners. Women had an especially difficult time telling their 
current and past romantic partners about their HIV status. The implications of the 
HIV diagnosis for women and their partners were far-reaching and had the 
potential to adversely affect multiple others, including the partners of the 
women’s’ partners. Telling partners was also worrisome because the women 
knew that a diagnosis of HIV could threaten the stability and quality of their 
romantic relationship and in some cases end their relationships permanently.  
The women found telling a current romantic partner of the HIV diagnosis 
was particularly challenging because of the implication that they may have been 
infected by their partner or that their partner may have infected them. The women 
and their romantic partners sometimes had to confront the possibility that one, 
the other, or both had been unfaithful during the course of their relationship. In 
some cases, disclosure of the HIV diagnosis brought to light that a partner 
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previously knew of his or her HIV status and intentionally withheld the information 
from the women. In other cases, a partner accused the women of infecting him or 
her. In many cases, a disclosure was followed by arguments and discord in the 
relationship. Gretchen, who was diagnosed when she was 48 and infected by a 
much younger partner, described how her partner reacted to her when she 
became upset to learn that he tested HIV-positive. She said, “[He said], ‘Well, I 
don’t know what the fuck you’re upset about. I’ve got my whole life ahead of me.’ 
And I just sat there and said, “You have your whole life ahead of you and I 
don’t?” Cheron, whose partner initially concealed his HIV-positive status from 
her, described how they argued after she tested positive and when she found out 
that her partner was previously aware of his own HIV-positive status. She said, “I 
was hurt. I was upset. I cried. I went back to him. At the time we were living in a 
hotel room. We got into it a couple of times and we’d argue [and] cry. I was 
devastated for a while.” 
Some partners initially scoffed at the women’s suggestion to get tested but 
eventually agreed to testing to assuage the women’s fears. Gretchen’s partner, 
for example, initially refused to get tested. She said,  
I made him get checked. I told him that he had to. [I told him], ‘You 
don’t have a choice.’ He said, ‘No, I ain’t got this shit. I know me, I 
know what’s going on with my body.’ I [was] like ‘You need to go 
get checked, please.’ So he did and he was totally negative. I had 
never had such a huge burden lifted off my shoulders. 
 
Women who feared that they might have infected their partners described 
feeling tormented by thoughts and fears of infecting a former partner and waiting 
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in agony for his or her HIV test results. This was particularly difficult for the 
women who were still dealing with the initial shock of their own diagnosis.   
Sometimes women notified a former partner in hopes that they would 
come to understand how they became infected. This was an especially delicate 
situation because it implied that the women’s former partners had infected them.  
Former partners responded to the women’s news of their HIV diagnosis in 
a variety of ways. Some former partners, who had maintained amicable 
friendships with the women after the romantic relationship ended, responded to 
the women in a non-threatening and positive manner. These partners provided 
emotional support and reassurance to the women. Gretchen described how her 
former partner supported her. She said, “What [are] you crying for? They got 
medicine for this shit.” I didn’t know what to say. He kept telling me that he was 
very sorry it happened and that even though we [didn’t] live together [anymore] 
[that he was here for me].” These women were relieved by these supportive 
responses because they had feared that the former partners would be angry and 
lash out.  
Other former partners responded in a negative manner. Some “blocked” 
the women from social media sites in order to permanently sever all 
communication with the women, and some denied knowing anything about HIV 
and ignored the women’s concerns. Porsha said that her former partner “just 
blocked her” after she told him that she tested positive for HIV. She said, 
I called him and told him that I had HIV and that [he] was the last 
person I had sex with without a condom. [Then I asked him if he 
had HIV]. I knew he had it [because] he just hung up on me. He 
blocked me from Facebook, Urban Chat, all of the websites.  
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Erin described how her former partners responded when she contacted 
him about her new HIV diagnosis. Erin said that her first partner, “Acted like he 
didn’t know,” and that he second partner told her that at his last check-up his 
doctors told him that he “didn’t have anything.” Such negative responses 
exacerbated the feelings of chaos that women felt during this stage and 
prevented them from getting the closure they sought. 
Finally because confronting a current or former partner about HIV was 
potentially volatile, a couple of women avoided discussing their HIV status with 
former partners entirely. When talking about her former partner ‘Drea said,  
He [was] the only person that I [had] been with. I didn’t understand 
[how I was infected]. Well, I found out he [had] been cheating on 
me for the last six months, and that was the last time since we got 
tested…So I wanted to kill him. It was like so much rage in my life. 
 
Tiffany encountered similar challenges about confronting the 
person who she believed infected her. She explained,  
You can never say [for certain] who just gave it to [you] because 
that’s a hard case to prove. But the person [who] I believe gave it to 
me…when I saw him, we talked and he [told me] that he was 
positive. I just never told him that he infected me. I had so many 
questions. I didn’t really want to get physical with him because it 
was just like he could have not known…[When I saw him] he 
looked bad. He didn’t look how he use to look.  
 
The inability to pinpoint by whom and when they were infected, or 
to talk to former or current partners about their new diagnosis magnified 
these women’s sense of their world crashing down and impacted their 
ability to move on from this stage. 
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Shutting the World Out 
The second stage of Having the World Change occurred after the initial 
shock of the women’s diagnoses subsided. We labeled this stage Shutting the 
world out. The phrase “shutting out” is used to describe the action of confining 
oneself to a closed space, excluding oneself from something, or isolating oneself 
from a situation.231 This phrase was selected because it resonates with how the 
women dealt with the shock of their HIV diagnosis by withdrawing from family 
and close friends, keeping their HIV a secret, denying the reality of their HIV 
diagnosis, and avoiding HIV care. One woman, for example, claimed that her 
“mind just shut down” and that she did not want to do anything after she was 
diagnosed with HIV. Although the women did not want to “face” their diagnosis, 
this stage was nonetheless marked by a good deal of inner turmoil as they felt 
anxious, helpless, and confused.  
Health Care Encounters 
The women typically experienced a three or four week lag between their 
initial HIV diagnosis and their first visit with a care coordinator and their health 
care provider. Much of the stage of shutting out the world occurred outside the 
context of a healthcare setting and without interactions with health care 
providers. Once women connected to a care provider, the nature of their 
encounters with health care providers, the characteristics of the health care 
providers, and the health care setting influenced how they experienced the stage 
of shutting the world out. 
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Care coordinators. Because women were shutting out the world in this 
stage, encounters with care coordinators that enabled them to confront the 
realities of their illness and connect with on-going HIV care were most helpful. 
The care coordination visit was typically the women’s first healthcare encounter 
following their initial diagnosis; therefore, many felt scared and “uneasy” about 
receiving help. Encounters with the care coordinators were also the first time that 
many women had discussed their HIV with anyone. Care coordinators who could 
act as “sounding boards,” and did not act judgmental, were able to establish trust 
and get the women, who were otherwise shutting out the world, to talk about their 
experiences and feelings about HIV.  
Kim described importance of her care coordinator in helping her cease to 
deny her illness: 
I connected with her quickly [even though] I was still in denial and 
was also taking meds. I can’t help but to get teary-eyed. So she 
made me realize that even though I have this disease I can still live 
a life and outlive most people that don’t have it. [She told me that it 
was] all about taking care of [myself]. It was the major turning point 
in my life that made me realize [I had to get] out of denial. [After 
talking to her] it was like the weight [was] off my shoulders.” Even 
though [she] was a stranger I felt relaxed and comfortable with her. 
 
Care coordinators also played a critical role with women who were 
shutting out the world by connecting them to healthcare providers, preparing 
them for their HIV medical visits, and helping them with the anxiety they felt 
about seeing the health HIV care provider for the first time. Care coordinators 
accompanied some women to their first appointments and helped them 
understand information given by the health HIV care provider. Chantel described 
her first visit to the HIV care provider. She said,  
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[My] care coordinator went with me on my first doctor’s appointment 
because I was really scared and didn’t know [what to expect]. She 
made time to go with me to sit in there and listen and help me get 
[to the point of being] okay…That made the transition [to see the 
doctor] so much easier. 
 
 Although most care coordinators were supportive when women were 
shutting out the world, some were not. For example, woman felt disheartened 
when they perceived their care coordinators to be aloof. Star said, 
I left the [care coordination] center altogether because I didn’t like 
their treatment. It wasn’t personable at all. [The care coordinator] 
was just kind of doing her job. You know what I’m saying? And my 
life is more to me than someone’s job. My care is more important to 
me than someone’s job. Not only do I deal with being HIV [positive] 
I also deal with being transgender, which is another life struggle 
that I’ve been dealing with forever too. So I take it very seriously. 
   
Women who perceived their care coordinators to be uninterested in their 
care were hesitant to return for services, and this prolonged the time they did not 
receive care.  
Health care providers (HCPs). Because women were shutting out the 
world, engaging with HCPs was often challenging as it meant facing the HIV 
diagnosis the women had received. During this stage, some women avoided all 
contact with their health care providers and “just ran from it [HIV].” They delayed 
care in order to “shut out” the HIV. Some women were reluctant to access care 
because they feared going to a clinic would expose that they were HIV-positive. 
As a result, many women did not receive consistent care and were thus at risk for 
adverse health outcomes. 
For women who did receive care from a HCP during this stage, the first 
visit was particularly unsettling as it was their first introduction to formal medical 
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care. Some women felt exposed when they began care and perceived that the 
world was “staring at them.” Even those women who sought care at clinics known 
specifically for HIV care wanted a more “discreet” way to access care.  
Because women were shutting out the world, HCPs who educated women 
about the realities of HIV, alleviated their fears about HIV, presented the grave 
consequences of avoiding treatment, and initiated HAART were most helpful. 
Such encounters helped women acknowledge their HIV disease, encouraged 
them to start treatment, and allowed them “come to terms with the fact” that they 
were truly HIV-positive. For example, HCPs who warned participants that 
“coming off and on” medications could cause medication resistance and limit 
their future treatment options helped women accept treatment. The HCP of one 
woman, for example, told her that if she delayed starting medication, her HIV was 
“going to turn into AIDS.” This woman started medication because she did not 
want to die. Kim described the moment when she had to make a decision about 
starting medication. She said, “She [her HCP] gave me a choice of three pills or 
one combined pill. So, [it] stuck in my head, death, or live your life…” 
In some instances, however, encounters with HCPs exacerbated the 
women’s withdrawal and denial. For example, women “shut down” when they felt 
“rushed” during their visit with the HCP, when they were not given time to ask 
questions or discuss their concerns, and when HCPs did not involve them in their 
treatment decisions. Porsha stated, “He [the doctor] talked about a lot of stuff that 
day. He moved so fast…We ran through everything; the medicine and all that. I’ll 
ask questions and it’s like they just rush through it…” 
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Some women felt that their HCP was uncomfortable providing care to 
them because they were transgender, and this experience particularly 
contributed to women’s avoidance of care and withdrawal from their care 
providers. Denise said, 
He [the doctor] did everything, but not like usually a doctor would 
do it. You know how the doctor will put the thing [stethoscope] on 
you and listen and all this and that? He wouldn’t touch right here 
(indicating her breast/chest area). You know what I’m saying? It 
was like really weird. But then after that, I never go to see the 
doctor again. I got a new doctor. 
 
Women also shut down and avoided care when their HCP referred to 
them as men. Maxine explained the inconsistencies in how HCP referred to her 
during her health care encounters contributed to her shutting down. She said, “I 
even hear people after the appointments, they [the HCP] might have said “she” in 
the meeting, but then when they’re talking among themselves, it’s “him” and “he.” 
Brenda also described the significant impact that being referred to as a male by 
her HCP had on her engagement in care:  
The nurse practitioner had a student in one day with me. She 
explained to the student in front of me, that even though I had the 
surgery I was still considered male. I said, don’t tell her that…I said, 
you know what, [just] because I have this chromosome or that 
chromosome doesn’t make me male. What makes you female or 
male is totally inside and out. I [told her] that there are women born 
every day without a reproductive system, which is terrible, but that 
doesn’t make them any less of a woman than I am now. I [then told] 
her don’t you sit there and tell that girl who’s trying to learn 
something that it’s that cut and dry. So I walked away from her and 
I’ve never been back.  
 
The lack of gender affirmation was, embarrassing, made some women 
reluctant remain in care, and interrupted their care experience. Porsha said, 
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It’s the most embarrassing part [being called by male name] 
because people will be sitting there next to me talking and thinking 
I’m a girl and everything. Then the next thing you hear [is] my first 
[male] name. So I have to get up and go up there and everybody is 
looking at me like, ‘Are you for real?’…[Once] the doctor walked in 
and walked right back out of the room. I heard him say, ‘Well, 
where is [referring to me by my male name]? They were like, 
‘That’s her.’ [The doctor responded], ‘That’s her? The door was 
open. He came back in and was like ‘I’m so sorry.’   
 
In jail or prison. For women who were shutting out the world and in jail or 
prison, interacting with health care providers was especially problematic. The 
women’s reluctance to acknowledge their disease or obtain treatment was 
exacerbated by the lack of privacy and confidentiality experienced while 
incarcerated.  
Prison health care providers often attempted to engage the women in care 
by repeatedly prodding them to attend their clinic visits and start treatment. Some 
women were irritated by these attempts because entering care would force them 
to confront the realities of their diagnosis and because going to clinic 
appointments would signal to other inmates that they were sick. Chantel said, “I 
[wanted them] to leave me alone, [to] just [let] me live my life, and make my own 
decision, my own choice. I didn’t want medication. I wasn’t ready for that 
decision. Especially not in prison.” Other women wanted to be “left alone” and 
refused treatment because they still felt healthy and were still able to do all the 
things that they did prior to their diagnosis. Kim, who was incarcerated multiple 
times and continued to deny the realities of her illness said, 
I went through a series of phases in my life where [after] I found out 
I had it [HIV], to see if my body, my immune system was really out 
of whack or still working. So when I realized that it was still working, 
I just automatically assumed that I didn’t have it. I didn’t lose 
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weight, and that’s another thing I looked at myself too. I said [to 
myself], ‘You’re not losing any weight, you’re still the same size, 
your appetite is still there.’ [I would] get a cold [and I would] get 
over it. [I would get] a cut [and it would] heal [in] the same [amount 
of] time [as before]. 
 
Even after being released from jail or prison a couple of women did not 
seek care until years after their initial diagnoses. A few women, however, 
received care only when they were incarcerated. Maxine explained, “I was never 
on the streets long enough to go the doctor. And if I was out on the streets long 
enough to go to the doctor I don’t like when I was out of prison it [HIV] was ever a 
concern.”  
In a hospital. Some women were hospitalized for treatment of other 
health conditions during their shutting down stage. The family members of these 
women learned of the participants’ HIV status from the participants’ HCP by 
chance. Star, who was avoiding telling her family about HIV, said, 
My family found out…because I broke both of my heels. I was in 
the hospital and the doctor came in. My sister-in-law was sitting 
there, and the doctor came in and said something [like], ‘Is it okay 
for her to be here?’ I was like yes, [it’s] fine. [Then] the doctor said 
something about [me] being HIV-positive. I just had to respond 
normally. I looked over at her and she was crying…she had to 
leave the room because, you know, she had just found out that I 
was HIV-positive…And I said, ‘Don’t tell anybody.”  
 
Stephanie shared a similar experience. She said,  
 
“My step-dad found out from my doctor. The doctor came in and 
said, ‘Oh, you’re HIV-positive.’ And my step-father was sitting there 
and I just looked real alarmed. He [step-father] was so calm and he 
never reacted. So that’s how he found out.   
 
While this manner of revelation was upsetting to the women and their 
family members, it did help these women move from the shutting out stage. 
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Women felt “relieved” and no longer felt “pressured” to initiate the discussion with 
their family members when their health care providers shared the news. These 
women felt more comfortable sharing their HIV status with other family members 
after their health care providers made the initial disclosure. Stephanie explained 
how after her step-father found out, she “eventually told her aunts because she 
was real close to them.” Star also shared the news of her status with her mom 
after her sister-in-law unintentionally learned of Star’s HIV status. She said, 
[Afterwards] I told my mother. My mother didn’t cry, but my sister was still 
crying…They didn’t treat me any different.”  
Mental health professionals. Some participants received care from 
mental health professionals including psychiatrists and licensed mental health 
social workers. Though these professionals were often tasked with helping 
participants come to terms with their new HIV diagnosis, the participants often 
shut down more as a result of these encounters. Denise described how she 
withdrew from mental health care after an encounter with her psychiatrist:  
The [psychiatrist] said, “I’ve never dealt with anybody like this 
[transgender] before.” I looked at him and said, ”Well, honey is 
there some kind of paperwork I need to sign for you to release your 
duties or something? Because this ain’t going to work.” He said, 
“No, but I will put you back in the system so you can find a new 
doctor.”  
 
In addition to wanting support and guidance on managing life’s 
challenges, women also wanted guidance and support on how to move forward 
as women and disclose their transgender identity to others, but often felt they 
could not talk to their psychiatrist about this. Crystal described why she avoided 
talking about her transgender identity with her therapist: 
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I deal with the HIV better than I deal with anything. The only things 
we [she and the psychiatrist] talk about [are] stress [and] things that 
release stress because I deal with a lot of things. So we don’t just 
talk about the HIV. I don’t have a problem with HIV. I can deal [and] 
live with that…The transgender, no. I actually don’t have anybody 
to really talk to about that. [Nobody] I really trust about the 
transsexual stuff. Not that I can’t talk to my psychiatrist, but I 
haven’t. There [are] other things that made me feel [more anxious]. 
 
Having a mental health provider who did not understand the women’s 
needs as transgender women caused them to shut down further. A couple of 
women were referred to a licensed mental health social worker for support in 
dealing with HIV and other life stressors. While these professionals were 
perceived as more helpful than psychiatrists, the therapists’ approaches could 
also be off-putting and thus cause the participants to withdrawal even further. 
Gretchen described how the therapist asked her questions: “Sometimes [the way 
that] therapists act [when they say], “Oh really, and what did you do then?” and 
how they act makes me want to look at them and say, “God, do you have to act 
like that?!”   
Auxiliary staff. Encounters with auxiliary staff such as front office 
administrators, receptionists, and medical assistants could also influence 
participants’ experiences of shutting out the world. Because these care providers 
were often the first point of contact for participants prior to their visit with a care 
coordinator or HCP, they played a critical role in setting the tone for the entire 
visit. Prior to their care coordination or medical visit, women would check-in with 
a front office receptionist or medical assistant. During this encounter women 
would sign their names and then provide copies of their driver’s license or other 
photo identification and their insurance information. Because most women had 
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not completed sexual reassignment surgery, their legal documentation still 
contained their male names. As a result, front office staff would refer to the 
women by their legal male name, or other pronouns such as “sir,” “he,” and 
“Mister” instead of their preferred name. Women were especially embarrassed 
when these staff referred to them as men even though they were dressed as 
women and when these interactions occurred while others were also in the 
waiting room. These experiences often discouraged the participants from 
following through with their care appointment and thus exacerbated their process 
of shutting out the world. Jessica said, 
Just the whole thing in waiting rooms and everything, of people 
[calling me] Mister. Or they wouldn’t, until I got my drivers licensed 
and everything changed, wouldn’t [call me by my preferred name]. 
They wouldn’t put it on my chart…I had to remind people. Because 
they wouldn’t look up, they don’t look up. They don’t look at you. 
They just look at a chart and then start calling you sir and all of that, 
and Mister. There were times when I got pretty heated with some of 
them. And, [if] I [was] sitting in the waiting room, I wouldn’t even 
answer.  
 
Chantel described how upsetting it was to interact with auxiliary staff. She 
explained,  
The woman at the desk continues to call me he. I asked her more 
than once to quite calling me he…I mean I have breasts. I’ve had 
work done. I mean whatever her thoughts are, [she] should be 
keeping them to herself. If I go off [on her] I’d be wrong. I mean just 
every time I go in there and she says he. I’m just like screw it! That 
shows how much [she] respects me. That just makes me not want 
to go. 
 
In other instances, however, front office staff would protect the women’s 
identities by using removable sign-in stickers that would not allow other clinic 
attendees to see their names on the list. Because some women felt uneasy 
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about sitting in the waiting room of an HIV clinic, some front office staff gave 
them the option to wait in a more private room until they were ready to be seen 
by the HCP. Women also felt more welcomed and were less inclined to 
disengage from care with auxiliary staff referred to them by their “girl name,” and 
when staff used pronouns such as “she” and “her” when referring to them.  
 Support groups. A few women were referred to support groups to help 
them manage the psychosocial stress of their new diagnosis and to meet other 
people who were living with the disease. Women attended these groups, but 
seldom felt included. In some cases, support group sessions made women feel 
more ostracized. Gretchen said, 
They [care coordinator centers] have support groups, but they 
really don’t have any support groups for girls like me…Most of the 
help available out there for HIV, especially at the [care coordinator 
centers] is geared towards the gay community…In my heart it was 
very wrong [to include] transsexual women into the [Lesbian, gay, 
and bisexual (LGB)] umbrella. 
 
 Interactions with Important Others 
During the Shutting Out the World stage women often avoided activities 
and interactions with important others or interacted infrequently with them to 
keep their HIV a secret for a longer period of time. Avoiding encounters with 
others however led to social isolation that in turn often worsened the women’s 
emotional distress and fear and reinforced their denial of their illness. How 
important others reacted to the women avoiding them and or to the women’s 
revelation of their HIV strongly influenced how the women experienced this 
stage.   
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Family members. Women were especially likely to avoid family members 
whom the women feared would reject or judge them because of their HIV status. 
Telling a parent was the “biggest obstacle” for some participants because of the 
negative stereotypes associated with HIV and because of the shame women felt 
about their HIV status. Not disclosing their HIV protected some women from 
negative responses but also shut them off from potential sources of support. 
Many women felt frustrated because they wanted their families to know about 
their HIV but did not know how to tell them about their diagnosis.  
The pressures of keeping their HIV a secret from their families eventually 
began to “eat [away]” at these women and created additional emotional distress. 
Some eventually shared the news with their families because they were so 
emotionally distraught that they would “break down at the drop of a hat.” In some 
cases, the women’s emotional breakdowns prompted family members to ask 
questions and encourage the participant to “open up.” For example, ‘Drea’s 
mother asked questions to determine why the ‘Drea was always so tearful. She 
said,  
My mother is just a wonderful person. She knows everything, I feel 
like, sometimes. She [kept] saying, ‘Something’s not right about 
you.’ She kept saying it for years, [that] something was not right. 
She knew that I wasn’t dating [any] more. She knew he [boyfriend] 
had cheated on me. But she didn’t know everything. And, I told her 
[about HIV]. I just broke down in tears. I cried. I boo-hooed. She 
said, ‘You should have told me. You should [not] have fought this 
alone. We’re here for you.’ [Since] then my sister, and my brother, 
and [the rest of] my family [have] been there. That’s when things 
actually picked up for me. 
 
Parents’ acceptance of the women lessened their sense of shame and 
subsequently their avoidance and withdrawal. In addition, positive messages 
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such as, “I still love you” and “I still accept you for whatever the circumstances” 
gave the women the courage to reconnect with other family members. Star 
described how she felt after telling her family that she was HIV:  
I felt like a burden was lifted off of me. When I told my family, I felt 
like I could tell the world. I feel like that was what mattered, was my 
family knowing. I was relieved of that pressure of hiding a deep 
secret. 
 
Family members who were knowledgeable about HIV were able to help 
women understand the course of the disease and the realities of treatment.   
Women diagnosed during the pre-HAART era were especially fearful of 
being rejected by their families and kept their HIV a secret to prevent their 
families from “shying away.” During the pre-HAART era people believed that HIV 
was spread through casual contact and thus pre-HAART women especially 
struggled with telling they were HIV-positive because they could lose all ties with 
their families.  
These families responded in varying ways. Brenda’s mother, for example, 
learned through “soap operas” that she watched how HIV was spread and thus 
did not fear being infected by touching or hugging Brenda. Physical support such 
as hugging or touching was very affirming and instrumental in moving these 
women from the shutting out stage. Families who were not aware of how HIV 
was spread, however, responded in a way that made participants feel 
unaccepted. Jessica, who was diagnosed with HIV during the 1980’s said, 
The only thing that was weird was that I was at a family dinner, like 
a Thanksgiving or something. I had a drink, like a pop, or 
something with ice, and my little niece went to grab for it. I was the 
first one that said no, and everybody else was like, ‘No!’ and ran 
towards [her]. People didn’t know really know a lot.  
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Some family members never questioned the women about their 
withdrawal and avoidance of family contact. These women resented this because 
they felt that their families should have known that they were going through a 
difficult time even without them “saying anything.” Chantel explained, 
I was depressed. I stayed depressed for a longtime. I started 
having anxiety attacks. I felt like people didn’t understand what I 
was going through, even though they [didn’t know]. I didn’t know 
how to tell them; [and], I didn’t tell them, but I felt like they should 
still understand that I’m going through something. Whatever it [was] 
didn’t matter, [they should have] just understood that I was not 
feeling [well].  
 
Some women disclosed their HIV status to their families but family 
members were either silent or responded negatively to the women, and this 
further exacerbated their isolation and withdrawal. Many women had previously 
strained relationships with their families because they were transgender. Some 
of these family members further shamed the participants because of their HIV 
status. Monique explained, “My dad thinks that if you’re a homosexual the 
consequences of your sins [is that] you will get HIV.” These negative responses 
from family members created additional tension between the women and their 
families and resulted in some women permanently severing ties with their family 
members. For other women, the negative reactions from their families pushed 
them further into drug use and other self-destructive behaviors. 
Friends.  Some women also shut out their friends, not wanting to 
disappoint them because of the newly diagnosed HIV. Porsha for example, 
claimed that she was reluctant to tell her friends that she was HIV-positive 
because she had previously advised them to be careful and protect themselves 
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from HIV and therefore feared she would her look like a “hypocrite.” Other 
women were selective in which friends they told of their HIV status. For instance, 
some women disclosed their status mainly to their HIV-positive friends, close 
friends, and friends who were health care workers.  
Women felt less isolated when they had friends who were HIV-positive. 
Crystal, for example, said, “Because I had friends [that were HIV positive], I was 
aware of the situation [and] knew what to expect.” HIV-positive friends also 
helped women engage in care by advising them on which agencies were “good,” 
dealt best with transgender women, and were most discreet. Drea, for instance, 
sought a friend’s advice on where to go for care. She said, “A friend told me 
[about a clinic that] could help me over all the other agencies [and] get me 
everything [that I needed].” This information was especially helpful to women who 
had delayed entry into care because they feared others finding out about their 
HIV status.   
For some women being part of the “entertainment industry” and knowing 
other transgender women who were entertainers and HIV-positive lessened their 
fears about living with HIV and helped them come to terms with their HIV. Brenda 
described how being in the “majority,” meaning being an HIV-positive entertainer, 
helped her accept her HIV:  
A lot of the entertainers are in the same boat that I am. So we 
break the ice, especially in the back rooms and stuff where the real 
show goes on, with levity about the situation. We know it’s serious. 
But we handle it better than most people because we’re 
entertainers and we’ve got to. 
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By comparison, women who did not interact with other transgender 
women were more like to deny their illness, avoid care, and have a difficult time 
coming to terms with their illness. Denise, for example, avoided telling her family 
and friends about HIV for a “long time” said that she “really [didn’t] deal with any 
of my kind [transgender women]. Elise, who also struggled with moving out of 
this stage, said that she did not “fool with” other transgender women. Some 
women who were diagnosed during the pre-HAART era came to terms with their 
HIV much faster and initiated HIV treatment early because they had witnessed 
the devastating health effects of HIV on their friends who “did not take care of 
themselves or get healthcare.” Remembering how their friends suffered 
motivated them to remain engaged in care. 
Some women lingered in the shutting out stage for some time because 
they found it hard to trust their friends enough to be open with them. Rachel 
described the people that she knew as “very shady,” and explained how not 
having friends that she could trust, influenced her shutting down. She said, 
I didn’t have no brothers, no sisters. I didn’t have no family. 
Everybody that was around me was around me for hustling, and I 
just felt horrible…I was really depressed because I was pretty much 
alone out there…A lot of everybody [was] going through the same 
shit. 
 
Gretchen also lingered in the shutting out stage because she did 
not have any friends to talk to. She said, “I’m in a situation where I don’t 
really have anybody to talk to about this stuff. So I just started talking to a 
therapist because I was having a lot of anxiety about it [HIV] and not being 
able to sleep.” Stephanie’s shutting out stage was also prolonged because 
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she did not have anyone to talk to. She said, “I couldn’t share the news 
with anybody, so I just started dealing with it [by] myself.”  
Romantic partners. Many women avoided romantic partners during the 
shutting out stage as the women blamed their partners for infecting them, felt 
guilty that they infected their partners, or wanted to avoid infecting their partners. 
Porsha described why she avoided intimate relationships: “I don’t want no [HIV] 
slip-ups, I don’t want no accidents, I don’t want nothing. Because a lot of men 
want to have sex with you without condoms.” For some women, withdrawal from 
romantic partners worsened the isolation that participants endured at this stage, 
and some feared that no one would ever want to be with them again. Stephanie, 
for example, said “Who’s gonna want to be with me? Who’s gonna want to be 
with a pretty sick girl?” For these women, having to tell others that they were HIV-
positive was “worse than telling someone [that they were] transgender.” By 
avoiding dating, they could avoid disclosing their HIV status, could avoid risking 
their privacy, and could avoid rejection.  
Some women struggled with whether or not to tell their romantic partners 
that they were HIV-positive. Chantel described this dilemma:   
I [had] to get it in my mind that if I take a chance and have sex or if I 
felt like I could trust [someone] enough not to harm me. Because 
words are very deadly [and] dangerous. I was scared to let people 
know that I [was] positive...I’m  a lonely individual and I like people, 
but over the years I’ve learned [that] I don’t have to tell them if I’m 
[not] going to have sex. Then, I need to let them know. 
 
Some women did begin dating during this period without disclosing their 
HIV status. These women initially delayed telling partners about their HIV 
because they feared rejection. If partners rejected the women when their HIV 
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status was revealed, the women were more likely to avoid future relationships 
which then exacerbated their loneliness. Other women disclosed their HIV status 
to partners to fulfill to their legal and moral obligations. Prospective partners 
responded in a variety of ways. Some ended the relationship immediately, which 
hurt the women and discouraged them from pursuing subsequent relationships. 
These women grieved the loss of current and future relationships and further 
withdrew from others. Denise explained, “My goal was to be in a relationship, 
have children, and even a career. But who would want to be in a relationship 
[with me]? I could barely even get a man to understand me being a woman and 
respecting me as one [before HIV].”   
Partners who were HIV-positive helped women who were shutting out the 
world come to terms with the realities of their diagnosis by helping them deal with 
the fear and uncertainty they felt about having HIV. They also encouraged the 
women to engage in care by attending their appointments with them and 
reminding them to take their HIV medication. HIV-positive partners also lessened 
the social isolation and fear of rejection that the women experienced during the 
shutting out stage.  
  No one. Several women kept the news of their HIV diagnosis to 
themselves for a lengthy period of time following their initial diagnosis and 
therefore received little support in this stage. These women did not tell family, 
friends, or current or former partners because of embarrassment or fear of 
rejection, and struggled with keeping the news from their families for years. Kim 
never told her family because she did not know how to start the discussion. 
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To this day [five years after being diagnosed] I still haven’t told my 
family. They don’t know. I haven’t really found the courage or 
strength to tell them. I don’t really know how to, that’s the thing 
about it. I don’t know how to get them all together in a room and tell 
them that I’m HIV-positive. But I’m not letting it be a weight on my 
shoulders.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
107 
Living in a Dark World 
The third stage of Having the World Change occurred when participants 
engaged in health- and life-threatening behaviors and descended into a 
dangerous world. We labeled this stage Living in a dark world to capture the 
hazards and devastation that pervaded the women’s lives at this point. The term 
“dark world” refers to a dismal, bleak, and dark place of existence232 and thus 
best captures the sense of despair that the women experienced during this 
stage. One woman, for example, believed that she was stuck in a “continuous 
cycle” of destruction. Drug use and sex work presented particular dangers for the 
women.  
Some women began to “binge drink,” smoke marijuana, and “self-
medicate” with other drugs in an attempt to deal with their HIV, whereas other 
women who already had a long history of drug abuse increased their use during 
this period, leading to other high-risk behaviors. For example, some women 
engaged in unprotected sex work encounters to procure drugs, thereby 
increasing their risk of reinfection and their clients’ risk of infection. A few women 
also engaged in illegal activities such as fraudulent check writing and “boosting” 
(stealing merchandise for the purpose of reselling) as a way to earn more money 
for drugs.  
The stress of the HIV diagnosis in conjunction with other life struggles 
such as homelessness, unemployment, lack of family support, and being 
transgender caused some participants to initiate sex work and others to increase 
their involvement in the sex work they had engaged in before the diagnosis. 
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Women were often pushed into sex work because they could not get jobs as 
transgender women. Despite the risks associated with sex work, many 
participants felt “stuck” because they had no other options for employment. As 
Tiffany said, “If I don’t do this anymore, how am I going to live? I can’t get a job 
as a transgender [and] I’m not happy as a male. So what do I do?” Women who 
engaged in sex work often used drugs that “put them in the mindset” for sex work 
and helped them “get into character.”  
Some women were “on the verge of giving up” during this stage and 
became suicidal. Women who had a history of depression were especially prone 
to becoming suicidal during this time. A few women made overt suicide attempts, 
and others “overdosed” on drugs in an attempt to end their lives. Rachel, for 
example, increased their use of “hard drugs” such as methamphetamine, heroin, 
and crack and used them in quantities large enough to cause death. A few 
women made suicide gestures such as sliding a razor over their wrists and 
“staring down” the barrel of a loaded gun. Denise said, “Sometimes I think about 
hurting myself because it really…it really is hard, it’s hard…It’s hurtful. I wanted 
to slit my wrists. I didn’t want to live no more.”  
During this stage, sex work, drug use, and life has a transgender woman 
occurred in the context of a dangerous milieu of the “streets.” Because of their 
transgender status, many women feared being attacked “on the streets.” They 
were often in danger of being killed or injured, rape, or robbed. Women described 
constantly living in fear for their lives and always worrying if someone would kill 
them just because they were transgender. Porsha, for example, said, “Life is 
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really hard for us transgender women out here.” Women had been harassed and 
brutalized by police, assaulted and raped by men, and verbally threatened, 
harassed, and called names such as “he-she-freak” by those they encountered 
on the street. The world of sex work was especially precarious. These women 
were also at risk for being killed or raped when refusing to perform certain sex 
acts. 
Health Care Encounters 
The most common pattern of health care encounters that occurred during 
the stage of living in a dark world was inconsistent or no care. Women interacted 
only sporadically with care coordinators, primary HIV care providers, providers at 
drug rehabilitation centers, and providers at homeless shelters. These 
encounters, however, influenced how the women experienced life in a dark 
world.  
Care coordinators. Women’s encounters with care coordinators during 
this stage often focused on the participants’ unstable life patterns, unsafe 
environments, and risky behaviors. As well as refer participants to HIV care, care 
coordinators also helped them secure housing, obtain food vouchers, and 
complete applications for insurance.  
Some participants sought help from care coordinators for their self-
destructive behaviors. Care coordinators advised participants on how to manage 
these behaviors and avoid behavioral triggers, such as friends who used drugs 
and parties were drugs were available, as well as encouraged them to consider 
substance abuse treatment. Care coordinators who were supportive but not 
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authoritarian were most helpful. Chantel said, “They would give me their opinion, 
[but said] that [it] was up to me to make a decision [about] whether I wanted to do 
it or not. They were not forcing [me]. They [were] just suggesting that maybe it 
was not good for [me].”  
Despite the chaos that consumed their lives during this dark stage, some 
women attempted to “stay in touch” with their care coordinator. Chantel explains, 
“During my usage I was missing a lot of my appointments. I stayed in touch with 
my care coordinator and tried to stay up [with my appointments]. But my using 
and alcohol wouldn’t let me.” During times when the participants’ self-destructive 
behaviors and unstable lifestyles interrupted their care, care coordinators often 
made repeated attempts to reengage participants in care.  
The women’s functioning during the stage of living in a dark world was 
improved if they maintained even intermittent contact with their care coordinators 
by “drifting in and out of care.” Even brief encounters allowed care coordinators 
to reconnect with participants and discuss the risks inherent in their behaviors. 
Care coordinators continued to encourage participants to receive services 
regularly despite the chaos in their lives. The care coordinator of one participant 
told one woman, “When you’re ready [to get help], you let me know. The in and 
out, in and out, it’s too much.”  
On the other hand, women who avoided all contact with their care 
coordinators did not have access to HIV care for extended periods of time and 
did not take advantage of the help and resources available through care 
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coordination programs. Tiffany, who was homeless, used drugs, and worked as a 
sex worker never showed for her initial intake: 
He [care coordinator] kept trying [and trying] to get in touch with 
me. [He would call and say], “We have to get in touch with you 
[and] start your first intake.” [I would say], “Yes, I’ll meet you, I’ll 
meet you. [But] would never go. At that point I guess the symptoms 
went away…and I [didn’t] have time to worry about meds and stuff 
like that. I needed to get housing and stuff. 
 
Health care providers (HCPs). Encounters with HCPs at this stage 
centered on the adverse health consequences associated with the participants’ 
risk behaviors. Women who dwelled in this stage were preoccupied by their life 
struggles at the expense of attending to their HIV. For these participants, HIV 
was not an “immediate” health care need and many missed HIV care 
appointments and delayed starting medication because they were “getting high.” 
Participants who were taking HIV medication also experienced multiple treatment 
interruptions because of their illicit drug use. Some of these participants would 
discontinue their medication therapy altogether, and others would medications 
irregularly. Chantel said, 
I would stay disconnected [from care] for like three to four months. 
But it didn’t stop me from going to get my medication. I didn’t stop 
my medication. I just would have big days that I would miss. Two or 
three days I’d miss; [and] then, I’d take them again. I always tried to 
make sure that I kept my medication around regardless.  
 
The lack of consistent HIV care created additional health challenges and 
further exacerbated their health damaging behaviors. For instance, some women 
who went on and off of their medication experienced HIV drug resistance, 
progression to AIDS, and higher “numbers [HIV viral loads].”  
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Similar to care coordinators, staff at the HCPs office often contacted 
women who missed their appointments by phone to find out why they did not 
show for their appointments and to reschedule their visits. Some women felt 
“bad” about missing their visits, but “made [up] excuses” about why they did “not 
show,” and continued to skip their visits. 
However, the few women who did attend appointments regularly had an 
opportunity to talk about their drug use and other life-threatening behaviors with 
their HCPs. Many of the women who used drugs were aware of their dangers, 
and thus these participants informed their HCPs about their drug use. Chantel, 
for example, stated, “I [had] to let them [HCP] know [about the drug use] so they 
[would] know what they [had to] do on their end to keep me okay.”  
Some HCPs used the health care encounter as their opportunity to 
challenge women about their drug use. These providers were firm in their 
recommendations that participants stop using drugs and warned them of the 
adverse health consequences. Elise told her doctor that she was “getting high” 
stated, “My doctor was like, ‘Make a choice. Either you keep getting high or get 
the treatment and take the medications so that [you] can live longer.’ And I chose 
the medicine.” Other providers were more supportive than challenging but still 
instrumental in helping women move beyond the dark world.  
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Rachel said, 
I had a nervous breakdown. I was doing drugs real bad and went to 
the doctor and just broke down. [I told] the doctor that the reason 
why I do this stuff is because I’m depressed, I have low self-
esteem, I felt alone. I was messing with heroin, [and] I OD’d a 
couple of times. It was depression [and I was] self-medicating with 
drugs…She hugged me, and of course, [asked me] if I wanted to go 
to rehab, and comforted me in the best way she could. 
 
Inconsistent or no care was also common among women who 
experienced other adversities beyond those of drug use. For example, having 
multiple chronic health problems, living in poverty, and not having transportation 
could disrupt care. Women who moved around frequently due to homelessness 
had a difficult time remaining consistent with care, which added to their emotional 
stress and caused them to be physically ill. Several women only sought care 
after acquiring pneumonia. For these women, the onset of illness or other 
physical symptoms of HIV prompted them to connect to HIV care.  
Jails or prison. Several women were arrested and jailed for their 
involvement in sex work. These women often delayed or dismissed HIV care 
altogether because they did not want other inmates to know that they were HIV-
positive. Some women were incarcerated numerous times and had a more 
difficult time staying “consistent” with their HIV care. For example, some women 
would adhere to their HIV care when they were not in prison and would stop 
treatment when they were re-incarcerated. These periodic lapses in care resulted 
in irreversible health consequences for these participants. Maxine said,  
The most important thing for me at that particular time was to not 
have to deal with that [HIV]. Nobody dealt with it in prison. [I would] 
go to the  doctor and they’d take my blood. It wasn’t about 
medication…I was still on drugs and couldn’t stay consistent to [my] 
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HIV [treatment]. At this point in my life I’m on the last choices [of HIV 
medication] until they make more.  
 
Mental health professionals. Some women were referred for mental 
health care to for help in dealing with their life struggles but declined. For these 
women, HCPs recommendations that they receive a “psychological, psychiatric 
evaluation” were not welcomed. Tiffany said, 
They thought I needed a psychological, psychiatric evaluation 
because I explained to them everything [the drug use, prostitution, 
homelessness that I had gone through]. I [told them] “I’m fine. Trust 
me.” She said, “We do this all the time.” She was trying to give me 
her professional viewpoint. I [was] like, “No, I’m alright. Trust me. 
I’ve been going this long. I don’t need to sit in a room to have 
somebody tell me what they think I should do because they’re 
going home to their three-bedroom house, their wife and kids, and 
dog. I’m not. So…you can’t tell me how to live [in] my shoes based 
off a book you were trained in in college until you live it. So we had 
that battle, and of course I never went to see [the psychiatrist]. 
 
The women were especially offended when they perceived that they were 
recommended for mental health care because they were transgender. 
Drug rehabilitation providers. Some women were referred to drug 
rehabilitation programs to help with their addictions. They received treatment in 
residential programs, inpatient treatment programs, or support groups. These 
treatments were not often helpful. Often the participants felt threatened in 
treatment because of they were transgender or because they were not ready to 
commit to recovery. Rachel said,  
I went to rehab twice and rehab just isn’t for me. Being a 
transgender woman and going into these rehabs, they expect you 
to use a men’s restroom, [and] you have a bunch of catty women 
that are making comments and stuff…I only stayed in rehab a 
week. Not having structure in my life and then going into this place 
and having structure, I felt like I don’t need to be here. I can [just] 
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leave. Which was stupid. I should have stayed the course. But the 
mentality that I was in, [I just said], let’s go.  
 
Although most staff members at drug rehab centers were inexperienced in 
caring for transgender persons, some women attributed their successful 
completion of drug treatment to the drug center staff. Drug center staff were most 
helpful to the women when they normalized their interactions with the women, 
treated the women with “respect,” and who ensured that the women had a 
welcoming environment. 
 As part of their treatment for substance abuse, some women were 
referred to group therapy for help with managing their addictions. Only those 
groups that used a personalized approach, however, proved to be helpful. 
Chantel said, “I don’t like a big crowds of people…I can deal with it, but I need to 
talk to somebody about something more personal, more intimate. I know [that] I 
keep using, [but] what is my problem? I don’t understand.” The lack of one-on-
one interactions prevented women from exploring the deeper issues related to 
their substance abuse and prolonged their recovery. 
Staff in homeless shelters. Several women in this stage were homeless 
and sought housing at shelters or boarding homes. The environment in the 
homeless shelter could cause further distress. Some negative encounters with 
staff in the homeless shelters intensified the instability of their lives. Cheron, for 
example said, “It’s nasty [and] not fit for nobody, period.”  
As a condition of receiving temporary shelter, women were expected to 
present as men and they found this highly distressing. Cheron said, “They put 
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you in there with all of the men. They make you take off your hair, your makeup, 
all of that. You have to because you have to blend in.”   
Participants who stayed in homeless shelters also worried about their 
belongings being stolen by others and feared for their safety. Tiffany, who was 
sick with pneumonia and who had recently been “kicked out” of a friend’s house 
said,  
I went to the drop-in [and] my fear was tuberculosis. The people 
[were] dirty [and] trying to hit on me… It was hard. I mean having to 
take showers with other guys, you know? Getting talked to [like I 
was] crazy. I had to go in with the guys [and] dress up like [a guy]/ I 
couldn’t be on the female side because they said females might 
have an issue…[Then] my suitcase [was stolen]. I [tried] to get my 
stuff back, but it was to the point that I’m like, you know what? Fuck 
it. I don’t’ even care no more. I just took what I could get [back] and 
left from there to start over. So it’s like I kept backpedaling. It was 
horrible. 
 
Some women sought temporary refuge in a boarding home. While the 
purpose of the boarding home stay was to give women time to reestablish 
themselves, it usually exacerbated their troubles. Crystal, for example, said, “It 
was like a drug haven…I ran away with the drugs.”  
Interactions with Important Others 
Like with the prior stages, women’s interactions with important people in 
their lives at during the stage of living in a dark world influenced how they 
experienced this time. These important others included family members, friends, 
and romantic partners.   
Families. Most women interacted only intermittently with their families 
during this stage. For most women, these occasional encounters with family 
members helped minimize the chaos in their lives. Rachel, who was 
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“prostituting,” using drugs, and living in hotels, described her dark world stage, “I 
took a break from all the road and stuff, and went and stayed with some family, 
and just got myself together. Got on some right medication that didn’t make me 
depressed, and then went back out on the road again.”  
Some women, however, were driven to heavier drug use because of 
family tragedies. Family tragedies could also trigger depression and suicidal 
thoughts. Chantel said,  
My nephew was in a school bus crash. He was only six years old 
and he lost his leg…He was in a coma for a month and I went [to 
be with] him for two weeks straight…I started using [real]…I was at 
that point where I really didn't care. I kept taking my medication, but 
just didn’t care about anything else in life…I was drinking heavy, I 
just didn’t care. I was suicidal [and] didn’t want to be bothered. 
 
Women who were incarcerated and heavily involved in drug use during 
this stage often had no contact with their families. Others were isolated from their 
families because of abuse within the family. Family estrangement could worsen 
the women’s experiences of living in a dark world. 
Friends. Some women were drawn deeper into the dark stage as a result 
of their interactions with friends who were also living in a dark world. For 
example, some women reverted to using drugs again or started using harsher 
drugs when they were around friends who were actively using. Women involved 
in sex work were often friends with other sex workers, most of whom also used 
drugs. For these women, drugs were easily accessible at parties, clubs, and 
other social venues that they frequented as part of their sex work. As a result, 
they were constantly immersed in drug-ridden, dangerous environments that 
threatened their physical safety.      
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Women, whose friends who were “in recovery,” were most helpful in 
moving women beyond the dark world. Women found support in friends who had 
similar life challenges. These friends connected participants to recovery services 
and provided them housing so that they could get “off the street.” Because many 
of these friends were also HIV-positive, they assisted participants with getting 
into care where they could receive more formal help for their addiction and other 
social needs. Maxine, who felt supported by her friends said, 
When I finally got out [of prison I] met some people that helped me 
to understand what HIV care was. [One friend] was working at [an 
AIDS service organization] and he was in recovery too. I can 
honestly say that I’m alive because of him. I don’t think that I would 
have ever made it this far [if] it had not been for him and [a couple of 
other friends] because [they] did not judge me. They loved me until I 
learned to love myself. [They] were there between the prison trips 
and [gave me] a place to live, [even though] I was a crack head, 
[and] never put me out [on the street] because I was HIV-positive.   
 
Women often entered into sex work through their associations with other 
transgender sex workers. These friends “showed women the way” and “taught 
them how to get money.” While sex work afforded participants a way out of the 
homeless shelters and provided a means of greater financial stability, it also 
prolonged their existence in the dark world. Tiffany said, “I became wrapped up 
in that lifestyle. And once you get wrapped up in that lifestyle, you forget about 
being human. Everything is about money, you become greedy.”  
Romantic partners. The women’s romantic relationships were tentative 
and often volatile at this stage. The instability of the women’s lives made them 
vulnerable to partner abuse and other forms of violence. Women who were in 
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relationships during this stage were living “double lives” because they did not 
want their partners to know what they were going through.  
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Reconstructing the World 
The fourth stage of Having the World Change occurred when the women 
emerged from the stage of living in the dark world. We labeled this stage 
reconstructing the world. This phrase is commonly used to describe the process 
of rebuilding one’s life after a devastating event.233 This phrase was selected 
because it resonates with the women’s sense that they were rebuilding their lives 
that had been previously shattered by their HIV. One woman, for example, felt 
like she “had the world again.” During this stage the women focused on restoring 
their sense of self, regaining control over their lives, and planning for the future. 
The women felt “driven to live,” to take better care of themselves, to live healthier 
lives, and to pursue life-long goals. Denise, for example, claimed, “As long as I 
can control what is going to happen, I’m going to live a long, long life.”  
For many women reconstructing their world was closely tied to their being 
transgender. During this stage some women decided to live “full time” as women, 
and they experienced this as freeing and empowering. Brenda, who underwent 
sexual reassignment surgery after her HIV diagnosis, claimed that it helped her 
to “pursue what I really felt inside.”  
As the women focused on restructuring their worlds, their feelings of 
hopelessness and desperation began to diminish and they worried less about the 
“image” associated with being HIV-positive. Many no longer defined themselves 
by their HIV or obsessed about being HIV-positive and became comfortable 
discussing their illness experiences openly with others. Elise said, “At first I was 
[scared] to go out into the world. But then I [realized that] HIV [was] really nothing 
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and [that] a lot of people can’t really tell [that] I’m HIV-positive.” The women 
gained the courage to reestablish themselves and to move forward with their 
lives in the wake of HIV.  
At this stage, some women who had previously thought of HIV as a fatal 
illness now viewed it as just “another” disease. Jessica, for example, described it 
as “the new diabetes.” Adopting this illness perspective minimized the shame 
and fear that participants previously had about being HIV-positive. Maxine said, 
“I’ve learned to live with, or [rather] forced HIV to live with me so it doesn’t 
become one of those things, like being a transwoman, that overshadows me.” By 
reframing how they viewed their diagnosis, women experienced the negative 
emotions previously tied to HIV less frequently and had the sense that they 
regained control of their lives.   
Some women experienced their HIV diagnosis as a “turning point” that 
forced them to confront other negative aspects of their lives. These women 
withdrew from relationships that were harmful to them and some abandoned 
dangerous or risky behaviors such as sex work and drug use. Women who were 
successful in reconstructing the world were empowered and motivated “to get 
better…to get stronger, to rebuild [themselves], and to become better people.”  
Cheron said, “HIV is a big thing. But at the same time, it’s not so bad [and it’s not] 
going to stop me from living.” 
 Many women relied on their spiritual beliefs that “God is a loving [and 
forgiving] god” and that “God doesn’t make mistakes;” and their religious 
practices such as “fasting” and “praying” to “come to grips” with their HIV. 
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Monique said, “I was fasting to cleanse my body from [what I felt were] the evil 
spirits that I had inside [of] me.” A few women attributed their emotional healing 
to their beliefs in a “higher power.” Some women’s religious beliefs helped them 
to realize that they were not “bad people” and as a result they became less 
concerned about what other people thought about them being HIV-positive. 
 During this stage, some women regained control over their lives by using 
their personal experiences with HIV to help others. Brenda, for example, claimed 
that “Ever since [being diagnosed] I’ve just been on a mission to help give back.” 
Publicly disclosing their HIV status to others gave participants a greater sense of 
esteem and made them feel accomplished. In giving back participants felt that 
they were “helping the world in some sort of way.” Some participants gave back 
to the larger community by serving as spokespersons for various HIV programs, 
serving as “gay activists,” and publicly educating others about HIV. Others gave 
back on a smaller scale by educating other transgender women about HIV and 
helping those that were HIV-positive get into care. Star said,  
I’m to the point where I don’t care if people know I have it. I haven’t 
made a billboard saying, ‘Hey, I’m HIV-positive,’ but I’m not denying 
it. I can speak on it to help people be more aware of what their 
status is, and I can be used as a symbol of hope maybe.  
 
Women who had previously struggled with addiction and other life 
challenges reconstructed their worlds through sobriety. Some who were 
previously involved in sex work and other crimes “came off prostitution,” found 
alternative ways of earning income, and rebuilt a stable life. Some participants 
who were repeatedly incarcerated rediscovered the world outside of prison. Kim 
said, “I want[ed] to do better and bigger things with my life. I haven’t been back to 
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the penitentiary in three years. [I am] drug free and working my ass off. I have 
[had] two promotions at my job now.”    
Health Care Encounters 
Women who progressed to the stage of reconstructing the world 
interacted regularly with their care providers, remained engaged in care, and 
played an active role in their health care decisions. Positive health care 
encounters enabled participants to reconstruct their worlds. 
Care coordinators. Strong and consistent relationships with the care 
coordinators were especially helpful to participants as they reconstructed their 
worlds. These relationships were particularly important to participants who were 
estranged from their families or who had not been able to tell their families about 
their HIV diagnosis. Women in these situations indicated that their relationships 
with these care coordinators, especially those who were “more personal than 
client-based,” were a “god-send.” Talking to care coordinators about HIV and 
family concerns gave these women “peace of mind” and allowed them to “get 
things off their chest.” Care coordinators also encouraged participants to 
reevaluate relationships that were not healthy or supportive of their new way of 
living and existing. Care coordinators “listened and gave” participants’ advice on 
dealing with destructive family dynamics and other negative relationships.  
Care coordinators helped women reconstruct their worlds by providing 
active assistance in practical matters. For example, some care coordinators 
helped women find regular, steady jobs so that would not have to “hustle” 
anymore. Care coordinators also helped women in establishing their new 
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transgender identities by assisting them with getting their names legally changed 
and constantly referring to them by their female names. 
 Health care providers (HCPs). On-going stable relationships with HCPs 
to whom women felt strongly connected helped them reconstruct their worlds. 
Women felt especially strong connections to their care providers when they 
shared things in common. For example, some women felt more of a “connection” 
to care providers who were also HIV-positive, who were gay, or who were 
experienced in providing care to members of the LGBT community. Maxine said, 
“[My doctor] was HIV-positive…He convinced me to share that I was positive in 
order to get better…He helped me to understand that I was a powerful 
individual.” 
Because embracing their transgender identity was important for some 
women in reconnecting to their world, HCPs also helped these women by 
facilitating feminization by prescribing hormone therapies. Maxine described how 
her doctor, who was gay and HIV-positive, helped her achieve feminization:  
He was the first doctor that asked me if I was on hormones. I never 
understood why he asked me if I was on hormones. But he knew 
[that I was transgender]. He talked to me about hormones and told 
me that these things [becoming a woman] were really possible. 
 
HCP also played a critical role in helping women reconstruct their worlds 
by helping them reframe their perspectives about living with HIV and assuring 
them that they were not dying from “something,” but rather “living” with a disease. 
Such encounters helped women “feel alive again” and gave them hope.  
Mental health professionals. During the reconstruction stage some 
women received care from psychiatrists. Psychiatrist played a key role in helping 
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women address dysfunctional family issues that threatened their emotional and 
mental health and overall state of happiness. Crystal said,  
[He] helped me deal with going [back home] and dealing with other 
people in my family that affected me during that time. So I went 
back and I faced it. I figured that if you face something and you go 
on, don’t hate anyone, but just go on, [then] you will look better and 
peaceful. 
 
Mental health professionals also helped women with “mental health 
issues” reconstruct their worlds by exercising “lots of patience” during their 
encounters and helping them to avoid incarceration and other criminalization by 
helping them manage their legal issues. Psychiatrists helped women find closure 
about strained relationships with their families, which facilitated their healing and 
boosted their progress towards reconstructing their worlds.  
Interaction with Important Others  
During the stage of reconstructing the world, women established new 
relationships with important others who could support them in reconnecting to 
and rebuilding their worlds. As with the earlier stages, how important others 
engaged with women strongly influenced how they experienced this stage.  
Family members. During the stage reconstructing the world, many 
women reconnected to their families or connected with them in new ways. Some 
women who had been estranged from their family reestablished a relationship 
with them. These women felt “joy” and were “ecstatic” when this occurred. Kim 
said, “It was like the hole my heart had been finally sealed.” Often, this 
reconnection was related to the new transgender identity some of the women 
had assumed. Family members who accepted their new identities, such as by 
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referring to the women by their female names, helped women reestablish 
themselves in the world. Brenda described how her mother helped with her 
gender transition:  
She refinanced her car to get the money, which was $13,500 for 
the surgery. I have since paid her back, but if it hadn’t been for her 
[I would not have been able to afford the surgery]. She was there 
and helped [me after] the surgery and everything. 
 
Reconstructing relationships with family members sometimes occurred 
many years after the women were diagnosed with HIV or came out to their 
families as transgender. Some relationships were repaired when family members 
came to understand what the women had endured, and, in these instances, the 
participants felt vindicated related to past grievances. Maxine said,   
My brother never realized until he got older and went to counseling 
that my father had abused me the entire time we were growing up. 
And for my brother to finally say ‘I understand what happened. I 
understand what you went through.’ It was all I ever wanted. 
 
Some women who reconstructed their lives had on-going family support, 
and these families played a significant role in this stage by “loving [the women no 
matter what” and providing on-going emotional and physical support. These 
women felt empowered by having their family “in their corner” as they moved 
forward with their lives.  
  Friends. Some women reconstructed their worlds by forming new 
friendships and creating new family structures with friends who were gay, 
lesbian, and transgender. These new families resembled traditional, nuclear 
families and were led by “gay” or “house fathers,” and they were comprised of 
“gay” sons, daughters, and siblings. Women that belonged to these families had 
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been invited by the “gay father” to join his house as “gay children.” Gay fathers 
provided the women with oversight, support, and guidance during the stage of 
reconstructing the world and helped them to establish a meaningful family 
connection. These new families were especially important for women who 
remained estranged from their birth families. Tiffany was homeless before joining 
the “house” and whose her mother was unaware of her transgender identity. She 
explained,   
We’re [friends and I] like a house basically. We go places [together] 
and it makes me feel like I have that family that I really don’t have. I 
mean I do have [family], but it’s a different support because [they] 
are more of a peer to me than a parent…It’s great having support, 
knowing that [I] can come in and do anything and say anything, and 
[that] they will guide me in the right direction because they’ve been 
through it [HIV]. 
 
Other women reconstructed their worlds by adopting “gay children.” 
Women adopted “gay children” in order to assemble a more complete family, to 
make up for the family they never had, and to have a more meaningful life. Star 
said, 
My children love me. They call me mommy, or mother. They come 
to me for guidance, and care, and I give it to them. I do the best 
that I can. I love my children. They’re the closet that I [will ever] 
have to having my own children. They love me back and I’m very 
real with them…I keep it real [with them] because this is the real 
world that we live in. I’ve got about 17. Some of them are near and 
far. They idolize me, they love me, and they love being an 
extension of me. I’ve had a moment of being hands-on with them, 
teaching them, and nurturing them to what they should try to be. 
 
These new family structures thus provided the foundation on which these 
women reconstructed their world and their lives and offered them the chance to 
reinvest in and mentor similar others.   
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Some women reestablished themselves in the world through performance. 
Women found new meaning, purpose, and value in their lives as entertainers. 
Star said, “It’s [performing] the only thing in this world that belongs to me…when 
I’m out on stage and I’m under the spotlight, and I am who I am.” Other women 
reconstructed their worlds by establishing kinships with other entertainers. Tiffany 
described how her relationship with other entertainers helped her restructure her 
world and reestablish her identity: 
When I’m dancing, I have my whole house or other people cheering 
me on so it feels really good. It makes me feel good about my other 
life that I did live [before HIV]…Dancing makes [me forget about 
HIV]. It’s kind of like a relief. Just expressing how I feel [through 
dance]. It’s kind of hard to explain, but it’s like you [are] vogeuing 
how you feel. If I feel pretty, I’m going to come out and I’m going to 
swing my hair. [When I’m dancing] I don’t even think about [HIV]. I 
just think about me [and] the way I want to live.  
 
Connecting with friends or similar others that were gay, transgender, or 
HIV-positive gave some women drive and confidence to reconstruct their worlds 
and overcome the stigma and shame associated with being HIV-positive. One 
woman shared, “It’s like we’re all going through the same thing, but it feels good.” 
Friends helped rebuild the women’s self-esteem and influence their new 
identities. Maxine claimed, “[My friends] gave me the ability to have a 
voice…they taught me how to ask for exactly what I wanted and how to advocate 
for myself."  
Romantic partners. Some women reconstructed their worlds by pursuing 
new romantic relationships. Women whose partners supported them after 
learning the news of their HIV were instrumental in helping the women rebuild 
their world. Other women had partners who, despite their HIV-negative status, 
 
 
129 
were also accepting and willing to initiate a relationship. These partners were 
especially encouraging as many participants felt that having HIV severely limited 
their chances of establishing future meaningful relationships. Gretchen who met 
her partner through and online dating site and disclosed her status to him over 
the phone said, 
[I told him], there’s something I gotta tell you, I didn’t tell you in the 
beginning cause I didn’t think that I would ever meet you…But I 
have to tell you this. So I told him the whole story about how it 
happened and everything. His response to me was, ‘Oh my god. 
You’re worried about that? What do you think they make condoms 
for?” I just sat there and was like, ‘Oh god, so you’re not made at 
me?” He said, ‘No.’ And I said, ‘Yay, I’m so glad!”  
Some women did not develop new romantic relationship at this stage, but 
were optimistic about “falling in love” again and finding someone who would 
accept them being transgender and HIV-positive. ‘Drea said, “I [have] two 
barriers against me. I’m a transgendered woman, plus I’m positive. But I’m willing 
to find men who are willing to accept it [and], hopefully just fall in love with me.” 
Summary 
The findings of this study are presented in a model that is organized by a 
core concept of Having the World Change and is comprised of four stages: the 
world crashing down, shutting out the world, living in a dark world, and 
reconstructing the world. Having HIV changed the women’s identities, 
relationships, and daily lives in ways that were profound and ubiquitous. The 
women described a process that began with experiencing the devastation of 
learning that were infected with HIV followed by a period in which they denied the 
realities of the disease, avoided care, and withdrew from others. For some, this 
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period was followed by a time in which they engaged in risky behaviors and 
found themselves in dangerous situations. Some women then experienced a 
period in which they reestablished a sense of identity, reconnected with important 
others, and developed a lifestyle that was satisfying and health-affirming. 
While the model is presented as a linear process with well-defined stages, 
in actuality there was great deal of variability in terms of how women traveled 
through those stages. For example, while all of the women experienced the first 
stage, they experienced the second stage in varying degrees; some experienced 
much avoidance and withdrawal for long periods of time, whereas others moved 
through this stage fairly quickly and faced the realities of the illness and engaged 
in consistent care fairly soon after diagnosis. Not all the women experienced the 
third stage as some reported few, if any, destructive behaviors. Not all of the 
women had “reached” stage four and many were still in one of the earlier stages 
when they were interviewed.   
In addition, women did not always go through the stages in a linear 
fashion. Some “recycled” through the stages. For example, some women began 
to reconstruct their lives and then encountered other life challenges such as 
major illnesses, disruptions in a relationship, or assaults that returned them to an 
earlier stage. Others experienced some aspects of two stages simultaneously. 
For example, some women continued to experience the destructive behaviors 
that characterized stage three while beginning to engage in some of the healing 
behaviors that characterized stage four. As examples of non-linear courses, 
Figure 2 represents the trajectory of a woman who did not experience stage 
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three because she received a good deal of support during stage two, shutting out 
the world. 
 
 
Figure 2. This figure illustrates the illness career or trajectory of an HIV-positive 
transgender woman who received support. 
In contrast, Figure 3 represents the trajectory of a woman who recycled 
through stage two and three after reaching stage four, reconstructing the world 
because she experienced a significant loss that served as a “set back.” 
 
Figure 3. This figure illustrates the illness career or trajectory of an HIV-positive 
transgender woman who experienced a set-back. 
The findings confirm that healthcare settings and healthcare encounters, 
regardless of stage, influence the women’s experience with HIV. Healthcare 
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encounters that helped the women understand their illness, feel understood as 
transgender women, confront their self-destructive behaviors, and engage in 
appropriate and consistent care helped participants fare well. Staff at HIV 
counseling and testing sites that routinely provided HIV testing and care 
coordinators who worked primarily with HIV clients tended to be most helpful as 
they were knowledgeable about the illness, more supportive of the women, and 
better positioned to provide more pragmatic help such direct referrals and help 
with housing, insurance, and transportation. By comparison, healthcare 
encounters in hospitals, jails, and commercial plasma centers tended to be more 
problematic due to lack privacy and having staff that were less knowledgeable 
about HIV and HIV treatment.  
Care coordinators in particular played a significant role in helping women 
navigate the treatment system and obtain social services. Care coordinators 
facilitated women’s early initiation of and retention in care by providing direct 
referrals to a health care provider, escorting women to HIV care, and using a 
non-judgmental approach. HCPs who allayed the women’s fears about dying by 
educating them about HIV and who were able to engage them in consistent care, 
including medication therapy, were also particularly helpful.  
In contrast, healthcare encounters in which the women were ignored, 
judged, or disrespected, especially as transgender women, impeded their care 
and hampered their healing. Encounters with mental health professionals were 
often not experienced positively by the women. Several structural factors within 
the treatment system also served as barriers. These factors included long lag 
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times between the HIV diagnosis and the initial intake appointment with a care 
coordinator, delays in insurance approvals, frequent changes of HCPs, HIV only 
clinics (as opposed to comprehensive care), lack of integrated care (e.g. HIV 
care, primary care, and hormone therapy) services, and a lack of transgender-
friendly care settings.  
Similarly the findings confirm that relationships with important others 
strongly influenced how participants experienced the HIV illness career. 
Relationships with family were very important and throughout all the stages 
family members were most helpful if they were understanding and nonjudgmental 
- not only of the women’s HIV, but also of their lives as transgender women. 
Family members who were rejecting of the women or who were estranged from 
them exacerbated the women’s distress. Friends, especially those who were also 
HIV positive and transgender, often provided alternative family structures for the 
women; offered housing, food, and other basic essentials of living; and helped 
them to initiate HIV and substance abuse care. In contrast, interactions with 
romantic partners were often complex and challenging especially if the partners 
had infected the women or conversely if the women had infected the partner. Yet 
some partners, especially those who were also HIV-positive, were very accepting 
and supportive of the women. 
The experiences of the women as both transgender and HIV-infected 
women were often closely intertwined. In several instances, the women’s 
healthcare was impeded because they encountered providers were who not 
tolerant of, knowledgeable about, or sensitive to transgender persons. Some 
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women were rejected or mistreated by important others both because they were 
transgender and HIV positive, and some of their destructive behaviors were tied 
to both their gender identity and to their illness. Conversely, the women often 
received the most support for their HIV course from other women who were 
transgendered. 
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Chapter V. Discussion 
Summary and Conclusion 
 
The primary goals of this dissertation were to describe the illness careers 
of HIV-positive transgender women and to discuss how interactions with 
important others in the social network, and health care providers in the treatment 
network influenced their illness careers. This final chapter includes a brief 
overview of the major findings, limitations, implications for practice and future 
research, and conclusions.  
Significance of the Study 
 
This study is unique in that it is, to our knowledge, the only study that has 
examined the illness career from the perspective of transgender women living 
with HIV. This study adds to the state of the science by presenting a stage model 
that describes the psychosocial process that ensues following an HIV diagnosis 
among a group of HIV-positive transgender women. What is unique about this 
model is that it offers a theoretical explanation of how the illness career is 
influenced by the health care setting, interactions with health care providers, and 
interactions with important others. Because this model is grounded in the 
experiences of the transgender women, it also offers an explanation of how a 
transgender gender identity influences health. This model further adds to the 
state of the knowledge by identifying the stages following an HIV diagnosis 
where transgender women are most: vulnerable, at risk for self-harm, violence, 
and death; and at risk for not engaging in or falling out of care. As a result, this 
model can be used to help inform interventions that will target these critical 
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stages and thus improve the care experiences and illness trajectories for this 
population.    
Major Findings and Consistency with Existing Research 
 
The findings of this study are presented in a stage model that is organized 
by a core concept of Having the World Change and is comprised of four stages: 
the world crashing down, shutting out the world, living in a dark world, and 
reconstructing the world  The stages included in this model parallel the stages 
that have been reported in previous studies on coping with HIV and other serious 
illnesses.234-239 In addition, the model incorporates many overlapping principles of 
the theory of stress and coping (world crashing down, shutting out, living in a 
dark world), the theory of resilience (world crashing down and reconstructing), 
the stages of grief (all four stages) the theory of uncertainty (shutting out), and 
trauma and recovery (all four stages).234,239-242 These findings also add further 
validity to the claims of the Network Episode Model (NEM), which proposes that 
relationships and interactions with health care providers in the treatment system 
and with important others in the social network influence the illness 
trajectory.132,134,136,243  
The findings reveal that the illness career for participants in this study was 
influenced by the health care setting and four key groups of people: health care 
providers (which include care coordinators, primary HIV care providers, and 
mental health professionals) and family members, friends, and romantic partners. 
Results also confirm that transgender identity influences the illness trajectory and 
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the nature of interactions with health care providers and important others in the 
social network.   
In this study the role of the care coordinator must be recognized as the 
most fundamental factor that enabled participants’ movement from one stage to 
the next. Care coordinators who could: 1) establish trust or “connect” with 
participants: 2) were “sounding boards” 3) assisted participants with obtaining 
insurance, food, housing, and other essentials; 4) educated participants about 
HIV; and 5) escorted participants to HIV care appointments, were most influential 
in moving the participants out of the most vulnerable stages (world crashing 
down, shutting out the world, living in a dark world). In particular, the “sounding 
board” effect that care coordinators provided enabled participants to articulate 
their uncertainties and problems in ways that helps them rectify and resolve their 
troubles244 throughout the illness career and that facilitated their movement 
towards the final stage reconstructing the world. This study further validates the 
care coordinators’ vital role in coordinating and optimizing engagement in care 
for people living with HIV.10,14,245,246 
The role of HCPs in this study must also be recognized in getting 
participants to acknowledge their disease and start HIV treatment when they 
educated them about the benefits of starting treatment and the consequences of 
delaying or consistently interrupting treatment. Interactions with HCPs sometimes 
hindered participants’ attempts to manage their illness career. Participants’ 
movement across the stages was hampered when HCPs did not involve them in 
decision-making regarding their care, did not answer participants’ questions or 
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concerns, “rushed” through their encounters, and were not affirming of the 
participants’ transgender identity. 
Relationships with family and friends were very important throughout all 
stages of the model and influenced the illness careers in different, but equally 
important ways. Family members who gave participants positive, and affirming 
messages, who were knowledgeable about HIV, including how HIV is 
transmitted, and who knew other people that were HIV-positive were particularly 
helpful in supporting participants along the illness career. Parental acceptance 
(especially from mothers) of the participants’ transgender identity and non-
judgmental attitude about HIV, enabled participants to move from the stage of the 
world crashing down to the stage of reconstructing the world.  
By comparison, if family members (especially parents),were not accepting 
of the participants’ transgender identity, blamed the participants’ HIV diagnosis 
on their gender identity, lacked knowledge about HIV, and gave negative and 
degrading messages, often hampered participants’ movement to the final stage 
of reconstructing the world. Participants who were not supported by their families 
often lingered in the stages of shutting out the world and living in a dark world, 
had significant challenges pulling their lives back together after their HIV 
diagnosis, and many never reached the final stage of reconstructing the world. 
Friends who were HIV-positive provided support throughout each stage. 
Positive and affirming messages from family and friends were helpful throughout 
the illness career. But friends who were HIV-positive (especially friends who were 
gay or transgender) were especially helpful in moving participants out of the most 
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traumatic and vulnerable stages of world crashing down and shutting out the 
world. The shared identity of being HIV positive created an instant connection 
between participants and these friends, and therefore lessened the fear, isolation 
and shame that participants felt during the early phases of their illness career. 
Specifically, friends who were HIV-positive helped participants move on to the 
subsequent stages, by answering the participants’ questions about living with 
HIV, by helping them get connected with HIV care, and by assuaging their fears 
about dying.  
During the stage of living in a dark world, most participants withdrew from 
family and avoided encounters with health care providers, but maintained 
intermittent contact with friends who shared similar life challenges, such as a 
history of drug use or homelessness. Friends who were in recovery helped 
participants move out of this stage by offering housing, food, other basic living 
essentials, and by helping them to initiate treatment for substance abuse and 
HIV. Friends who were gay or transgender also helped participants move out of 
this stage by providing alternate family structures and permanent housing. By 
comparison friends who were actively using drugs, who were engaging in sex 
work, and who were committing crimes to support their drug habits, hampered 
participants’ movement out of this stage. 
In terms of disclosure, the participants in this study grappled less with 
telling their friends that they were HIV-positive than they did with telling their 
families. These findings corroborate other studies that have suggested that 
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disclosing one’s HIV-positive status to a friend is often easier than disclosing to a 
relative.247 
Relationships with romantic partners were also very important throughout 
all stages of the model, but were often tenuous and complex. Throughout the 
illness career participants experienced stress and anxiety about disclosing their 
HIV status to others. Disclosure in the context of a romantic relationship, 
however, often caused participants, who may have progressed to the stage of 
reconstructing the world to cycle back to earlier stages. Participants who were 
rejected, shunned, or blamed for infecting or exposing their partner often 
returned to the stage of shutting out the world.  
Findings from the present study suggest that disclosure is a constant 
source of stress that occurs throughout the illness career, resurfaces with new 
romantic relationships, and causes participants to recycle through previous 
stages of the model. These findings are consistent with previous studies that 
represents disclosure as a lingering source of acute and chronic stress, yet 
legally required for avoiding criminalization.248 Two key factors enabled or helped 
ease the distress of disclosure to a romantic partner. The first was being in a 
romantic relationship with someone else who was HIV-positive. The second was 
non-disclosure. Prior research has suggested that non-disclosure is a coping 
mechanism used as a means to protect oneself from the negative responses of 
others.248,249   
Results from this study further substantiate how unstable life patterns such 
as homelessness, sex work, and drug use, and negatively affects the illness 
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career. Participants in this study who had unstable life patterns often lingered in 
the stage of living in a dark world and received inconsistent to no care. These 
findings are consistent with prior research that on the relationship between HIV 
risk, substance abuse, unstable housing, mental illness, and incarceration.250-255 
Results suggest that these unstable life patterns were exacerbated in certain 
care settings that were intended alleviate the instability. For instance, participants 
who sought temporary housing in homeless shelters and boarding homes 
experienced many set-backs. These participants felt threatened in homeless 
shelters because they were housed with men, because they were verbally 
attacked for being transgender, and because their belongings were stolen. The 
environment in boarding homes also worsened the instability because they were 
drug-ridden. Participants who sought temporary housing in these settings were 
often pressured to, and often did, resume their drug use.  
Mental illnesses such as bipolar disorder, schizophrenia, depression, and 
suicidality were common among the participants in this study. Findings indicate 
that these participants often traveled back and forth between shutting out the 
world and living in a dark world and received inconsistent to no care. Participants 
who sought care at inpatient drug rehabilitation centers and substance abuse 
support groups often fared worse in those settings. The inpatient drug 
rehabilitation centers were not inclusive of transgender women and substance 
abuse support groups did not allow for individualized care and counseling. As 
stated earlier, participants who received support from friends who were former 
addicts, and housing support from chosen kin, fared better during this stage. 
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Findings in the current study also support prior research that the formal 
treatment (health care) system influences the illness trajectory.132,136-138,243,256 In 
this study, there were general systems of care issues that could not be tied to a 
particular health care provider or interaction, but still influenced the participants’ 
illness careers. These were nuances such as lack of privacy in health care 
settings, changes to health care providers, which led to inconsistent or no care 
for some participants in this study, delays in getting insurance, and the lag time 
between when participants first tested HIV-positive and when they first were seen 
by a care coordinator or primary HIV care provider.  
In this study, the lack of privacy (e.g. “call-backs” to get test results and 
“calls” to the clinic”) in the jail and prison setting negatively influenced the 
participants’ illness trajectory and health care experiences by discouraging 
participants from initiating or adhering to HIV care. These findings are consistent 
with prior research on the impact of incarceration and prison release on 
adherence to HIV treatment outcomes.257-260 The lack of privacy and 
confidentiality in jails and prisons is evidenced in a recent study conducted in 
North Carolina on jail personnel’s perception of privacy and confidentiality. Most 
of the participants agreed with the statement that, “if an inmate is taking 
medications in jail, other inmates will know about it.” Also, in this same study, 64 
(81%) of the correctional facilities indicated that detention officers openly 
distributed medications in view of other inmates.261 
Findings in the current study suggest that frequent changes to care 
providers disrupt continuity of care. These results are consistent with findings 
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from other studies that have demonstrated a link between frequent changes in 
health care providers and underutilization of care.123 “Passing off” transgender 
clients to other care providers due to inexperience or discomfort in providing care 
to transgender women also emerged as a major finding that disrupted care. 
“Passing off” clients is also a form of institutional erasure that discourages care 
utilization, adds to the difficulties of tracking this population’s service utilization, 
and creates an illusion of population scarcity.123  
Inherent in these general systems issues were problems such as non-
inclusive environments of care. This study did not allow full exploration of ways 
that the health care environment influenced the illness careers of the participants 
in this study. However, tentative findings suggest that several strategies could be 
used to improve engagement in care and health outcomes: 1)Employing other 
transgender people in the various treatment system settings (HIV CTS, HIV 
clinics, and primary care clinics); 2) providing cultural competency training for 
front line staff such as receptionists, and auxiliary staff; educating HCP about 
transgender people and their health needs; 4) adapting intake and other 
transgender health-related forms to reflect transgender identities would facilitate 
engagement in care and subsequently improve health outcomes.123  
Limitations 
 
The findings must be understood in the context of several study 
limitations. The sample included18 transgender women living with HIV, many of 
whom had experienced major life challenges such as substance abuse, 
incarceration, physical violence and assault, and were involved in sex work 
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throughout the course of their illness career. Thus, this model may not be 
generalizable to transgender women who do not share similar experiences. In 
addition, this model was informed by the experiences of HIV-positive transgender 
women who had some level of interactions with health care providers and who 
had received some type of formal HIV care. Therefore, this model may not 
represent the illness trajectories of HIV-positive transgender women who have 
never entered formal care.  
There were several limitations related to the socio-demographic makeup 
of the sample. Most of the participants (n=10, 56%) were unemployed, a small 
number (n=2, 11%) had a college degree, and some (n=2, 11%) never 
completed high school. Therefore the model may not reflect the illness careers of 
transgender women who are insured, who are employed, and who have higher 
educational attainment.  
In addition, because participants’ narratives were retrospective, their 
memories of past events may have been distorted or diminished. Even with this 
limitation, we believe that the narratives shared by the 18 participants in this 
study provided rich data that will help increase our knowledge of their illness 
careers and increase our understanding of how interactions with important others 
in their social network and interactions with HCPs in the treatment network 
influence their illness trajectories. 
The Having the World Change model is a stage model that suggests that 
the illness careers of HIV-positive transgender women is a dynamic and 
progressive trajectory that involves four stages. We do not, however, wish to 
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imply that all of the participants moved through the stages in a sequential or 
predictable manner. Some participants instead passed over stages, some 
lingered in stages, and some recycled to earlier stages. While we identified 
factors that enabled participants to move from one stage to the next, we 
acknowledge that are likely other factors facilitated or restricted participants’ 
progress towards reconstructing the world, for example, that we did not identify. 
Thus the model serves as a theoretical depiction of how the illness career 
unfolded in our group of participants.    
There were also some limitations related to recruitment. Respondents 
were recruited in an urban, Midwestern city, mostly at sites serving low-income, 
minority clients. Other transgender women in the study’s setting and in other 
parts of the county may experience the HIV illness career differently and may 
have different experiences during their encounters with health care providers, 
family members, and romantic partners.  
Face-to-face interviews may have also biased respondents to give 
responses that were more positive than their actual experiences. In addition, the 
investigator’s role as a nurse with the local health department and her 
relationship with care providers in the community may have also biased 
respondents to give responses they felt to be more socially acceptable. 
Nevertheless, these data were obtained from various care settings and shed light 
on the understudied issues health care access and the psychosocial needs of 
transgender women following their initial diagnosis.    
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More research is needed to determine if the findings in this study are 
applicable to the larger population of transgender persons living with HIV. It is 
important to note, however, that the grounded theory methods used in this study 
allow for in-depth exploration of transgender women’s experiences through their 
own words and from their perspectives. As such, this approach provides a more 
grounded description of the problems and possible solutions. 
Practice Implications 
The Having the World Change model has utility for health care providers 
who work with HIV-positive transgender women. By determining an individual’s 
current stage in the model, a care coordinator, health care provider, mental 
health professional, would be alerted the types of help and support that might 
facilitate movement to the next stage. The findings indicate, for example, that a 
transgender woman who is in the world crashing down stage needs emotional 
and informational support, active referrals to HIV care, a private setting in which 
they can discuss their questions and concerns with a care provider, and physical 
and emotional support and affirming messages from a family member or friend to 
move on. Whereas the transgender woman who is in the shutting out the world 
phase needs to feel a sense of connection and trust towards their care 
coordinator, education about HIV and the benefits of treatment from their HCP, to 
feel safe and respected, and acceptance from important others to begin to deal 
with the realities of their illness and to emerge from their state of isolation and 
withdrawal.  
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 The model might also broaden health care providers’ perspectives with 
regard to the stages through which transgender women progress after an initial 
HIV diagnosis, the variety of ways in which they attempt to cope with their illness, 
and the life challenges that disrupt their attempts to cope and access care. This 
model, therefore, can give HCPs insight into how they can best facilitate progress 
along the various stages and best facilitate positive coping and engagement in 
care. The factors that caused participants to shut down, avoid care, and deny 
their HIV for example, suggest that HCPs should consider how the health care 
setting (privacy and inclusiveness) and interactions with various health care 
providers and auxiliary staff attribute to shutting down.  
Because being accepted and respected as women was also very 
important to establishing trust with participants, gender affirmation and support 
for outwardly embracing and disclosing one’s transgender identity to others 
should routinely be addressed during health care interactions and adopted as a 
supportive and therapeutic measure. This is true for interactions throughout the 
illness career, but is particularly relevant to transgender women who are in the 
shutting out the world stage. Finally because the lack of privacy in the care 
setting routinely emerged as an issue of great concern for participants in the 
shutting out the world stage and discouraged them from acknowledging their 
illness and engaging in care, confidentiality should continually be addressed as a 
therapeutic issue for transgender women who are in shutting out the world stage. 
 The model also suggests that there is a great deal of variability in how 
transgender women move through the various stages. For example, there were 
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several participants who did not experience a shutting out the world stage, but 
instead progressed on to the stage of reconstructing their world. By comparison 
there were several participants who lingered in the stage of shutting out the world 
and then progressed to and remained in the stage of living in a dark world when 
they did not receive adequate support. HCPs should have an understanding of 
these dynamic and nuanced processes by which HIV- transgender women 
experience their illness career and tailor the nature of their encounters to address 
the variation in needs that present throughout the illness trajectory.  
Care coordinators primarily managed the psychosocial needs of 
participants in this study. This model, therefore, could help this group of care 
providers identify the psychosocial needs of transgender women (based on 
stage) and then assist them by tailoring their interactions accordingly. For 
example, a care coordinator that encounters a transgender woman who is living 
in a dark world, interactions and interventions should address unstable life 
patterns such as homelessness, adverse behaviors such as substance use, 
dangerous environments such as “life on street” and the world of commercial sex 
work; and should address the basic essentials of living such as food and access 
to insurance. In contrast, care coordinators’ interactions with a transgender 
woman in the reconstructing the world stage should focus on supporting her new 
way of living and existing and identifying strategies to sustain the new way of 
living over time. Examples include finding stable employment that would allow for 
permanent housing, transitioning out of sex work, and developing other life skills 
that will encourage independence and self-efficacy, and build self-esteem.  
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 The model suggests relationships with important others also strongly 
influenced how participants experienced the illness career. As such, HCP may 
consider strategies for including supportive family members and friends, 
especially friends who are also HIV-positive or transgender, in the early stage 
(world come crashing down and shutting out the world) health care encounters 
with transgender women. When possible, HCP may also consider scenarios that 
would engage supportive family members and friends in strategies to help HIV-
positive transgender women to better cope with their illness acknowledge their 
disease, and remain engaged in HIV care. Findings suggest that transgender 
women’s family structure may deviate from the definition of a traditional family 
and instead be composed of chosen family members or fictive kin. HCPs should 
be aware of these variations in family structure and support the involvement of 
chosen or fictive kin throughout all stages of the illness career.  
Families were most helpful if they understood about the participants’ HIV 
and their lives as transgender women, therefore, including select family members 
in health care encounters that focus on HIV education and transgender identity 
can optimize family members’ capacity to support transgender women 
throughout the illness career. Participants also fared relatively well during the 
stage of the world come crashing down when they received emotional and 
physical support from their family. Therefore, providers in HIV counseling and 
testing settings should encourage individuals to have a supportive and trusted 
family member or friend with them when they receive their HIV test results and 
during the post-test counseling session.  
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The presence of these supportive important others will benefit the 
individual in several ways. First, the presence of a supportive person when 
receiving an HIV-positive result can soften the initial shock and trauma that 
ensues during the stage of the world crashing down. Second, because 
participants expressed feeling a great deal of confusion and anxiety during this 
stage, a supportive family member or friend can interact with the care provider in 
this setting to ensure that all of the appropriate information regarding follow-up 
care is provided, to communicate concerns, and ask other questions that might 
help engage the individual in HIV care. Third because participants struggled with 
disclosing their HIV status to important others, especially family members, 
throughout the course of their illness career, having a family member present 
during the world crashing down phase would help alleviate the burden that 
participants felt from wanting to, but not being able to tell their family about their 
HIV. Family members or trusted friends who are involved in this stage could then 
also support and help participants in future disclosures to important others.  
HCPs should also be aware that while disclosing one’s HIV status to 
family and friends is challenging, that disclosing one’s HIV status to a romantic 
partner is particularly distressing. HCPs need to have an awareness that 
individuals who receive negative responses from important others in their social 
network are at risk of repeat trauma and may cycle back to earlier stages or 
engage in adverse behaviors in an effort to deal with the trauma. Therefore, 
disclosure (guidance on how, when, and to whom) must be routinely addressed 
as a therapeutic issue. HCPs can use the model to determine an individual’s 
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position along the illness career and then advise them on the best approach and 
strategies for disclosure. Since participants fared pretty well through the 
disclosure stage when their HCPs made the initial disclosure to their families, 
HCPs may consider routinely supporting individuals with disclosure. 
It is also important to note that many participants in this study received 
their initial HIV diagnosis in jail or prison. Jail and prison-based providers need to 
be alerted to the severe emotional trauma, fear, isolation, and denial that occurs 
during the stages that follow an initial diagnosis and be proactive in providing 
emotional support and opportunities for transgender women to discuss their 
diagnosis with a HCP in a safe and confidential setting.262  
The jail and prison setting complicated every stage of the illness career for 
participants in this study. One process that helped these participants to 
acknowledge their illness, initiate treatment, and reconnect with others was pre-
release case management. Previous research suggest that pre-release case 
management facilitates engagement in HIV after release, however, transgender 
women who are not nearing release have educational and psychosocial needs 
that are not being addressed during incarceration.262,263 Therefore, another 
recommendation would be to integrate the case management approach to care 
throughout the cycle of incarcerate for HIV-positive transgender women, not just 
prior to release. In a study on the prevention needs of HIV-positive men and 
women awaiting release from prison, Catz and colleagues reported that 
education for HIV-infected inmates should focus how viral load impacts 
transmission, ways to protect oneself (from reinfection) and others from being 
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newly infected, and should focus on enhancing behavioral skills.262 The findings 
in the current study corroborate the need for this type of education for 
transgender women also throughout their incarceration. 
Finally, the Having the World Change model has implications for public 
health practitioners and can be used to help optimize engagement in the HIV 
Care Continuum (also known as the Treatment Cascade). See Figure 4.  
 
 
 
 
Figure 4. The HIV continuum of care or treatment cascade. This figure 
illustrates the steps that follow an initial diagnosis of HIV. 
The HIV Care Continuum is the series of steps from the time a person is 
diagnosed with HIV until they are successfully engaged in care and virally 
suppressed. The HIV Care Continuum is part of the National HIV/AIDS Strategy 
to improve outcomes of people living with HIV/AIDS in the US and to identify 
areas in need of improvement.195,264 According to the latest CDC analysis of the 
1.2 million people living with HIV in the U.S., 86% were diagnosed with HIV. Of 
the 86% diagnosed, 40% were engaged in HIV care, 37% were receiving 
antiretroviral therapy, and 30% were virally suppressed.195,264,265  
Public health practitioners should be aware that the most crucial points 
along the HIV Continuum of Care (HIV testing and diagnosis, linkage to care, and 
entry into care) run parallel to the most vulnerable stages of Having the World 
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Change (world crashing down, shutting out the world, and living in a dark world). 
The model then can alert these providers of the psychosocial needs of 
transgender women during the time points of HIV testing and diagnosis and entry 
to care and inform strategies that may be used to help facilitate movement along 
the continuum of care. Examples include employing transgender HIV testers, 
encouraging individuals to bring supportive family members or friends with them 
when they get tested for HIV and when they receive their results, decreasing the 
lag time (currently 2-3 weeks) between the time that someone tests HIV-positive 
and the time they first see a care coordinator primary HIV care provider, 
engaging peers and other members of the social network in activities to engage 
and retain this population in care, and addressing other structural barriers to HIV 
care such as homelessness, substance abuse, and sex work.  
In sum, the Having the World Change helps identify the stages of the 
illness career during which transgender women are most emotionally vulnerable, 
are most at risk for physical harm, adverse health effects, and death; and are 
most at risk for not engaging in or falling out of HIV care. In this respect, the 
model helps identity, in a more practical sense, the key points along the illness 
career where health care professionals and important others in the social 
network might be able to intervene and prevent HIV-positive transgender women 
from lingering in and recycling back to vulnerable stages. Because important 
others in the social network and health care providers in the treatment network 
played a significant role in helping participants cope with their illness, the model 
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may help inform interventions that integrate support and counseling from both the 
social and the treatment networks. 
Implications for Future Research 
 In their 2011 report, The Health of Lesbian, Gay, Bisexual, and 
Transgender People: Building a Foundation for a Better Understanding, the IOM 
outlined several recommendations across a number of areas that would advance 
the understanding LGBT health.266 One recommendation was to expand all 
aspects of evidence-based research for transgender-specific health care.266 The 
Committee especially called for research that examines the social influences on 
the lives of LGBT people and that examines inequities in health care.266 Because 
longitudinal, prospective studies are largely absent from LGBT research,266 the 
next logical step might include a longitudinal prospective study to validate the 
stages in the model Having the World Change and to further explore the factors 
that enable and inhibit transitions across the various stages. Such a study would 
provide insight into how the illness trajectory for HIV-positive transgender women 
changes over time, would allow for further examination of how the social network 
can be used to engage and retain transgender women in HIV care, and to 
examine how changes within the health care setting and nuances of interactions 
with health care providers influence the illness trajectory.  
In this study, differences were observed in how African American 
transgender women experienced the illness the career. For instance, most 
African American participants had unstable life patterns (homelessness, drug 
use, sex work, unemployment), seemed to linger in the stages of shutting out the 
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world and living in a dangerous world, and reported more frequent challenges 
with incarceration and repeat incarcerations. However the small sample size and 
higher representation of African American participants in this study (n=10, 55%) 
makes it difficult to determine if these were true differences. Therefore a 
subsequent study that has a larger sample size and equal distribution of 
participants across racial/ethnic groups, would allow for closer examination of 
how the HIV illness career may differ by race/ethnicity.  
Again, participants in jail or prison encountered numerous barriers to HIV 
primary care, initiation of and adherence to HAART, HIV denial, depression, and 
social isolation. Studies to date have examined the role of pre-release case 
management on linkage to HIV care upon release and the influence of directly 
observed HAART therapy on viral suppression,246,258 but there is a dearth of 
literature on the influence of prison-based care coordination models on 
adherence to HIV care and illness coping. These interventions should be 
explored in future studies.  
The majority of participants in this study (n=12, 66%) had been living with 
HIV between 1-5 years, a moderate number (n=3, 16%) for 21-25 years, and a 
smaller number (n=1, 6%) for more than 25 years. Because health needs and 
relationships with important others change over the course of an illness and over 
the course of a lifetime, future studies should also examine how the HIV illness 
trajectory changes for transgender women as they age. Such a study will inform 
HCPs on how this populations’ health care needs change over time and therefore 
provide insight into how treatment needs should be tailored to address the 
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changing needs, especially for transgender women living with HIV into later 
adulthood.  
The changing needs of older transgender women as they age were noted 
in the current study. A few participants, who had been living with HIV for more 
than 20 years, reported dealing with other health issues such as cancer and 
AIDS dementia, and social issues such as loneliness and depression. According 
to the CDC, people aged 55 and older accounted for more than one-quarter 
(n=313,200, 26%) of the estimated 1.2 million people living with HIV in the US in 
2011.267 With advances in HIV treatment, people are now living longer and this 
number will continue to increase. Therefore, more research is needed on the 
health issues that HIV-positive transgender women face as they age.  
       Findings in this study also confirm that there is a dearth of information on 
the general health needs of this population. While the participants in this study 
acknowledged that HIV was a problem, for many, it was not their most pressing 
health concern. Participants who had completed sexual reassignment surgery 
described not knowing how to take care of their vaginas and described problems 
with issues such as vaginal dryness and shrinkage. Other participants who had 
breasts shared that no one ever taught them how to examine their breasts and 
were unaware that hormones increased their risk for breast cancer. 
Men who have sex with men (MSM) are 17 times more likely to develop 
anal cancer than heterosexual men,268 however, participants indicated that their 
health care providers did not talk to them about anal cancer. In many cases 
providers did not examine these parts even when participants complained of 
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symptoms like rectal itching, burning, and pain. Screening for anal cancer in 
transgender women should follow the same protocol for anal cancer screening 
for MSM. This calls for more research on best the practices for managing the 
overall health care for transgender women, regardless of their HIV status.     
Participants in this study expressed having other health issues or 
concerns that were rarely discussed or addressed within the context of their 
interactions with health care providers. Therefore further research is needed to 
expand our understanding of the educational and competency needs of HCPs 
caring for transgender women and to identify additional gaps in health services 
for this population.  
 Finally, because health care settings that were non-inclusive and 
interactions with HCPs who were not affirming or respectful of participants’ 
transgender status disrupted care and hindered healing, more research is 
urgently needed to evaluate the quality of care currently received by transgender 
women and to inform development of transgender-friendly environments of care.  
Conclusion 
 The HIV illness career for transgender women is defined by concepts of 
trauma, loss, isolation, and withdrawal, denial, dangerous and life-threatening 
behaviors, and resilience. The stages in the model represent the psychosocial 
and behavioral efforts that this group of transgender women used to manage or 
cope with their HIV. The findings in this study confirm that transgender women 
face many complex and dynamic health, behavioral, and social challenges when 
attempting to cope with an HIV diagnosis. The theoretical model developed in 
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this study can be used to educate and inform care coordinators, primary HIV care 
providers, and mental health professionals about the processes and enabling 
factors that facilitate coping, healing, and engagement in care for transgender 
women living with HIV.  
While the model presented in this study could apply to anyone diagnosed 
with HIV, meaning that most people who are diagnosed with HIV will go through 
similar stages, there are certain aspects that are very unique to transgender 
women and that should be considered when interpreting the model. Unlike non-
transgender people, transgender women encounter stigma and discrimination 
that is solely predicated on their non-conforming gender identities. HIV adds 
another layer of stigma and discrimination that worsens the illness trajectory of 
these women and further intensifies their social isolation. The combined effect of 
transgender and HIV stigma factors amplifies the vulnerability that transgender 
women experience during the first three stages (world crashing down, shutting 
out the world, and living in a dark world) of the model, increases their risk for not 
linking to HIV care, and decreases their likelihood of getting the appropriate 
support needed to move them out of the most vulnerable stages. 
Within the context of the health care encounter, gender affirmation is 
necessary for establishing trust with and engaging transgender women in care. 
Unlike non-transgender people, gender affirmation is directly tied to transgender 
women’s emotional and mental health. Therefore, gender affirmation should be 
thought of as a strategy for engaging transgender women in HIV care and for 
acknowledging and coping with HIV throughout their illness career.   
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In general, health care providers are poorly prepared to care for non-
transgender people. This lack of transgender health knowledge and competency 
among health care provider complicates the illness career of HIV-positive 
transgender women and threatens their well- being across all stages of the 
model. Therefore, the quality of the health care encounter with transgender 
women, particularly during the stages of shutting out the world and living in a 
dark world, may play a greater role in engaging and retaining transgender 
women in care than it would with their non-transgender counterparts.  
Finally, with regards to the factors that enabled participants to move from 
one stage to the next, another aspect unique to transgender women was social 
ties with similar others. Relationships with other transgender women, chosen kin, 
or health care providers, who identified as gay, played a key role in helping the 
women cope with and acknowledge their illness. 
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Appendices 
Appendix A  
Network Episode Model 
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Appendix B 
Network Episode Model Key Terms & Definitions 
 
The Illness Career 
Key Entrances refer to the route or means through which an individual begins 
their illness career or trajectory. These include the sick role, patient role, chronic 
role, disabled role, and dying career.  
Key exits refer to events that result in discharge of an individual from the illness 
career. These include termination of care, recovery from illness, or death.   
Key timing/sequence refers to events that affect the timing and sequencing of 
entry and navigation through care. These include factors such as having multiple 
health care providers, the medical team composition, ordering of consultations, 
delay and spacing of consultations, and the degree and length of compliance132 
Social Support System 
 
Network Structure refers to the size, density, duration, reciprocity, strength of the 
network ties, and multiplexity.138,269   
 
 Network size refers to the number of individuals and density to the 
number of links.   
 
 Density refers to the ratio of the number of ties observed in a network to 
the number of ties theoretically possible. For example, if Participant A has 
only six key ties in her network, potentially she could have many others 
from work, her neighborhood, and her extended family.224 
 
 Duration refers to the length of relationship time, and reciprocity is the 
degree of symmetry in a relationship.   
 
 Reciprocity refers to a person’s ability to reciprocate support, goods, and 
services to the people in his/her network.224 
 
 Strength of network ties is defined as the intensity or connectedness of 
relationships. 
 
 Mulitiplexity refers to the degree to which a pair is linked by multiple 
roles138,269, or the number of people performing more than one role or 
function within the network.224Community network content refers to the 
belief and attitudes toward health and professional medical care.138 
 
Community network functions refer to the information, advice, regulation, 
expressive or emotional support, and material or practical support that occurs 
within the larger support system.138   
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The Treatment System 
Treatment network structure refers to the size, density, duration, reciprocity, 
strength of the network ties, and multiplexity of the treatment system (refer to 
definitions listed under the social support network structure above). 138,269   
Treatment network content refers to support obtained through formal networks 
such as HIV medical providers, case managers, or care coordinators, and it 
includes factors such as treatment efficacy, diagnostic capacity and technology, 
and staff attitudes and culture towards health, clients, community, and treatment 
organizations.138,142  
Treatment network functions are defined as information, advice, regulation, 
expressive or emotional support, and material or practical support that occur 
within treatment systems.138  
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Appendix C 
Procedure for Direct Call from Health Care Provider to Prospective 
Participants 
 
Hello, I am calling to let you know about an opportunity to participate in a 
research study on healthcare utilization among HIV-positive transgender women.  
 
If you are interested in being in the study you will be asked to participate in a 60-
90 minute interview with a Dana Hines, a nurse researcher at Indiana University 
School of Nursing.  
 
It will not cost you anything to participate in the study and if you decide that you 
do not want to participate it will not affect your ability to receive care and 
treatment at our clinic/care coordination site/agency. 
 
If you decide to participate in the study you will be given a $50 gift card for your 
time.   
 
Does this sound like a study in which you would like to participate? 
 
If prospective participant responds 
yes: 
 
If prospective participant 
responds no: 
 
Okay, may have I permission to give 
Dana your telephone number to 
schedule an interview with you? 
Okay, that is fine. Thank you for 
your time and thank you for 
considering.  
If participant gives permission for PI to call: 
Care provider will call PI and give her the first name only of the woman and 
her preferred telephone number. PI will contact the participant by phone and 
schedule an interview. 
If participant wants to participate in the study, but does not want give 
permission for PI to make direct call: 
Health care provider will give instructions on how to contact researcher.   
 
“Okay, that is fine. If you are still interested in participating you can contact 
Dana at “xxx-xxxx” to schedule an interview. Thank you for your time”. 
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Appendix D 
Procedure for Face-to-Face Recruitment Approach 
 
Clinic or care coordination staff will give PI a list of dates/times that potentially 
eligible clients are scheduled for a clinic or care coordination appointment. 
 
PI will schedule time to be present at the clinic or care coordination site on 
specified dates. 
 
PI will wait in a private room designated by staff for study participants. 
 
Staff responsible for the check-in process will briefly introduce the study 
opportunity to each transgender woman who checks in. 
 
Specifically staff will state the following: 
 
Staff: “Would you be interested in participating in a research study on 
transgender women?” 
 
If participant responds no: 
Okay, that is fine. Thank you for considering. 
 
If prospective participant responds “yes”. 
 
Staff: “Okay, great. After your appointment you will have the opportunity to meet 
with a nurse researcher to talk about your experiences with healthcare utilization. 
Here is a copy of the study flyer and a study information sheet to explain more. 
Once you are done with your visit “____” will escort you to the “___” room for 
your interview. There you will meet with the nurse learn more about the study 
and participate in an interview”. 
 
After participant is escorted to the private meeting room 
 
PI: Hello, my name is Dana and I am a PhD student at Indiana University School 
of Nursing. I am conducting a study on health care use among HIV-positive 
transgender women. Are you interested in volunteering to be in this study? 
 
Participant: yes.  
 
PI: Great, thank you so much. Before we get started I would like to review some 
important information about the study. Will review study information sheet, ask if 
participant has any questions, and then proceed with the interview. 
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Appendix E 
Letter to Eligible Transgender Women 
 
 
DATE 
 
Name 
 
 
Dear                         ,  
 
 
We are writing you to let you know that you are eligible to participate in a 
research study. The purpose of the study is to learn more about the health care 
experiences of transgender women living with HIV. This study is especially 
interested in learning how important social relationships and health care 
encounters impact utilization of care. We believe that this study will help doctors, 
nurses, and care coordinators understand how to improve health care 
experiences and of transgender women.   
 
If you are interested in being in the study, please tell the receptionist or nurse 
that you are interested in hearing more about the study. Dana Hines, a nurse 
researcher from Indiana University School of Nursing, will then come in and meet 
with you to discuss the details of the study. If you chose to participate, you will be 
given a $50 gift card for you time. You may be asked to stay an additional 60-90 
minutes after your clinic appointment to complete the interview.      
 
If you are not interested in participating, then please tell the receptionist or nurse.  
If you decide that you do not want to participate, it will not affect your ability to 
receive care and treatment at our clinic/care coordination site/agency.  
 
Sincerely, 
 
 
 
Clinic or Agency Director or Designee 
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Appendix F 
Demographic Collection Sheet 
 
1. From where did you learn about the study? ____________________ 
 
2. How old are you? ______ 
 
3. Which of the following best describes your gender? 
a. Female 
b. Transgender woman 
c. Gender queer 
4. Which of the following best describes your sexual orientation? 
a. Gay 
b. Bisexual 
c. Heterosexual 
d. Queer 
e. Sexual 
5. What was your sex at birth? ________________________________ 
 
6. What is the highest grade or level of school you have completed? 
______________ 
7. Which of the following best describes your race? 
a. Black or African American 
b. White 
c. American Indian or Alaskan Native 
d. Native Hawaiian or Pacific Islander 
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8. Which of the following best describes your ethnicity? 
a. Hispanic 
b. Non-Hispanic 
c. Asian 
9. Which of the following best describes where you live? 
a. City (urban area) 
b. Country (rural area) 
10. What is your zip code?_______________ 
11. Do you have any children?  
a. Yes    
b. No 
12. Are you presently in a relationship?   
a. Yes 
b. No  
 
13. If you answered yes to above, for how long have you been partnered? 
_________ 
 
14. Are you employed? 
 
a. Yes 
b. No 
 
15. If you answered yes to the above, please describe the type of work that you 
do. 
________________________________________________________________
________________________________________________________________  
16. Do you have health insurance?  
a. Yes 
b. No 
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17. If you answered yes to the question above, please describe what kind? 
_____________________________________________________________ 
 
 
 
 
18. Have you ever had any major surgeries?  
 
a. Yes  
b. No 
If you answered yes to above, please list: 
__________________________________________________________ 
__________________________________________________________ 
19. Please list any other health problems or concerns below: 
________________________________________________________________ 
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Appendix G 
Semi-Structured Interview Guide and Script 
 
1. Introduction: Thank you for taking the time to talk to me today. I really 
appreciate your willingness to help me out with this interview. Have you ever 
been interviewed before? Well, the main reason why I would like to interview you 
is to learn about your experiences with getting into and staying in care after 
learned that you were HIV positive. Findings from this study will be used to help 
doctors, nurses, social workers, and others better understand the unique 
experiences of transgender women with seeking, entering, and remaining in HIV 
care. Before we begin the interview would you mind completing this demographic 
data collection sheet for me? This information will be used to provide an overall 
description of the women who participated in this study. Please do not write your 
name on the form. After we complete the interview the information on this form 
will be entered into a secured data file and the paper copy destroyed.  
 
2. Interviewee Role: I want you to feel that this is your interview. I am here to 
listen to what you have to say. I am very interested in your experiences and 
feelings, so please feel free to share anything that comes to mind. My job is to 
listen to you so that I can better understand these experiences. 
 
3. Explain Audio Recording Procedures: As I explained when we talked on the 
phone, I will record our conversation so that I do not have to take notes and so I 
can get your complete answer. This also helps me be sure that my report will 
accurately reflect your experiences. In addition to me, the only other person who 
will ever listen to the recording is a professional transcriptionist. After the 
interview is transcribed I will erase it within a week. Is this okay with you?  
 
4. Assure Interviewee of Confidentiality: Please feel free to speak openly with 
me. Maintaining your privacy is the most important thing to me, and anything you 
say during this interview will be kept private and confidential. I will not include 
your name or any other information that could identify you in my report. Also, if I 
ask you any questions that you do not want to answer, you can just say, “pass”, 
and we will skip those questions. 
 
5. Time Frame of Interview: The interview will last about 90 minutes. If you 
need a break at any time, just let me know. 
 
6. Obtain Informed Consent: Before we begin the interview, I would like to go 
over the study’s informed consent/information form, which describes the study, 
your part in the study, the steps we will take to ensure to your confidentiality, and 
the fact that your participation is voluntary. You can take this written copy of the 
form with you (Wait for the participant to read the information). Do you have any 
questions about the study or the information you read? If not, do you give your 
permission to participate in the study by being interviewed? (If the participant 
agrees, then start the interview). Ok thank you for your help with the study. Do 
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you have any more questions before we start? Ok, then I will begin recording the 
interview now. (Start recorder and record verbal consent prior to asking any 
interview questions)..“We are now recording. Today is…201_. My name is Dana 
Hines. I am a doctoral nursing student at Indiana University Indianapolis. Today I 
have the privilege to be interviewing Ms. Williams (pseudonym). So Ms. Williams, 
I would like to ask your permission to record this interview. A professional 
transcriptionist will transcribe the recording from the interview and I will use the 
recording and the transcription for study and research purposes. The tape 
recording will be destroyed within a week. I will need this amount of time to verify 
or double check the recording against the typed copy of your interview. (If verbal 
consent is given and audio recorded, proceed with the interview.)   
 
Main Interview Questions 
Thank you for completing the demographic data sheet for me. First I would like 
for us to begin with some background questions so that I can get to know more 
about you before we talk about your experiences with HIV care. Afterwards, I 
will ask you some questions about your experiences with testing HIV positive, 
seeking care after finding out you had HIV, getting into care, and then staying in 
care. I just want to get as full a picture as I can of your experiences in your own 
words. Please know that I want to learn as much as I can about these important 
experiences of yours, but I do not want you to feel any pressure to answer any 
questions that make you feel uncomfortable. Just let me know if I ask a question 
that you would rather not answer and we will move on to the next one. Does that 
sound okay? Do you have any questions before we move on?   
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Study Aims Opening Question Potential Follow-Up 
Questions (probes) 
Life as a 
transgender woman 
About what age were you 
when you began to think 
of yourself or feel as 
though you were a girl (or 
woman)? 
1. How and when did 
you begin the transition? 
2. Was there 
someone that you 
confided in or talked to 
during this time? 
3. How did you come 
to accept that you were 
transgender? 
4. How has/does 
being transgendered 
effect how you go about 
day to day living? 
5. Have there been 
(or are there) times when 
you did not feel safe 
because you were 
transgendered? Can you 
explain more about what 
happened? 
Testing HIV Positive Tell me about the time 
when you first learned that 
you were HIV-positive. 
 
1. How did you cope 
with the news? 
2. How are you coping 
now? 
3. Who or what was 
helpful to you during that 
time?  
4. What about now? 
From where do you get 
the support that you 
need? 
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HIV Care Seeking Please tell me about your 
experience of getting into 
care after first learning that 
you were HIV positive. 
 
 
6. Did you seek care 
right away? 
7. Did anyone 
encourage you to seek 
care or is this something 
that you did on your own? 
8. Can you describe 
for me what was 
happening in your life at 
the time you decided to 
seek care? 
9. (a) What led to you 
to seek care the first 
time? Or 4 (b) If you were 
not getting care, but then 
did, what led you to that 
point? 
10. Can you tell me 
about any other types of 
health care that you have 
sought since learning that 
you were HIV positive? 
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HIV Care Entry Talk to me about your 
transition into care. 
 
 
Some people first see a 
HIV care coordinator or 
support person before 
seeing a doctor or nurse.  
If you met with a support 
provider first, please start 
with that experience and 
then move on to when 
and if you have ever seen 
a medical care provider 
(also allow potential 
probes for the reverse 
process to occur or no 
support provider). 
1. Did you enter care 
right away or was there a 
delay?  Can you explain 
more about what 
happened and what it 
was like for you? How is it 
for you now? 
2. In thinking about 
your experience of 
entering or getting 
connected to HIV care, 
can you describe for me 
what went well? What did 
not go well, if anything?  
3. Did anything get in 
the way of you getting 
into care? 
4. How did you get 
connected to your current 
care coordination site?  
5. What about your 
HIV doctor or nurse 
practitioner? How did you 
get connected to him or 
her?  
6. Were there other 
medical providers or 
conditions that affected 
your decision to seek 
care? 
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Remaining 
engaged in HIV 
care 
Talk to me about your 
experiences with 
continuing or discontinuing 
HIV care. 
Some people enter HIV, 
have an initial medical 
visit and never return to 
care. Other people 
remain in care for long 
periods of time. 
1. Have you stayed in 
care the entire time since 
being diagnosed with 
HIV? Or, have you ever 
stopped going to see the 
doctor or nurse? 
2. Can you explain 
more about what 
happened to make you 
stay in care? Or, how 
long did you stay out of 
care?  
3. How is being in 
care for you now? 
Have you been told that 
you needed to take 
medication for HIV? (a) 
What is taking medication 
like for you?  
Social 
relationships 
Who are the people in 
your life with whom you 
discuss important 
matters? 
 
1. What sort of 
matters do you discuss 
with them? 
2. How would 
describe your relationship 
with this person? 
3. In what ways did 
these individuals help you 
in your decision to seek, 
enter and remain 
engaged in care? 
In what ways were they 
not so helpful to you 
during these processes? 
Health care 
encounters 
Now I would like you to tell 
me about the nurses, 
doctors, care coordinators 
and other support people 
that you have met 
throughout your time of 
living with HIV.  
4. Letter to Eligible 
Transgender 
Women_11.9.13 
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Closing Questions 
We are almost finished. Thank you again for sharing your experiences with 
me. One final question before we end, do you have anything else you would 
like to share with me about your experiences with seeking care, entering into 
care, and/or staying in care? Is there anything you would say to other 
transgender women who are seeking care for HIV? How about folks who 
provide services to transgender women? Would you have anything to share 
with them?     
 
9. Thank you 
That is it for the interview. The information you have shared with me has been 
very helpful. If you have any other questions or just want to talk about the 
interview experience, please feel free to give me a call. [Will leave flyers for 
snowball sampling and a HIV prevention and transgender health resource 
packet.] 
 
10. Provide Compensation  
Thank you again for taking the time to come and talk to me about your 
experiences. Here is the gift card that I mentioned as a way of saying thank 
you for taking the time to participate. 
  
 
 
176 
Appendix H 
Social Network Map 
 
The following data collection tool will be used to generate names of 
important people in the women’s social network. Specifically the women will be 
asked to list the names of the people with whom they discuss issues related to 
their transgender identity, HIV, health care and other important social and health 
issues. This tool will also be used to generate discussions about how each 
person influenced their care utilization.  
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Appendix I 
Trans-friendly Health Care Encounters 
 
The Trans-friendly Health Care Encounters Wheel will be used to 
generate qualities and characteristics that the women find to be helpful to them 
entering care, remaining in care, and those qualities that they find to be 
respectful to their transgender identity and qualities that they prefer in their 
healthcare team. 
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Appendix J  
Recruitment Flyers
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